森田 智視

最終更新日時: 2019/06/21 20:04:37

印刷する

氏名(漢字/フリガナ/アルファベット表記)
森田 智視/モリタ サトシ/Morita, Satoshi
所属部署・職名(部局/所属/講座等/職名)
医学部附属病院/臨床研究総合センター/教授
学部兼担
部局 所属 講座等 職名
医学部
電子メールアドレス
メールアドレス
smorita @ kuhp.kyoto-u.ac.jp
取得学位
学位名(日本語) 学位名(英語) 大学(日本語) 大学(英語) 取得区分
博士(保健学) 東京大学
researchmap URL
https://researchmap.jp/7000002723
研究テーマ
(日本語)
ベイズ流統計手法 臨床試験デザイン 臨床試験におけるアダプティブディシジョンメイキング
(英語)
Bayesian statistical methods Clinical trial designs Adaptive decision making in clinical trials
研究概要
(日本語)
医学統計学とバイオインフォマティックスを通じて早期臨床開発から臨床研究までを連動的にサポートするための研究活動を行っています。医学統計ではベイズ流統計に基づいた新規臨床試験デザイン開発を行います。ゲノム情報などのバイオマーカーデータを新治療法開発(効果予測因子探索など)に活用するためのバイオインフォマティックス研究にも積極的に取り組みます。また、患者quality of lifeをはじめとするpatient-reported outcomesの評価法とデータ解析法に関する研究も行います。医学研究者とのコラボレーションの中で議論した問題点の解決を大きなモティベーションとしてこれらの研究活動を積極的に推進しています。
(英語)
Our research interests are on study designs and data analysis of early to late phase clinical trials. In biomedical statistics, we are mainly focusing on developing new Bayesian approaches. In bioinformatics, we are performing collaborative research projects to find useful markers to predict the treatment effect. Furthermore, we are also interested in patient-reported outcome researches, e.g., quality of life assessment of cancer patients.
研究分野(キーワード)
キーワード(日本語) キーワード(英語)
医学統計学 Medical statistics
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
M. Nakamura; S. Nanto; A. Hirayama; T. Takayama; M. Nishikawa; K. Kimura; S. Morita; T. Aizawa; R. Asano; Y. Matsumaru; C. Hamada; T. Isshiki M. Nakamura; S. Nanto; A. Hirayama; T. Takayama; M. Nishikawa; K. Kimura; S. Morita; T. Aizawa; R. Asano; Y. Matsumaru; C. Hamada; T. Isshiki M. Nakamura; S. Nanto; A. Hirayama; T. Takayama; M. Nishikawa; K. Kimura; S. Morita; T. Aizawa; R. Asano; Y. Matsumaru; C. Hamada; T. Isshiki Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): Study design and rationale Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): Study design and rationale Optimal duration of dual antiplatelet therapy following treatment with the endeavor zotarolimus-eluting stent in real-world Japanese patients with coronary artery disease (OPERA): Study design and rationale Catheterization and Cardiovascular Interventions Catheterization and Cardiovascular Interventions Catheterization and Cardiovascular Interventions 2014 英語 公開
T. Yoshikawa; K. Tanabe; K. Nishikawa; Y. Ito; T. Matsui; Y. Kimura; N. Hirabayashi; S. Mikata; M. Iwahashi; R. Fukushima; N. Takiguchi; I. Miyashiro; S. Morita; Y. Miyashita; A. Tsuburaya; J. Sakamoto T. Yoshikawa; K. Tanabe; K. Nishikawa; Y. Ito; T. Matsui; Y. Kimura; N. Hirabayashi; S. Mikata; M. Iwahashi; R. Fukushima; N. Takiguchi; I. Miyashiro; S. Morita; Y. Miyashita; A. Tsuburaya; J. Sakamoto T. Yoshikawa; K. Tanabe; K. Nishikawa; Y. Ito; T. Matsui; Y. Kimura; N. Hirabayashi; S. Mikata; M. Iwahashi; R. Fukushima; N. Takiguchi; I. Miyashiro; S. Morita; Y. Miyashita; A. Tsuburaya; J. Sakamoto Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: Early results of the randomized phase II COMPASS trial Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: Early results of the randomized phase II COMPASS trial Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: Early results of the randomized phase II COMPASS trial Annals of Surgical Oncology, 21, 1, 213-219 Annals of Surgical Oncology, 21, 1, 213-219 Annals of Surgical Oncology, 21, 1, 213-219 2014 英語 公開
T. Iwasawa; T. Ogura; F. Sakai; T. Kanauchi; T. Komagata; T. Baba; T. Gotoh; S. Morita; T. Yazawa; T. Inoue T. Iwasawa; T. Ogura; F. Sakai; T. Kanauchi; T. Komagata; T. Baba; T. Gotoh; S. Morita; T. Yazawa; T. Inoue T. Iwasawa; T. Ogura; F. Sakai; T. Kanauchi; T. Komagata; T. Baba; T. Gotoh; S. Morita; T. Yazawa; T. Inoue CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis CT analysis of the effect of pirfenidone in patients with idiopathic pulmonary fibrosis European Journal of Radiology, 83, 1, 32-38 European Journal of Radiology, 83, 1, 32-38 European Journal of Radiology, 83, 1, 32-38 2014 英語 公開
N. Horita; M. Yomota; M. Sasaki; S. Morita; M. Shinkai; Y. Ishigatsubo; T. Kaneko N. Horita; M. Yomota; M. Sasaki; S. Morita; M. Shinkai; Y. Ishigatsubo; T. Kaneko N. Horita; M. Yomota; M. Sasaki; S. Morita; M. Shinkai; Y. Ishigatsubo; T. Kaneko Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients Evaluation of the chronic obstructive pulmonary disease assessment test in Japanese outpatients Clinical Respiratory Journal Clinical Respiratory Journal Clinical Respiratory Journal 2014 英語 公開
K. Misawa; Y. Mochizuki; N. Ohashi; T. Matsui; H. Nakayama; K. Tsuboi; M. Sakai; S. Ito; S. Morita; Y. Kodera K. Misawa; Y. Mochizuki; N. Ohashi; T. Matsui; H. Nakayama; K. Tsuboi; M. Sakai; S. Ito; S. Morita; Y. Kodera K. Misawa; Y. Mochizuki; N. Ohashi; T. Matsui; H. Nakayama; K. Tsuboi; M. Sakai; S. Ito; S. Morita; Y. Kodera A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study A randomized phase III trial exploring the prognostic value of extensive intraoperative peritoneal lavage in addition to standard treatment for resectable advanced gastric cancer: CCOG 1102 study Japanese Journal of Clinical Oncology, 44, 1, 101-103 Japanese Journal of Clinical Oncology, 44, 1, 101-103 Japanese Journal of Clinical Oncology, 44, 1, 101-103 2014 英語 公開
Y. Hattori; M. Satouchi; N. Katakami; S. Fujita; R. Kaji; A. Hata; Y. Urata; T. Shimada; J. Uchida; K. Tomii; S. Morita; S. Negoro Y. Hattori; M. Satouchi; N. Katakami; S. Fujita; R. Kaji; A. Hata; Y. Urata; T. Shimada; J. Uchida; K. Tomii; S. Morita; S. Negoro Y. Hattori; M. Satouchi; N. Katakami; S. Fujita; R. Kaji; A. Hata; Y. Urata; T. Shimada; J. Uchida; K. Tomii; S. Morita; S. Negoro A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001) A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001) A phase II study of pemetrexed in patients with previously heavily treated non-squamous non-small cell lung cancer (HANSHIN Oncology Group 001) Cancer Chemotherapy and Pharmacology, 73, 1, 17-23 Cancer Chemotherapy and Pharmacology, 73, 1, 17-23 Cancer Chemotherapy and Pharmacology, 73, 1, 17-23 2014 英語 公開
N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego shortness of breath questionnaire Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego shortness of breath questionnaire Small, moderate, and large changes, and the minimum clinically important difference in the University of California, San Diego shortness of breath questionnaire COPD: Journal of Chronic Obstructive Pulmonary Disease, 11, 1, 26-32 COPD: Journal of Chronic Obstructive Pulmonary Disease, 11, 1, 26-32 COPD: Journal of Chronic Obstructive Pulmonary Disease, 11, 1, 26-32 2014 英語 公開
M. Shimada; Y. Morine; H. Nagano; E. Hatano; T. Kaiho; M. Miyazaki; T. Kono; T. Kamiyama; S. Morita; J. Sakamoto; M. Kusano; S. Saji; T. Kanematsu; M. Kitajima M. Shimada; Y. Morine; H. Nagano; E. Hatano; T. Kaiho; M. Miyazaki; T. Kono; T. Kamiyama; S. Morita; J. Sakamoto; M. Kusano; S. Saji; T. Kanematsu; M. Kitajima M. Shimada; Y. Morine; H. Nagano; E. Hatano; T. Kaiho; M. Miyazaki; T. Kono; T. Kamiyama; S. Morita; J. Sakamoto; M. Kusano; S. Saji; T. Kanematsu; M. Kitajima Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001) Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001) Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001) International Journal of Clinical Oncology, 1-10 International Journal of Clinical Oncology, 1-10 International Journal of Clinical Oncology, 1-10 2014 英語 公開
T. Yoshikawa; K. Tanabe; K. Nishikawa; Y. Ito; T. Matsui; Y. Kimura; S. Hasegawa; T. Aoyama; T. Hayashi; S. Morita; Y. Miyashita; A. Tsuburaya; J. Sakamoto T. Yoshikawa; K. Tanabe; K. Nishikawa; Y. Ito; T. Matsui; Y. Kimura; S. Hasegawa; T. Aoyama; T. Hayashi; S. Morita; Y. Miyashita; A. Tsuburaya; J. Sakamoto T. Yoshikawa; K. Tanabe; K. Nishikawa; Y. Ito; T. Matsui; Y. Kimura; S. Hasegawa; T. Aoyama; T. Hayashi; S. Morita; Y. Miyashita; A. Tsuburaya; J. Sakamoto Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study Accuracy of CT Staging of Locally Advanced Gastric Cancer after Neoadjuvant Chemotherapy: Cohort Evaluation within a Randomized Phase II Study Annals of Surgical Oncology, 1-5 Annals of Surgical Oncology, 1-5 Annals of Surgical Oncology, 1-5 2014 英語 公開
M. Toyoda; T. Ajiki; Y. Fujiwara; H. Nagano; S. Kobayashi; D. Sakai; E. Hatano; M. Kanai; S. Nakamori; A. Miyamoto; A. Tsuji; S. Kaihara; H. Ikoma; S. Takemura; H. Toyokawa; H. Terajima; S. Morita; T. Ioka M. Toyoda; T. Ajiki; Y. Fujiwara; H. Nagano; S. Kobayashi; D. Sakai; E. Hatano; M. Kanai; S. Nakamori; A. Miyamoto; A. Tsuji; S. Kaihara; H. Ikoma; S. Takemura; H. Toyokawa; H. Terajima; S. Morita; T. Ioka M. Toyoda; T. Ajiki; Y. Fujiwara; H. Nagano; S. Kobayashi; D. Sakai; E. Hatano; M. Kanai; S. Nakamori; A. Miyamoto; A. Tsuji; S. Kaihara; H. Ikoma; S. Takemura; H. Toyokawa; H. Terajima; S. Morita; T. Ioka Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004) Cancer Chemotherapy and Pharmacology, 1-7 Cancer Chemotherapy and Pharmacology, 1-7 Cancer Chemotherapy and Pharmacology, 1-7 2014 英語 公開
M. Takada; H. Ishiguro; S. Nagai; S. Ohtani; H. Kawabata; Y. Yanagita; Y. Hozumi; C. Shimizu; S. Takao; N. Sato; Y. Kosaka; Y. Sagara; H. Iwata; S. Ohno; K. Kuroi; N. Masuda; H. Yamashiro; M. Sugimoto; M. Kondo; Y. Naito; H. Sasano; T. Inamoto; S. Morita; M. Toi M. Takada; H. Ishiguro; S. Nagai; S. Ohtani; H. Kawabata; Y. Yanagita; Y. Hozumi; C. Shimizu; S. Takao; N. Sato; Y. Kosaka; Y. Sagara; H. Iwata; S. Ohno; K. Kuroi; N. Masuda; H. Yamashiro; M. Sugimoto; M. Kondo; Y. Naito; H. Sasano; T. Inamoto; S. Morita; M. Toi M. Takada; H. Ishiguro; S. Nagai; S. Ohtani; H. Kawabata; Y. Yanagita; Y. Hozumi; C. Shimizu; S. Takao; N. Sato; Y. Kosaka; Y. Sagara; H. Iwata; S. Ohno; K. Kuroi; N. Masuda; H. Yamashiro; M. Sugimoto; M. Kondo; Y. Naito; H. Sasano; T. Inamoto; S. Morita; M. Toi Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) Survival of HER2-positive primary breast cancer patients treated by neoadjuvant chemotherapy plus trastuzumab: a multicenter retrospective observational study (JBCRG-C03 study) Breast Cancer Research and Treatment Breast Cancer Research and Treatment Breast Cancer Research and Treatment 2014 英語 公開
N. Horita; N. Miyazawa; T. Yoshiyama; T. Sato; M. Yamamoto; K. Tomaru; M. Masuda; K. Tashiro; M. Sasaki; S. Morita; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; T. Yoshiyama; T. Sato; M. Yamamoto; K. Tomaru; M. Masuda; K. Tashiro; M. Sasaki; S. Morita; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; T. Yoshiyama; T. Sato; M. Yamamoto; K. Tomaru; M. Masuda; K. Tashiro; M. Sasaki; S. Morita; T. Kaneko; Y. Ishigatsubo Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan Development and validation of a tuberculosis prognostic score for smear-positive in-patients in Japan International Journal of Tuberculosis and Lung Disease, 17, 1, 54-60+i-ii International Journal of Tuberculosis and Lung Disease, 17, 1, 54-60+i-ii International Journal of Tuberculosis and Lung Disease, 17, 1, 54-60+i-ii 2013 英語 公開
A. Inoue; K. Kobayashi; M. Maemondo; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; M. Harada; H. Yoshizawa; I. Kinoshita; Y. Fujita; S. Okinaga; H. Hirano; K. Yoshimori; T. Harada; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa A. Inoue; K. Kobayashi; M. Maemondo; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; M. Harada; H. Yoshizawa; I. Kinoshita; Y. Fujita; S. Okinaga; H. Hirano; K. Yoshimori; T. Harada; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa A. Inoue; K. Kobayashi; M. Maemondo; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; M. Harada; H. Yoshizawa; I. Kinoshita; Y. Fujita; S. Okinaga; H. Hirano; K. Yoshimori; T. Harada; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Annals of Oncology, 24, 1, 54-59 Annals of Oncology, 24, 1, 54-59 Annals of Oncology, 24, 1, 54-59 2013 英語 公開
S. Hasegawa; Y. Yamamoto; M. Taguri; S. Morita; T. Sato; R. Yamada; T. Oshima; N. Yukawa; T. Yoshikawa; Y. Rino; T. Imada; M. Masuda S. Hasegawa; Y. Yamamoto; M. Taguri; S. Morita; T. Sato; R. Yamada; T. Oshima; N. Yukawa; T. Yoshikawa; Y. Rino; T. Imada; M. Masuda S. Hasegawa; Y. Yamamoto; M. Taguri; S. Morita; T. Sato; R. Yamada; T. Oshima; N. Yukawa; T. Yoshikawa; Y. Rino; T. Imada; M. Masuda A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer A randomized phase II trial of omentum-preserving gastrectomy for advanced gastric cancer Japanese Journal of Clinical Oncology, 43, 2, 214-216 Japanese Journal of Clinical Oncology, 43, 2, 214-216 Japanese Journal of Clinical Oncology, 43, 2, 214-216 2013 英語 公開
M. Morimoto; K. Numata; M. Kondo; S. Moriya; S. Morita; S. Maeda; K. Tanaka M. Morimoto; K. Numata; M. Kondo; S. Moriya; S. Morita; S. Maeda; K. Tanaka M. Morimoto; K. Numata; M. Kondo; S. Moriya; S. Morita; S. Maeda; K. Tanaka Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study Radiofrequency ablation combined with transarterial chemoembolization for subcapsular hepatocellular carcinoma: A prospective cohort study European Journal of Radiology, 82, 3, 497-503 European Journal of Radiology, 82, 3, 497-503 European Journal of Radiology, 82, 3, 497-503 2013 英語 公開
N. Sakane; K. Kotani; K. Takahashi; Y. Sano; K. Tsuzaki; K. Okazaki; J. Sato; S. Suzuki; S. Morita; K. Izumi; M. Kato; N. Ishizuka; M. Noda; H. Kuzuya N. Sakane; K. Kotani; K. Takahashi; Y. Sano; K. Tsuzaki; K. Okazaki; J. Sato; S. Suzuki; S. Morita; K. Izumi; M. Kato; N. Ishizuka; M. Noda; H. Kuzuya N. Sakane; K. Kotani; K. Takahashi; Y. Sano; K. Tsuzaki; K. Okazaki; J. Sato; S. Suzuki; S. Morita; K. Izumi; M. Kato; N. Ishizuka; M. Noda; H. Kuzuya Japan Diabetes Outcome Intervention Trial-1(J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: Rationale, design, and recruitment Japan Diabetes Outcome Intervention Trial-1(J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: Rationale, design, and recruitment Japan Diabetes Outcome Intervention Trial-1(J-DOIT1), a nationwide cluster randomized trial of type 2 diabetes prevention by telephone-delivered lifestyle support for high-risk subjects detected at health checkups: Rationale, design, and recruitment BMC Public Health, 13, 1 BMC Public Health, 13, 1 BMC Public Health, 13, 1 2013 英語 公開
T. Kikuchi; H. Tan; T. Mihara; K. Uchimoto; D. Mitsushima; K. Takase; S. Morita; T. Goto; T. Andoh; Y. Kamiya T. Kikuchi; H. Tan; T. Mihara; K. Uchimoto; D. Mitsushima; K. Takase; S. Morita; T. Goto; T. Andoh; Y. Kamiya T. Kikuchi; H. Tan; T. Mihara; K. Uchimoto; D. Mitsushima; K. Takase; S. Morita; T. Goto; T. Andoh; Y. Kamiya Effects of volatile anesthetics on the circadian rhythms of rat hippocampal acetylcholine release and locomotor activity Effects of volatile anesthetics on the circadian rhythms of rat hippocampal acetylcholine release and locomotor activity Effects of volatile anesthetics on the circadian rhythms of rat hippocampal acetylcholine release and locomotor activity Neuroscience, 237, 151-160 Neuroscience, 237, 151-160 Neuroscience, 237, 151-160 2013 英語 公開
T. Hayashi; T. Yoshikawa; K. Bonam; H.M. Sue-Ling; M. Taguri; S. Morita; A. Tsuburaya; J.D. Hayden; H.I. Grabsch T. Hayashi; T. Yoshikawa; K. Bonam; H.M. Sue-Ling; M. Taguri; S. Morita; A. Tsuburaya; J.D. Hayden; H.I. Grabsch T. Hayashi; T. Yoshikawa; K. Bonam; H.M. Sue-Ling; M. Taguri; S. Morita; A. Tsuburaya; J.D. Hayden; H.I. Grabsch The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort: Comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort: Comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom The superiority of the seventh edition of the TNM classification depends on the overall survival of the patient cohort: Comparative analysis of the sixth and seventh TNM editions in patients with gastric cancer from Japan and the United Kingdom Cancer, 119, 7, 1330-1337 Cancer, 119, 7, 1330-1337 Cancer, 119, 7, 1330-1337 2013 英語 公開
M. Konishi; S. Sugiyama; K. Sugamura; T. Nozaki; K. Ohba; J. Matsubara; K. Sakamoto; Y. Nagayoshi; H. Sumida; E. Akiyama; Y. Matsuzawa; K. Sakamaki; S. Morita; K. Kimura; S. Umemura; H. Ogawa M. Konishi; S. Sugiyama; K. Sugamura; T. Nozaki; K. Ohba; J. Matsubara; K. Sakamoto; Y. Nagayoshi; H. Sumida; E. Akiyama; Y. Matsuzawa; K. Sakamaki; S. Morita; K. Kimura; S. Umemura; H. Ogawa M. Konishi; S. Sugiyama; K. Sugamura; T. Nozaki; K. Ohba; J. Matsubara; K. Sakamoto; Y. Nagayoshi; H. Sumida; E. Akiyama; Y. Matsuzawa; K. Sakamaki; S. Morita; K. Kimura; S. Umemura; H. Ogawa Basal and Ischemia-Induced Transcardiac Troponin Release into the Coronary Circulation in Patients with Suspected Coronary Artery Disease Basal and Ischemia-Induced Transcardiac Troponin Release into the Coronary Circulation in Patients with Suspected Coronary Artery Disease Basal and Ischemia-Induced Transcardiac Troponin Release into the Coronary Circulation in Patients with Suspected Coronary Artery Disease PLoS ONE, 8, 4 PLoS ONE, 8, 4 PLoS ONE, 8, 4 2013 英語 公開
K.-I. Okada; M. Kawai; K. Uesaka; Y. Kodera; H. Nagano; Y. Murakami; S. Morita; J. Sakamoto; H. Yamaue K.-I. Okada; M. Kawai; K. Uesaka; Y. Kodera; H. Nagano; Y. Murakami; S. Morita; J. Sakamoto; H. Yamaue K.-I. Okada; M. Kawai; K. Uesaka; Y. Kodera; H. Nagano; Y. Murakami; S. Morita; J. Sakamoto; H. Yamaue Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, randomized, placebo-controlled phase II trial (The Japan-PD study) Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, randomized, placebo-controlled phase II trial (The Japan-PD study) Effect of Daikenchuto (TJ-100) on postoperative bowel motility and on prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, randomized, placebo-controlled phase II trial (The Japan-PD study) Japanese Journal of Clinical Oncology, 43, 4, 436-438 Japanese Journal of Clinical Oncology, 43, 4, 436-438 Japanese Journal of Clinical Oncology, 43, 4, 436-438 2013 英語 公開
K. Kadonosono; A. Arakawa; M. Inoue; S. Yamane; E. Uchio; T. Yamakawa; M. Taguri; S. Morita; J.R. Ridgeley; Y. Yanagi K. Kadonosono; A. Arakawa; M. Inoue; S. Yamane; E. Uchio; T. Yamakawa; M. Taguri; S. Morita; J.R. Ridgeley; Y. Yanagi K. Kadonosono; A. Arakawa; M. Inoue; S. Yamane; E. Uchio; T. Yamakawa; M. Taguri; S. Morita; J.R. Ridgeley; Y. Yanagi Internal limiting membrane contrast after staining with indocyanine green and brilliant blue G during macular surgery Internal limiting membrane contrast after staining with indocyanine green and brilliant blue G during macular surgery Internal limiting membrane contrast after staining with indocyanine green and brilliant blue G during macular surgery Retina, 33, 4, 812-817 Retina, 33, 4, 812-817 Retina, 33, 4, 812-817 2013 英語 公開
K. Oba; X. Paoletti; Y.-J. Bang; H. Bleiberg; T. Burzykowski; N. Fuse; S. Michiels; S. Morita; Y. Ohashi; J.-P. Pignon; P. Rougier; J. Sakamoto; D. Sargent; M. Sasako; K. Shitara; A. Tsuburaya; E. Van Cutsem; M. Buyse K. Oba; X. Paoletti; Y.-J. Bang; H. Bleiberg; T. Burzykowski; N. Fuse; S. Michiels; S. Morita; Y. Ohashi; J.-P. Pignon; P. Rougier; J. Sakamoto; D. Sargent; M. Sasako; K. Shitara; A. Tsuburaya; E. Van Cutsem; M. Buyse K. Oba; X. Paoletti; Y.-J. Bang; H. Bleiberg; T. Burzykowski; N. Fuse; S. Michiels; S. Morita; Y. Ohashi; J.-P. Pignon; P. Rougier; J. Sakamoto; D. Sargent; M. Sasako; K. Shitara; A. Tsuburaya; E. Van Cutsem; M. Buyse Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis Role of chemotherapy for advanced/recurrent gastric cancer: An individual-patient-data meta-analysis European Journal of Cancer, 49, 7, 1565-1577 European Journal of Cancer, 49, 7, 1565-1577 European Journal of Cancer, 49, 7, 1565-1577 2013 英語 公開
T. Miyatake; Y. Ueda; A. Morimoto; T. Enomoto; S. Nishida; T. Shirakata; Y. Oka; A. Tsuboi; Y. Oji; N. Hosen; S.-I. Nakatsuka; S. Morita; J. Sakamoto; H. Sugiyama; T. Kimura T. Miyatake; Y. Ueda; A. Morimoto; T. Enomoto; S. Nishida; T. Shirakata; Y. Oka; A. Tsuboi; Y. Oji; N. Hosen; S.-I. Nakatsuka; S. Morita; J. Sakamoto; H. Sugiyama; T. Kimura T. Miyatake; Y. Ueda; A. Morimoto; T. Enomoto; S. Nishida; T. Shirakata; Y. Oka; A. Tsuboi; Y. Oji; N. Hosen; S.-I. Nakatsuka; S. Morita; J. Sakamoto; H. Sugiyama; T. Kimura WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: A phase II trial WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: A phase II trial WT1 peptide immunotherapy for gynecologic malignancies resistant to conventional therapies: A phase II trial Journal of Cancer Research and Clinical Oncology, 139, 3, 457-463 Journal of Cancer Research and Clinical Oncology, 139, 3, 457-463 Journal of Cancer Research and Clinical Oncology, 139, 3, 457-463 2013 英語 公開
Y. Kanda; J. Kanda; Y. Atsuta; Y. Maeda; T. Ichinohe; K. Ohashi; T. Fukuda; K. Miyamura; H. Iida; T. Mori; K. Iwato; T. Eto; K. Kawa; S. Morita; Y. Morishima Y. Kanda; J. Kanda; Y. Atsuta; Y. Maeda; T. Ichinohe; K. Ohashi; T. Fukuda; K. Miyamura; H. Iida; T. Mori; K. Iwato; T. Eto; K. Kawa; S. Morita; Y. Morishima Y. Kanda; J. Kanda; Y. Atsuta; Y. Maeda; T. Ichinohe; K. Ohashi; T. Fukuda; K. Miyamura; H. Iida; T. Mori; K. Iwato; T. Eto; K. Kawa; S. Morita; Y. Morishima Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow Impact of a single human leucocyte antigen (HLA) allele mismatch on the outcome of unrelated bone marrow transplantation over two time periods. A retrospective analysis of 3003 patients from the HLA Working Group of the Japan Society for Blood and Marrow British Journal of Haematology, 161, 4, 566-577 British Journal of Haematology, 161, 4, 566-577 British Journal of Haematology, 161, 4, 566-577 2013 英語 公開
H. Yoshioka; I. Okamoto; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; S. Atagi; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; Y. Nakanishi; K. Nakagawa H. Yoshioka; I. Okamoto; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; S. Atagi; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; Y. Nakanishi; K. Nakagawa H. Yoshioka; I. Okamoto; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; S. Atagi; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; Y. Nakanishi; K. Nakagawa Efficacy and safety analysis according to histology for s-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: Updated results of the west japan oncology group lets study Efficacy and safety analysis according to histology for s-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: Updated results of the west japan oncology group lets study Efficacy and safety analysis according to histology for s-1 in combination with carboplatin as first-line chemotherapy in patients with advanced non-small-cell lung cancer: Updated results of the west japan oncology group lets study Annals of Oncology, 24, 5, 1326-1331 Annals of Oncology, 24, 5, 1326-1331 Annals of Oncology, 24, 5, 1326-1331 2013 英語 公開
Y. Matsuzawa; M. Konishi; E. Akiyama; H. Suzuki; N. Nakayama; M. Kiyokuni; S. Sumita; T. Ebina; M. Kosuge; K. Hibi; K. Tsukahara; N. Iwahashi; M. Endo; N. Maejima; K. Saka; K. Hashiba; K. Okada; M. Taguri; S. Morita; S. Sugiyama; H. Ogawa; H. Sashika; S. Umemura; K. Kimura Y. Matsuzawa; M. Konishi; E. Akiyama; H. Suzuki; N. Nakayama; M. Kiyokuni; S. Sumita; T. Ebina; M. Kosuge; K. Hibi; K. Tsukahara; N. Iwahashi; M. Endo; N. Maejima; K. Saka; K. Hashiba; K. Okada; M. Taguri; S. Morita; S. Sugiyama; H. Ogawa; H. Sashika; S. Umemura; K. Kimura Y. Matsuzawa; M. Konishi; E. Akiyama; H. Suzuki; N. Nakayama; M. Kiyokuni; S. Sumita; T. Ebina; M. Kosuge; K. Hibi; K. Tsukahara; N. Iwahashi; M. Endo; N. Maejima; K. Saka; K. Hashiba; K. Okada; M. Taguri; S. Morita; S. Sugiyama; H. Ogawa; H. Sashika; S. Umemura; K. Kimura Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction Association between gait speed as a measure of frailty and risk of cardiovascular events after myocardial infarction Journal of the American College of Cardiology, 61, 19, 1964-1972 Journal of the American College of Cardiology, 61, 19, 1964-1972 Journal of the American College of Cardiology, 61, 19, 1964-1972 2013 英語 公開
T. Shiozawa; J.-I. Tadokoro; T. Fujiki; K. Fujino; K. Kakihata; S. Masatani; S. Morita; A. Gemma; N. Boku T. Shiozawa; J.-I. Tadokoro; T. Fujiki; K. Fujino; K. Kakihata; S. Masatani; S. Morita; A. Gemma; N. Boku T. Shiozawa; J.-I. Tadokoro; T. Fujiki; K. Fujino; K. Kakihata; S. Masatani; S. Morita; A. Gemma; N. Boku Risk factors for severe adverse effects and treatment-related deaths in Japanese patients treated with irinotecan-based chemotherapy: A postmarketing survey Risk factors for severe adverse effects and treatment-related deaths in Japanese patients treated with irinotecan-based chemotherapy: A postmarketing survey Risk factors for severe adverse effects and treatment-related deaths in Japanese patients treated with irinotecan-based chemotherapy: A postmarketing survey Japanese Journal of Clinical Oncology, 43, 5, 483-491 Japanese Journal of Clinical Oncology, 43, 5, 483-491 Japanese Journal of Clinical Oncology, 43, 5, 483-491 2013 英語 公開
A. Takeda; N. Sanuki; T. Eriguchi; T. Kaneko; S. Morita; H. Handa; Y. Aoki; Y. Oku; E. Kunieda A. Takeda; N. Sanuki; T. Eriguchi; T. Kaneko; S. Morita; H. Handa; Y. Aoki; Y. Oku; E. Kunieda A. Takeda; N. Sanuki; T. Eriguchi; T. Kaneko; S. Morita; H. Handa; Y. Aoki; Y. Oku; E. Kunieda Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer International Journal of Radiation Oncology Biology Physics, 86, 2, 257-263 International Journal of Radiation Oncology Biology Physics, 86, 2, 257-263 International Journal of Radiation Oncology Biology Physics, 86, 2, 257-263 2013 英語 公開
T. Fukui; M. Tabata; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Morita; S. Takanashi Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Early and long-term outcomes of coronary artery bypass grafting in patients with acute coronary syndrome versus stable angina pectoris Journal of Thoracic and Cardiovascular Surgery, 145, 6, 1577-1583.e1 Journal of Thoracic and Cardiovascular Surgery, 145, 6, 1577-1583.e1 Journal of Thoracic and Cardiovascular Surgery, 145, 6, 1577-1583.e1 2013 英語 公開
N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: A propensity score matching study Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: A propensity score matching study Long-acting beta-agonists reduce mortality of patients with severe and very severe chronic obstructive pulmonary disease: A propensity score matching study Respiratory Research, 14, 1 Respiratory Research, 14, 1 Respiratory Research, 14, 1 2013 英語 公開
Y. Urata; I. Okamoto; M. Takeda; Y. Hattori; K. Okuno; T. Shimada; T. Kurata; H. Kaneda; M. Miyazaki; M. Terashima; K. Tanaka; S. Morita; K. Nakagawa; S. Negoro; M. Satouchi Y. Urata; I. Okamoto; M. Takeda; Y. Hattori; K. Okuno; T. Shimada; T. Kurata; H. Kaneda; M. Miyazaki; M. Terashima; K. Tanaka; S. Morita; K. Nakagawa; S. Negoro; M. Satouchi Y. Urata; I. Okamoto; M. Takeda; Y. Hattori; K. Okuno; T. Shimada; T. Kurata; H. Kaneda; M. Miyazaki; M. Terashima; K. Tanaka; S. Morita; K. Nakagawa; S. Negoro; M. Satouchi Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer Phase 2 study of S-1 and carboplatin plus bevacizumab followed by maintenance S-1 and bevacizumab for chemotherapy-naive patients with advanced nonsquamous non-small cell lung cancer Cancer, 119, 12, 2275-2281 Cancer, 119, 12, 2275-2281 Cancer, 119, 12, 2275-2281 2013 英語 公開
T. Kawahara; S. Morita; H. Ito; H. Terao; R. Sakata; H. Ishiguro; K. Tanaka; H. Miyamoto; J. Matsuzaki; Y. Kubota; H. Uemura T. Kawahara; S. Morita; H. Ito; H. Terao; R. Sakata; H. Ishiguro; K. Tanaka; H. Miyamoto; J. Matsuzaki; Y. Kubota; H. Uemura T. Kawahara; S. Morita; H. Ito; H. Terao; R. Sakata; H. Ishiguro; K. Tanaka; H. Miyamoto; J. Matsuzaki; Y. Kubota; H. Uemura Ramelteon combined with an α<sub>1</sub>-blocker decreases nocturia in men with benign prostatic hyperplasia Ramelteon combined with an α<sub>1</sub>-blocker decreases nocturia in men with benign prostatic hyperplasia Ramelteon combined with an α<sub>1</sub>-blocker decreases nocturia in men with benign prostatic hyperplasia BMC Urology, 13 BMC Urology, 13 BMC Urology, 13 2013 英語 公開
A. Yamada; T. Ishikawa; I. Ota; M. Kimura; D. Shimizu; M. Tanabe; T. Chishima; T. Sasaki; Y. Ichikawa; S. Morita; K.-I. Yoshiura; K. Takabe; I. Endo A. Yamada; T. Ishikawa; I. Ota; M. Kimura; D. Shimizu; M. Tanabe; T. Chishima; T. Sasaki; Y. Ichikawa; S. Morita; K.-I. Yoshiura; K. Takabe; I. Endo A. Yamada; T. Ishikawa; I. Ota; M. Kimura; D. Shimizu; M. Tanabe; T. Chishima; T. Sasaki; Y. Ichikawa; S. Morita; K.-I. Yoshiura; K. Takabe; I. Endo High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival Breast Cancer Research and Treatment, 137, 3, 773-782 Breast Cancer Research and Treatment, 137, 3, 773-782 Breast Cancer Research and Treatment, 137, 3, 773-782 2013 英語 公開
N. Horita; T. Kaneko; M. Shinkai; M. Yomota; S. Morita; B.K.R. Mengr; Y. Ishigatsubo N. Horita; T. Kaneko; M. Shinkai; M. Yomota; S. Morita; B.K.R. Mengr; Y. Ishigatsubo N. Horita; T. Kaneko; M. Shinkai; M. Yomota; S. Morita; B.K.R. Mengr; Y. Ishigatsubo Depression in Japanese patients with chronic obstructive pulmonary disease: A cross-sectional study Depression in Japanese patients with chronic obstructive pulmonary disease: A cross-sectional study Depression in Japanese patients with chronic obstructive pulmonary disease: A cross-sectional study Respiratory Care, 58, 7, 1196-1203 Respiratory Care, 58, 7, 1196-1203 Respiratory Care, 58, 7, 1196-1203 2013 英語 公開
H. Hayashi; I. Okamoto; M. Taguri; S. Morita; K. Nakagawa H. Hayashi; I. Okamoto; M. Taguri; S. Morita; K. Nakagawa H. Hayashi; I. Okamoto; M. Taguri; S. Morita; K. Nakagawa Postprogression survival in patients with advanced non-small-cell lung cancer who receive second-line or third-line chemotherapy Postprogression survival in patients with advanced non-small-cell lung cancer who receive second-line or third-line chemotherapy Postprogression survival in patients with advanced non-small-cell lung cancer who receive second-line or third-line chemotherapy Clinical Lung Cancer, 14, 3, 261-266 Clinical Lung Cancer, 14, 3, 261-266 Clinical Lung Cancer, 14, 3, 261-266 2013 英語 公開
S. Hasegawa; C. Kunisaki; H. Ono; T. Oshima; S. Fujii; M. Taguri; S. Morita; T. Sato; R. Yamada; N. Yukawa; Y. Rino; M. Masuda S. Hasegawa; C. Kunisaki; H. Ono; T. Oshima; S. Fujii; M. Taguri; S. Morita; T. Sato; R. Yamada; N. Yukawa; Y. Rino; M. Masuda S. Hasegawa; C. Kunisaki; H. Ono; T. Oshima; S. Fujii; M. Taguri; S. Morita; T. Sato; R. Yamada; N. Yukawa; Y. Rino; M. Masuda Omentum-preserving gastrectomy for advanced gastric cancer: A propensity-matched retrospective cohort study Omentum-preserving gastrectomy for advanced gastric cancer: A propensity-matched retrospective cohort study Omentum-preserving gastrectomy for advanced gastric cancer: A propensity-matched retrospective cohort study Gastric Cancer, 16, 3, 383-388 Gastric Cancer, 16, 3, 383-388 Gastric Cancer, 16, 3, 383-388 2013 英語 公開
T. Takahashi; Y. Shibata; Y. Tojima; K. Tsuboi; E. Sakamoto; K. Kunieda; H. Matsuoka; K. Suzumura; M. Sato; T. Naganuma; J. Sakamoto; S. Morita; K. Kondo T. Takahashi; Y. Shibata; Y. Tojima; K. Tsuboi; E. Sakamoto; K. Kunieda; H. Matsuoka; K. Suzumura; M. Sato; T. Naganuma; J. Sakamoto; S. Morita; K. Kondo T. Takahashi; Y. Shibata; Y. Tojima; K. Tsuboi; E. Sakamoto; K. Kunieda; H. Matsuoka; K. Suzumura; M. Sato; T. Naganuma; J. Sakamoto; S. Morita; K. Kondo Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study Multicenter phase II study of modified FOLFOX6 as neoadjuvant chemotherapy for patients with unresectable liver-only metastases from colorectal cancer in Japan: ROOF study International Journal of Clinical Oncology, 18, 2, 335-342 International Journal of Clinical Oncology, 18, 2, 335-342 International Journal of Clinical Oncology, 18, 2, 335-342 2013 英語 公開
F. Asano; N. Shinagawa; T. Ishida; J. Shindoh; M. Anzai; A. Tsuzuku; S. Oizumi; S. Morita F. Asano; N. Shinagawa; T. Ishida; J. Shindoh; M. Anzai; A. Tsuzuku; S. Oizumi; S. Morita F. Asano; N. Shinagawa; T. Ishida; J. Shindoh; M. Anzai; A. Tsuzuku; S. Oizumi; S. Morita Virtual bronchoscopic navigation combined with ultrathin bronchoscopy a randomized clinical trial Virtual bronchoscopic navigation combined with ultrathin bronchoscopy a randomized clinical trial Virtual bronchoscopic navigation combined with ultrathin bronchoscopy a randomized clinical trial American Journal of Respiratory and Critical Care Medicine, 188, 3, 327-333 American Journal of Respiratory and Critical Care Medicine, 188, 3, 327-333 American Journal of Respiratory and Critical Care Medicine, 188, 3, 327-333 2013 英語 公開
T. Mihara; K. Tojo; K. Uchimoto; S. Morita; T. Goto T. Mihara; K. Tojo; K. Uchimoto; S. Morita; T. Goto T. Mihara; K. Tojo; K. Uchimoto; S. Morita; T. Goto Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: A systematic review and meta-analysis Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: A systematic review and meta-analysis Reevaluation of the effectiveness of ramosetron for preventing postoperative nausea and vomiting: A systematic review and meta-analysis Anesthesia and Analgesia, 117, 2, 329-339 Anesthesia and Analgesia, 117, 2, 329-339 Anesthesia and Analgesia, 117, 2, 329-339 2013 英語 公開
S. Kako; S. Morita; H. Sakamaki; H. Iida; M. Kurokawa; K. Miyamura; H. Kanamori; M. Hara; N. Kobayashi; Y. Morishima; K. Kawa; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda S. Kako; S. Morita; H. Sakamaki; H. Iida; M. Kurokawa; K. Miyamura; H. Kanamori; M. Hara; N. Kobayashi; Y. Morishima; K. Kawa; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda S. Kako; S. Morita; H. Sakamaki; H. Iida; M. Kurokawa; K. Miyamura; H. Kanamori; M. Hara; N. Kobayashi; Y. Morishima; K. Kawa; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis The role of HLA-matched unrelated transplantation in adult patients with Ph chromosome-negative ALL in first remission. A decision analysis Bone Marrow Transplantation, 48, 8, 1077-1083 Bone Marrow Transplantation, 48, 8, 1077-1083 Bone Marrow Transplantation, 48, 8, 1077-1083 2013 英語 公開
R. Koh; K. Hirasawa; S. Yahara; H. Oka; K. Sugimori; M. Morimoto; K. Numata; A. Kokawa; T. Sasaki; A. Nozawa; M. Taguri; S. Morita; S. Maeda; K. Tanaka R. Koh; K. Hirasawa; S. Yahara; H. Oka; K. Sugimori; M. Morimoto; K. Numata; A. Kokawa; T. Sasaki; A. Nozawa; M. Taguri; S. Morita; S. Maeda; K. Tanaka R. Koh; K. Hirasawa; S. Yahara; H. Oka; K. Sugimori; M. Morimoto; K. Numata; A. Kokawa; T. Sasaki; A. Nozawa; M. Taguri; S. Morita; S. Maeda; K. Tanaka Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms Antithrombotic drugs are risk factors for delayed postoperative bleeding after endoscopic submucosal dissection for gastric neoplasms Gastrointestinal Endoscopy, 78, 3, 476-483 Gastrointestinal Endoscopy, 78, 3, 476-483 Gastrointestinal Endoscopy, 78, 3, 476-483 2013 英語 公開
K. Imoto; K. Uchid; N. Karube; T. Yasutsune; T. Cho; K. Kimur; M. Masuda; S. Morita K. Imoto; K. Uchid; N. Karube; T. Yasutsune; T. Cho; K. Kimur; M. Masuda; S. Morita K. Imoto; K. Uchid; N. Karube; T. Yasutsune; T. Cho; K. Kimur; M. Masuda; S. Morita Risk analysis and improvement of strategies in patients who have acute type a aortic dissection with coronary artery dissection Risk analysis and improvement of strategies in patients who have acute type a aortic dissection with coronary artery dissection Risk analysis and improvement of strategies in patients who have acute type a aortic dissection with coronary artery dissection European Journal of Cardio-thoracic Surgery, 44, 3, 419-425 European Journal of Cardio-thoracic Surgery, 44, 3, 419-425 European Journal of Cardio-thoracic Surgery, 44, 3, 419-425 2013 英語 公開
H. Kawakami; I. Okamoto; H. Hayashi; M. Taguri; S. Morita; K. Nakagawa H. Kawakami; I. Okamoto; H. Hayashi; M. Taguri; S. Morita; K. Nakagawa H. Kawakami; I. Okamoto; H. Hayashi; M. Taguri; S. Morita; K. Nakagawa Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer Postprogression survival for first-line chemotherapy in patients with advanced gastric cancer European Journal of Cancer, 49, 14, 3003-3009 European Journal of Cancer, 49, 14, 3003-3009 European Journal of Cancer, 49, 14, 3003-3009 2013 英語 公開
Y. Shimoyama; A. Nozaki; M. Morimoto; S. Moriya; M. Kondo; H. Fukuda; K. Numata; E. Miyajima; M.S. Oba; M. Taguri; S. Morita; S. Maeda; K. Tanaka Y. Shimoyama; A. Nozaki; M. Morimoto; S. Moriya; M. Kondo; H. Fukuda; K. Numata; E. Miyajima; M.S. Oba; M. Taguri; S. Morita; S. Maeda; K. Tanaka Y. Shimoyama; A. Nozaki; M. Morimoto; S. Moriya; M. Kondo; H. Fukuda; K. Numata; E. Miyajima; M.S. Oba; M. Taguri; S. Morita; S. Maeda; K. Tanaka Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C Effects of IL-28B gene polymorphism on response to peginterferon plus ribavirin combination therapy for genotype 2 chronic hepatitis C Hepatology Research, 43, 9, 919-924 Hepatology Research, 43, 9, 919-924 Hepatology Research, 43, 9, 919-924 2013 英語 公開
Z. Nagashima; K. Tsukahara; S. Morita; T. Endo; T. Sugano; K. Hibi; H. Himeno; K. Fukui; S. Umemura; K. Kimura Z. Nagashima; K. Tsukahara; S. Morita; T. Endo; T. Sugano; K. Hibi; H. Himeno; K. Fukui; S. Umemura; K. Kimura Z. Nagashima; K. Tsukahara; S. Morita; T. Endo; T. Sugano; K. Hibi; H. Himeno; K. Fukui; S. Umemura; K. Kimura Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes Platelet reactivity in the early and late phases of acute coronary syndromes according to cytochrome P450 2C19 phenotypes Journal of Cardiology, 62, 3, 158-164 Journal of Cardiology, 62, 3, 158-164 Journal of Cardiology, 62, 3, 158-164 2013 英語 公開
N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo N. Horita; N. Miyazawa; S. Morita; R. Kojima; N. Kimura; T. Kaneko; Y. Ishigatsubo Preoperative chemotherapy is effective for stage III resectable non-small-cell lung cancer: Metaanalysis of 16 trials Preoperative chemotherapy is effective for stage III resectable non-small-cell lung cancer: Metaanalysis of 16 trials Preoperative chemotherapy is effective for stage III resectable non-small-cell lung cancer: Metaanalysis of 16 trials Clinical Lung Cancer, 14, 5, 488-494 Clinical Lung Cancer, 14, 5, 488-494 Clinical Lung Cancer, 14, 5, 488-494 2013 英語 公開
K. Nishino; F. Imamura; S. Morita; M. Mori; K. Komuta; T. Kijima; Y. Namba; T. Kumagai; S. Yamamoto; I. Tachibana; Y. Nakazawa; J. Uchida; S. Minami; R. Takahashi; Y. Yano; T. Okuyama; A. Kumanogoh K. Nishino; F. Imamura; S. Morita; M. Mori; K. Komuta; T. Kijima; Y. Namba; T. Kumagai; S. Yamamoto; I. Tachibana; Y. Nakazawa; J. Uchida; S. Minami; R. Takahashi; Y. Yano; T. Okuyama; A. Kumanogoh K. Nishino; F. Imamura; S. Morita; M. Mori; K. Komuta; T. Kijima; Y. Namba; T. Kumagai; S. Yamamoto; I. Tachibana; Y. Nakazawa; J. Uchida; S. Minami; R. Takahashi; Y. Yano; T. Okuyama; A. Kumanogoh A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment A retrospective analysis of 335 Japanese lung cancer patients who responded to initial gefitinib treatment Lung Cancer, 82, 2, 299-304 Lung Cancer, 82, 2, 299-304 Lung Cancer, 82, 2, 299-304 2013 英語 公開
Y. Yamada; D. Takahari; H. Matsumoto; H. Baba; M. Nakamura; K. Yoshida; M. Yoshida; S. Iwamoto; K. Shimada; Y. Komatsu; Y. Sasaki; T. Satoh; K. Takahashi; H. Mishima; K. Muro; M. Watanabe; Y. Sakata; S. Morita; Y. Shimada; K. Sugihara Y. Yamada; D. Takahari; H. Matsumoto; H. Baba; M. Nakamura; K. Yoshida; M. Yoshida; S. Iwamoto; K. Shimada; Y. Komatsu; Y. Sasaki; T. Satoh; K. Takahashi; H. Mishima; K. Muro; M. Watanabe; Y. Sakata; S. Morita; Y. Shimada; K. Sugihara Y. Yamada; D. Takahari; H. Matsumoto; H. Baba; M. Nakamura; K. Yoshida; M. Yoshida; S. Iwamoto; K. Shimada; Y. Komatsu; Y. Sasaki; T. Satoh; K. Takahashi; H. Mishima; K. Muro; M. Watanabe; Y. Sakata; S. Morita; Y. Shimada; K. Sugihara Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): An open-label, non-inferiority, randomised phase 3 trial Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): An open-label, non-inferiority, randomised phase 3 trial Leucovorin, fluorouracil, and oxaliplatin plus bevacizumab versus S-1 and oxaliplatin plus bevacizumab in patients with metastatic colorectal cancer (SOFT): An open-label, non-inferiority, randomised phase 3 trial The Lancet Oncology, 14, 13, 1278-1286 The Lancet Oncology, 14, 13, 1278-1286 The Lancet Oncology, 14, 13, 1278-1286 2013 英語 公開
Y. Koyama; T. Andoh; Y. Kamiya; S. Morita; T. Miyazaki; K. Uchimoto; T. Mihara; T. Goto Y. Koyama; T. Andoh; Y. Kamiya; S. Morita; T. Miyazaki; K. Uchimoto; T. Mihara; T. Goto Y. Koyama; T. Andoh; Y. Kamiya; S. Morita; T. Miyazaki; K. Uchimoto; T. Mihara; T. Goto Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits ?-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits ?-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats Bumetanide, an inhibitor of cation-chloride cotransporter isoform 1, inhibits ?-aminobutyric acidergic excitatory actions and enhances sedative actions of midazolam in neonatal rats Anesthesiology, 119, 5, 1096-1108 Anesthesiology, 119, 5, 1096-1108 Anesthesiology, 119, 5, 1096-1108 2013 英語 公開
Y. Hattori; M. Iwasaku; M. Satouchi; A. Nishiyama; Y. Korogi; K. Otsuka; S. Fujita; N. Katakami; M. Mori; K. Nishino; S. Morita; S. Negoro Y. Hattori; M. Iwasaku; M. Satouchi; A. Nishiyama; Y. Korogi; K. Otsuka; S. Fujita; N. Katakami; M. Mori; K. Nishino; S. Morita; S. Negoro Y. Hattori; M. Iwasaku; M. Satouchi; A. Nishiyama; Y. Korogi; K. Otsuka; S. Fujita; N. Katakami; M. Mori; K. Nishino; S. Morita; S. Negoro A phase II study of pemetrexed in chemotherapy-naïve elderly patients aged ≥75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003) A phase II study of pemetrexed in chemotherapy-naïve elderly patients aged ≥75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003) A phase II study of pemetrexed in chemotherapy-naïve elderly patients aged ≥75 years with advanced non-squamous non-small-cell lung cancer (HANSHIN Oncology Group 003) Japanese Journal of Clinical Oncology, 43, 12, 1184-1189 Japanese Journal of Clinical Oncology, 43, 12, 1184-1189 Japanese Journal of Clinical Oncology, 43, 12, 1184-1189 2013 英語 公開
Y. Yamamoto; Y. Tasaki; Y. Kuwada; Y. Ozawa; A. Katayama; Y. Kanemaki; K. Enokido; S. Nakamura; K. Kubouchi; S. Morita; M. Noritake; Y. Nakajima; T. Inoue Y. Yamamoto; Y. Tasaki; Y. Kuwada; Y. Ozawa; A. Katayama; Y. Kanemaki; K. Enokido; S. Nakamura; K. Kubouchi; S. Morita; M. Noritake; Y. Nakajima; T. Inoue Y. Yamamoto; Y. Tasaki; Y. Kuwada; Y. Ozawa; A. Katayama; Y. Kanemaki; K. Enokido; S. Nakamura; K. Kubouchi; S. Morita; M. Noritake; Y. Nakajima; T. Inoue Positron emission mammography (PEM): Reviewing standardized semiquantitative method Positron emission mammography (PEM): Reviewing standardized semiquantitative method Positron emission mammography (PEM): Reviewing standardized semiquantitative method Annals of Nuclear Medicine, 27, 9, 795-801 Annals of Nuclear Medicine, 27, 9, 795-801 Annals of Nuclear Medicine, 27, 9, 795-801 2013 英語 公開
T. Kono; T. Hata; S. Morita; Y. Munemoto; T. Matsui; H. Kojima; H. Takemoto; M. Fukunaga; N. Nagata; M. Shimada; J. Sakamoto; H. Mishima T. Kono; T. Hata; S. Morita; Y. Munemoto; T. Matsui; H. Kojima; H. Takemoto; M. Fukunaga; N. Nagata; M. Shimada; J. Sakamoto; H. Mishima T. Kono; T. Hata; S. Morita; Y. Munemoto; T. Matsui; H. Kojima; H. Takemoto; M. Fukunaga; N. Nagata; M. Shimada; J. Sakamoto; H. Mishima Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): A phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): A phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): A phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy Cancer Chemotherapy and Pharmacology, 72, 6, 1283-1290 Cancer Chemotherapy and Pharmacology, 72, 6, 1283-1290 Cancer Chemotherapy and Pharmacology, 72, 6, 1283-1290 2013 英語 公開
K. Oba; X. Paoletti; S. Alberts; Y.-J. Bang; J. Benedetti; H. Bleiberg; P. Catalano; F. Lordick; S. Michiels; S. Morita; Y. Ohashi; J.-P. Pignon; P. Rougier; M. Sasako; J. Sakamoto; D. Sargent; K. Shitara; E. Van Cutsem; M. Buyse; T. Burzykowski K. Oba; X. Paoletti; S. Alberts; Y.-J. Bang; J. Benedetti; H. Bleiberg; P. Catalano; F. Lordick; S. Michiels; S. Morita; Y. Ohashi; J.-P. Pignon; P. Rougier; M. Sasako; J. Sakamoto; D. Sargent; K. Shitara; E. Van Cutsem; M. Buyse; T. Burzykowski K. Oba; X. Paoletti; S. Alberts; Y.-J. Bang; J. Benedetti; H. Bleiberg; P. Catalano; F. Lordick; S. Michiels; S. Morita; Y. Ohashi; J.-P. Pignon; P. Rougier; M. Sasako; J. Sakamoto; D. Sargent; K. Shitara; E. Van Cutsem; M. Buyse; T. Burzykowski Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: A meta-analysis Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: A meta-analysis Disease-free survival as a surrogate for overall survival in adjuvant trials of gastric cancer: A meta-analysis Journal of the National Cancer Institute, 105, 21, 1600-1607 Journal of the National Cancer Institute, 105, 21, 1600-1607 Journal of the National Cancer Institute, 105, 21, 1600-1607 2013 英語 公開
X. Paoletti; K. Oba; Y.-J. Bang; H. Bleiberg; N. Boku; O. Bouché; P. Catalano; N. Fuse; S. Michiels; M. Moehler; S. Morita; Y. Ohashi; A. Ohtsu; A. Roth; P. Rougier; J. Sakamoto; D. Sargent; M. Sasako; K. Shitara; P. Thuss-Patience; E. Van Cutsem; T. Burzykowski; M. Buyse X. Paoletti; K. Oba; Y.-J. Bang; H. Bleiberg; N. Boku; O. Bouché; P. Catalano; N. Fuse; S. Michiels; M. Moehler; S. Morita; Y. Ohashi; A. Ohtsu; A. Roth; P. Rougier; J. Sakamoto; D. Sargent; M. Sasako; K. Shitara; P. Thuss-Patience; E. Van Cutsem; T. Burzykowski; M. Buyse X. Paoletti; K. Oba; Y.-J. Bang; H. Bleiberg; N. Boku; O. Bouché; P. Catalano; N. Fuse; S. Michiels; M. Moehler; S. Morita; Y. Ohashi; A. Ohtsu; A. Roth; P. Rougier; J. Sakamoto; D. Sargent; M. Sasako; K. Shitara; P. Thuss-Patience; E. Van Cutsem; T. Burzykowski; M. Buyse Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: A meta-analysis Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: A meta-analysis Progression-free survival as a surrogate for overall survival in advanced/recurrent gastric cancer trials: A meta-analysis Journal of the National Cancer Institute, 105, 21, 1667-1670 Journal of the National Cancer Institute, 105, 21, 1667-1670 Journal of the National Cancer Institute, 105, 21, 1667-1670 2013 英語 公開
I. Wasada; H. Eguchi; M. Kurita; S. Kudo; T. Shishida; Y. Mishima; Y. Saito; N. Ushiorozawa; T. Seto; K. Shimozuma; S. Morita; M. Saito; Y. Yokomizo; K. Ishizawa; Y. Ohashi; K. Eguchi I. Wasada; H. Eguchi; M. Kurita; S. Kudo; T. Shishida; Y. Mishima; Y. Saito; N. Ushiorozawa; T. Seto; K. Shimozuma; S. Morita; M. Saito; Y. Yokomizo; K. Ishizawa; Y. Ohashi; K. Eguchi I. Wasada; H. Eguchi; M. Kurita; S. Kudo; T. Shishida; Y. Mishima; Y. Saito; N. Ushiorozawa; T. Seto; K. Shimozuma; S. Morita; M. Saito; Y. Yokomizo; K. Ishizawa; Y. Ohashi; K. Eguchi Anemia affects the quality of life of japanese cancer patients Anemia affects the quality of life of japanese cancer patients Anemia affects the quality of life of japanese cancer patients Tokai Journal of Experimental and Clinical Medicine, 38, 1, 7-11 Tokai Journal of Experimental and Clinical Medicine, 38, 1, 7-11 Tokai Journal of Experimental and Clinical Medicine, 38, 1, 7-11 2013 英語 公開
T.T. Ishii; T. Kawate; Y. Nakatani; S. Morita; K. Ichimoto; S. Masuda T.T. Ishii; T. Kawate; Y. Nakatani; S. Morita; K. Ichimoto; S. Masuda T.T. Ishii; T. Kawate; Y. Nakatani; S. Morita; K. Ichimoto; S. Masuda High-speed imaging system for solar-flare research at hida observatory High-speed imaging system for solar-flare research at hida observatory High-speed imaging system for solar-flare research at hida observatory Publications of the Astronomical Society of Japan, 65, 2 Publications of the Astronomical Society of Japan, 65, 2 Publications of the Astronomical Society of Japan, 65, 2 2013 英語 公開
Y. Takada; Y. Suzukamo; F. Oike; H. Egawa; S. Morita; S. Fukuhara; S. Uemoto; K. Tanaka Y. Takada; Y. Suzukamo; F. Oike; H. Egawa; S. Morita; S. Fukuhara; S. Uemoto; K. Tanaka Y. Takada; Y. Suzukamo; F. Oike; H. Egawa; S. Morita; S. Fukuhara; S. Uemoto; K. Tanaka Long-term quality of life of donors after living donor liver transplantation Long-term quality of life of donors after living donor liver transplantation Long-term quality of life of donors after living donor liver transplantation Liver Transplantation, 18, 11, 1343-1352 Liver Transplantation, 18, 11, 1343-1352 Liver Transplantation, 18, 11, 1343-1352 2012/11 英語 公開
S. Arata; J. Suzuki; Y. Moriwaki; N. Suzuki; M. Iwashita; M. Sugiyama; S. Morita S. Arata; J. Suzuki; Y. Moriwaki; N. Suzuki; M. Iwashita; M. Sugiyama; S. Morita S. Arata; J. Suzuki; Y. Moriwaki; N. Suzuki; M. Iwashita; M. Sugiyama; S. Morita Characteristics of high-echoic objects in the hepatic vessels of patients with cardiopulmonary arrest: A prospective cohort study Characteristics of high-echoic objects in the hepatic vessels of patients with cardiopulmonary arrest: A prospective cohort study Characteristics of high-echoic objects in the hepatic vessels of patients with cardiopulmonary arrest: A prospective cohort study Emergency Medicine Journal, 29, 3, 213-217 Emergency Medicine Journal, 29, 3, 213-217 Emergency Medicine Journal, 29, 3, 213-217 2012 英語 公開
T. Higurashi; H. Takahashi; H. Endo; K. Hosono; E. Yamada; H. Ohkubo; E. Sakai; T. Uchiyama; Y. Hata; N. Fujisawa; S. Uchiyama; A. Ezuka; H. Nagase; T. Kessoku; N. Matsuhashi; S. Yamanaka; Y. Inayama; S. Morita; A. Nakajima T. Higurashi; H. Takahashi; H. Endo; K. Hosono; E. Yamada; H. Ohkubo; E. Sakai; T. Uchiyama; Y. Hata; N. Fujisawa; S. Uchiyama; A. Ezuka; H. Nagase; T. Kessoku; N. Matsuhashi; S. Yamanaka; Y. Inayama; S. Morita; A. Nakajima T. Higurashi; H. Takahashi; H. Endo; K. Hosono; E. Yamada; H. Ohkubo; E. Sakai; T. Uchiyama; Y. Hata; N. Fujisawa; S. Uchiyama; A. Ezuka; H. Nagase; T. Kessoku; N. Matsuhashi; S. Yamanaka; Y. Inayama; S. Morita; A. Nakajima Metformin efficacy and safety for colorectal polyps: A double-blind randomized controlled trial Metformin efficacy and safety for colorectal polyps: A double-blind randomized controlled trial Metformin efficacy and safety for colorectal polyps: A double-blind randomized controlled trial BMC Cancer, 12 BMC Cancer, 12 BMC Cancer, 12 2012 英語 公開
Y. Chiba; M. Kinoshita; Y. Okita; A. Tsuboi; K. Isohashi; N. Kagawa; Y. Fujimoto; Y. Oji; Y. Oka; E. Shimosegawa; S. Morita; J. Hatazawa; H. Sugiyama; N. Hashimoto; T. Yoshimine Y. Chiba; M. Kinoshita; Y. Okita; A. Tsuboi; K. Isohashi; N. Kagawa; Y. Fujimoto; Y. Oji; Y. Oka; E. Shimosegawa; S. Morita; J. Hatazawa; H. Sugiyama; N. Hashimoto; T. Yoshimine Y. Chiba; M. Kinoshita; Y. Okita; A. Tsuboi; K. Isohashi; N. Kagawa; Y. Fujimoto; Y. Oji; Y. Oka; E. Shimosegawa; S. Morita; J. Hatazawa; H. Sugiyama; N. Hashimoto; T. Yoshimine Use of <sup>11</sup>C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma: Clinical article Use of <sup>11</sup>C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma: Clinical article Use of <sup>11</sup>C-methionine PET parametric response map for monitoring WT1 immunotherapy response in recurrent malignant glioma: Clinical article Journal of Neurosurgery, 116, 4, 835-842 Journal of Neurosurgery, 116, 4, 835-842 Journal of Neurosurgery, 116, 4, 835-842 2012 英語 公開
S. Miyatake; N. Miyake; H. Touho; A. Nishimura-Tadaki; Y. Kondo; I. Okada; Y. Tsurusaki; H. Doi; H. Sakai; H. Saitsu; K. Shimojima; T. Yamamoto; M. Higurashi; N. Kawahara; H. Kawauchi; K. Nagasaka; N. Okamoto; T. Mori; S. Koyano; Y. Kuroiwa; M. Taguri; S. Morita; Y. Matsubara; S. Kure; N. Matsumoto S. Miyatake; N. Miyake; H. Touho; A. Nishimura-Tadaki; Y. Kondo; I. Okada; Y. Tsurusaki; H. Doi; H. Sakai; H. Saitsu; K. Shimojima; T. Yamamoto; M. Higurashi; N. Kawahara; H. Kawauchi; K. Nagasaka; N. Okamoto; T. Mori; S. Koyano; Y. Kuroiwa; M. Taguri; S. Morita; Y. Matsubara; S. Kure; N. Matsumoto S. Miyatake; N. Miyake; H. Touho; A. Nishimura-Tadaki; Y. Kondo; I. Okada; Y. Tsurusaki; H. Doi; H. Sakai; H. Saitsu; K. Shimojima; T. Yamamoto; M. Higurashi; N. Kawahara; H. Kawauchi; K. Nagasaka; N. Okamoto; T. Mori; S. Koyano; Y. Kuroiwa; M. Taguri; S. Morita; Y. Matsubara; S. Kure; N. Matsumoto Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease Homozygous c.14576G>A variant of RNF213 predicts early-onset and severe form of moyamoya disease Neurology, 78, 11, 803-810 Neurology, 78, 11, 803-810 Neurology, 78, 11, 803-810 2012 英語 公開
T. Yoshikawa; N. Hiki; M. Taguri; T. Sano; S. Nunobe; H. Taniguchi; R. Fukushima; H. Cho; S. Morita; A. Tsuburaya T. Yoshikawa; N. Hiki; M. Taguri; T. Sano; S. Nunobe; H. Taniguchi; R. Fukushima; H. Cho; S. Morita; A. Tsuburaya T. Yoshikawa; N. Hiki; M. Taguri; T. Sano; S. Nunobe; H. Taniguchi; R. Fukushima; H. Cho; S. Morita; A. Tsuburaya A phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer A phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer A phase III trial to evaluate the effect of perioperative nutrition enriched with eicosapentaenoic acid on body weight loss after total gastrectomy for T2-T4a gastric cancer Japanese Journal of Clinical Oncology, 42, 5, 459-462 Japanese Journal of Clinical Oncology, 42, 5, 459-462 Japanese Journal of Clinical Oncology, 42, 5, 459-462 2012 英語 公開
H. Yano; K. Hibi; N. Nozawa; H. Ozaki; I. Kusama; T. Ebina; M. Kosuge; K. Tsukahara; J. Okuda; S. Morita; S. Umemura; K. Kimura H. Yano; K. Hibi; N. Nozawa; H. Ozaki; I. Kusama; T. Ebina; M. Kosuge; K. Tsukahara; J. Okuda; S. Morita; S. Umemura; K. Kimura H. Yano; K. Hibi; N. Nozawa; H. Ozaki; I. Kusama; T. Ebina; M. Kosuge; K. Tsukahara; J. Okuda; S. Morita; S. Umemura; K. Kimura Effects of Valsartan, an Angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an Angiotensin-converting enzyme inhibitor Effects of Valsartan, an Angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an Angiotensin-converting enzyme inhibitor Effects of Valsartan, an Angiotensin II receptor blocker, on coronary atherosclerosis in patients with acute myocardial infarction who receive an Angiotensin-converting enzyme inhibitor Circulation Journal, 76, 6, 1442-1451 Circulation Journal, 76, 6, 1442-1451 Circulation Journal, 76, 6, 1442-1451 2012 英語 公開
H. Hayashi; I. Okamoto; S. Morita; M. Taguri; K. Nakagawa H. Hayashi; I. Okamoto; S. Morita; M. Taguri; K. Nakagawa H. Hayashi; I. Okamoto; S. Morita; M. Taguri; K. Nakagawa Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer Postprogression survival for first-line chemotherapy of patients with advanced non-small-cell lung cancer Annals of Oncology, 23, 6, 1537-1541 Annals of Oncology, 23, 6, 1537-1541 Annals of Oncology, 23, 6, 1537-1541 2012 英語 公開
S. Oizumi; K. Kobayashi; A. Inoue; M. Maemondo; S. Sugawara; H. Yoshizawa; H. Isobe; M. Harada; I. Kinoshita; S. Okinaga; T. Kato; T. Harada; A. Gemma; Y. Saijo; Y. Yokomizo; S. Morita; K. Hagiwara; T. Nukiwa S. Oizumi; K. Kobayashi; A. Inoue; M. Maemondo; S. Sugawara; H. Yoshizawa; H. Isobe; M. Harada; I. Kinoshita; S. Okinaga; T. Kato; T. Harada; A. Gemma; Y. Saijo; Y. Yokomizo; S. Morita; K. Hagiwara; T. Nukiwa S. Oizumi; K. Kobayashi; A. Inoue; M. Maemondo; S. Sugawara; H. Yoshizawa; H. Isobe; M. Harada; I. Kinoshita; S. Okinaga; T. Kato; T. Harada; A. Gemma; Y. Saijo; Y. Yokomizo; S. Morita; K. Hagiwara; T. Nukiwa Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: Quality of life analysis of north east Japan study group 002 trial Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: Quality of life analysis of north east Japan study group 002 trial Quality of life with gefitinib in patients with EGFR-mutated non-small cell lung cancer: Quality of life analysis of north east Japan study group 002 trial Oncologist, 17, 6, 863-870 Oncologist, 17, 6, 863-870 Oncologist, 17, 6, 863-870 2012 英語 公開
K. Kou; M. Aihara; T. Matsunaga; H. Chen; M. Taguri; S. Morita; H. Fujita; Y. Yamaguchi; T. Kambara; Z. Ikezawa K. Kou; M. Aihara; T. Matsunaga; H. Chen; M. Taguri; S. Morita; H. Fujita; Y. Yamaguchi; T. Kambara; Z. Ikezawa K. Kou; M. Aihara; T. Matsunaga; H. Chen; M. Taguri; S. Morita; H. Fujita; Y. Yamaguchi; T. Kambara; Z. Ikezawa Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis Association of serum interleukin-18 and other biomarkers with disease severity in adults with atopic dermatitis Archives of Dermatological Research, 304, 4, 305-312 Archives of Dermatological Research, 304, 4, 305-312 Archives of Dermatological Research, 304, 4, 305-312 2012 英語 公開
S. Arata; Y. Moriwaki; K. Takayama; M. Morimoto; K. Numata; M. Taguri; S. Morita; H. Imanari; K. Tanaka S. Arata; Y. Moriwaki; K. Takayama; M. Morimoto; K. Numata; M. Taguri; S. Morita; H. Imanari; K. Tanaka S. Arata; Y. Moriwaki; K. Takayama; M. Morimoto; K. Numata; M. Taguri; S. Morita; H. Imanari; K. Tanaka Establishment of artificial liver support by on-line hemodiafiltration for patients with acute liver failure Establishment of artificial liver support by on-line hemodiafiltration for patients with acute liver failure Establishment of artificial liver support by on-line hemodiafiltration for patients with acute liver failure Acta Hepatologica Japonica, 53, 1, 7-17 Acta Hepatologica Japonica, 53, 1, 7-17 Acta Hepatologica Japonica, 53, 1, 7-17 2012 英語 公開
M. Kosuge; T. Ebina; K. Hibi; N. Iwahashi; K. Tsukahara; M. Endo; N. Maejima; Z. Nagashima; H. Suzuki; S. Morita; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; N. Iwahashi; K. Tsukahara; M. Endo; N. Maejima; Z. Nagashima; H. Suzuki; S. Morita; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; N. Iwahashi; K. Tsukahara; M. Endo; N. Maejima; Z. Nagashima; H. Suzuki; S. Morita; S. Umemura; K. Kimura Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction Differences in negative T waves between takotsubo cardiomyopathy and reperfused anterior acute myocardial infarction Circulation Journal, 76, 2, 462-468 Circulation Journal, 76, 2, 462-468 Circulation Journal, 76, 2, 462-468 2012 英語 公開
S. Fujii; K. Watanabe; M. Ota; J. Watanabe; Y. Ichikawa; S. Yamagishi; K. Tatsumi; H. Suwa; C. Kunisaki; M. Taguri; S. Morita; I. Endo S. Fujii; K. Watanabe; M. Ota; J. Watanabe; Y. Ichikawa; S. Yamagishi; K. Tatsumi; H. Suwa; C. Kunisaki; M. Taguri; S. Morita; I. Endo S. Fujii; K. Watanabe; M. Ota; J. Watanabe; Y. Ichikawa; S. Yamagishi; K. Tatsumi; H. Suwa; C. Kunisaki; M. Taguri; S. Morita; I. Endo Single-incision laparoscopic surgery using colon-lifting technique for colorectal cancer: A matched case-control comparison with standard multiport laparoscopic surgery in terms of short-term results and access instrument cost Single-incision laparoscopic surgery using colon-lifting technique for colorectal cancer: A matched case-control comparison with standard multiport laparoscopic surgery in terms of short-term results and access instrument cost Single-incision laparoscopic surgery using colon-lifting technique for colorectal cancer: A matched case-control comparison with standard multiport laparoscopic surgery in terms of short-term results and access instrument cost Surgical Endoscopy and Other Interventional Techniques, 26, 5, 1403-1411 Surgical Endoscopy and Other Interventional Techniques, 26, 5, 1403-1411 Surgical Endoscopy and Other Interventional Techniques, 26, 5, 1403-1411 2012 英語 公開
K. Yamamura; A. Nakao; T. Fujii; S. Yamada; H. Sugimoto; H. Kasuya; S. Nomoto; Y. Kodera; S. Nakamura; S. Morita; S. Takeda K. Yamamura; A. Nakao; T. Fujii; S. Yamada; H. Sugimoto; H. Kasuya; S. Nomoto; Y. Kodera; S. Nakamura; S. Morita; S. Takeda K. Yamamura; A. Nakao; T. Fujii; S. Yamada; H. Sugimoto; H. Kasuya; S. Nomoto; Y. Kodera; S. Nakamura; S. Morita; S. Takeda Clinicopathologic study of intrapancreatic cancer spread in carcinoma of the body and tail of the pancreas Clinicopathologic study of intrapancreatic cancer spread in carcinoma of the body and tail of the pancreas Clinicopathologic study of intrapancreatic cancer spread in carcinoma of the body and tail of the pancreas Pancreas, 41, 5, 753-758 Pancreas, 41, 5, 753-758 Pancreas, 41, 5, 753-758 2012 英語 公開
S. Fukuhara; T. Akizawa; S. Morita; Y. Tsubakihara S. Fukuhara; T. Akizawa; S. Morita; Y. Tsubakihara S. Fukuhara; T. Akizawa; S. Morita; Y. Tsubakihara Understanding measurements of vitality in patients with chronic kidney disease: Connecting a quality-of-life scale to daily activities Understanding measurements of vitality in patients with chronic kidney disease: Connecting a quality-of-life scale to daily activities Understanding measurements of vitality in patients with chronic kidney disease: Connecting a quality-of-life scale to daily activities PLoS ONE, 7, 7 PLoS ONE, 7, 7 PLoS ONE, 7, 7 2012 英語 公開
T. Yoshikawa; T. Fukunaga; M. Taguri; C. Kunisaki; S. Sakuramoto; S. Ito; S. Morita; A. Tsuburaya T. Yoshikawa; T. Fukunaga; M. Taguri; C. Kunisaki; S. Sakuramoto; S. Ito; S. Morita; A. Tsuburaya T. Yoshikawa; T. Fukunaga; M. Taguri; C. Kunisaki; S. Sakuramoto; S. Ito; S. Morita; A. Tsuburaya Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized phase ii trial (landscope trial) Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized phase ii trial (landscope trial) Laparoscopic or open distal gastrectomy after neoadjuvant chemotherapy for operable gastric cancer, a randomized phase ii trial (landscope trial) Japanese Journal of Clinical Oncology, 42, 7, 654-657 Japanese Journal of Clinical Oncology, 42, 7, 654-657 Japanese Journal of Clinical Oncology, 42, 7, 654-657 2012 英語 公開
K. Shitara; S. Morita; K. Fujitani; S. Kadowaki; N. Takiguchi; N. Hirabayashi; M. Takahashi; M. Takagi; Y. Tokunaga; R. Fukushima; Y. Munakata; K. Nishikawa; A. Takagane; T. Tanaka; Y. Sekishita; J. Sakamoto; A. Tsuburaya K. Shitara; S. Morita; K. Fujitani; S. Kadowaki; N. Takiguchi; N. Hirabayashi; M. Takahashi; M. Takagi; Y. Tokunaga; R. Fukushima; Y. Munakata; K. Nishikawa; A. Takagane; T. Tanaka; Y. Sekishita; J. Sakamoto; A. Tsuburaya K. Shitara; S. Morita; K. Fujitani; S. Kadowaki; N. Takiguchi; N. Hirabayashi; M. Takahashi; M. Takagi; Y. Tokunaga; R. Fukushima; Y. Munakata; K. Nishikawa; A. Takagane; T. Tanaka; Y. Sekishita; J. Sakamoto; A. Tsuburaya Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: Multi-institutional retrospective analysis Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: Multi-institutional retrospective analysis Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: Multi-institutional retrospective analysis Gastric Cancer, 15, 3, 245-251 Gastric Cancer, 15, 3, 245-251 Gastric Cancer, 15, 3, 245-251 2012 英語 公開
S. Morita; P.F. Thall; P. Müller S. Morita; P.F. Thall; P. Müller S. Morita; P.F. Thall; P. Müller Prior effective sample size in conditionally independent hierarchical models Prior effective sample size in conditionally independent hierarchical models Prior effective sample size in conditionally independent hierarchical models Bayesian Analysis, 7, 3, 591-614 Bayesian Analysis, 7, 3, 591-614 Bayesian Analysis, 7, 3, 591-614 2012 英語 公開
T. Higurashi; K. Hosono; H. Endo; H. Takahashi; H. Iida; T. Uchiyama; A. Ezuka; S. Uchiyama; E. Yamada; H. Ohkubo; E. Sakai; S. Maeda; S. Morita; Y. Natsumeda; H. Nagase; A. Nakajima T. Higurashi; K. Hosono; H. Endo; H. Takahashi; H. Iida; T. Uchiyama; A. Ezuka; S. Uchiyama; E. Yamada; H. Ohkubo; E. Sakai; S. Maeda; S. Morita; Y. Natsumeda; H. Nagase; A. Nakajima T. Higurashi; K. Hosono; H. Endo; H. Takahashi; H. Iida; T. Uchiyama; A. Ezuka; S. Uchiyama; E. Yamada; H. Ohkubo; E. Sakai; S. Maeda; S. Morita; Y. Natsumeda; H. Nagase; A. Nakajima Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial Eicosapentaenoic acid (EPA) efficacy for colorectal aberrant crypt foci (ACF): a double-blind randomized controlled trial BMC Cancer, 12 BMC Cancer, 12 BMC Cancer, 12 2012 英語 公開
T. Fukui; M. Tabata; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Morita; S. Takanashi Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting Journal of Thoracic and Cardiovascular Surgery, 144, 4, 824-829 Journal of Thoracic and Cardiovascular Surgery, 144, 4, 824-829 Journal of Thoracic and Cardiovascular Surgery, 144, 4, 824-829 2012 英語 公開
M. Yoshimoto; S. Takao; M. Hirata; Y. Okamoto; S. Yamashita; Y. Kawaguchi; M. Takami; H. Furusawa; S. Morita; C. Abe; J. Sakamoto M. Yoshimoto; S. Takao; M. Hirata; Y. Okamoto; S. Yamashita; Y. Kawaguchi; M. Takami; H. Furusawa; S. Morita; C. Abe; J. Sakamoto M. Yoshimoto; S. Takao; M. Hirata; Y. Okamoto; S. Yamashita; Y. Kawaguchi; M. Takami; H. Furusawa; S. Morita; C. Abe; J. Sakamoto Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: A phase II study in patients with HER2-negative metastatic breast cancer Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: A phase II study in patients with HER2-negative metastatic breast cancer Metronomic oral combination chemotherapy with capecitabine and cyclophosphamide: A phase II study in patients with HER2-negative metastatic breast cancer Cancer Chemotherapy and Pharmacology, 70, 2, 331-338 Cancer Chemotherapy and Pharmacology, 70, 2, 331-338 Cancer Chemotherapy and Pharmacology, 70, 2, 331-338 2012 英語 公開
T. Tsushima; M. Taguri; Y. Honma; H. Takahashi; S. Ueda; T. Nishina; H. Kawai; S. Kato; M. Suenaga; F. Tamura; S. Morita; N. Boku T. Tsushima; M. Taguri; Y. Honma; H. Takahashi; S. Ueda; T. Nishina; H. Kawai; S. Kato; M. Suenaga; F. Tamura; S. Morita; N. Boku T. Tsushima; M. Taguri; Y. Honma; H. Takahashi; S. Ueda; T. Nishina; H. Kawai; S. Kato; M. Suenaga; F. Tamura; S. Morita; N. Boku Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy Oncologist, 17, 9, 1163-1170 Oncologist, 17, 9, 1163-1170 Oncologist, 17, 9, 1163-1170 2012 英語 公開
M. Morimoto; K. Numata; A. Nozaki; M. Kondo; S. Moriya; M. Taguri; S. Morita; M. Konno; A. Sugo; E. Miyajima; S. Maeda; K. Tanaka M. Morimoto; K. Numata; A. Nozaki; M. Kondo; S. Moriya; M. Taguri; S. Morita; M. Konno; A. Sugo; E. Miyajima; S. Maeda; K. Tanaka M. Morimoto; K. Numata; A. Nozaki; M. Kondo; S. Moriya; M. Taguri; S. Morita; M. Konno; A. Sugo; E. Miyajima; S. Maeda; K. Tanaka Novel Lens culinaris agglutinin-reactive fraction of a-fetoprotein: A biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations Novel Lens culinaris agglutinin-reactive fraction of a-fetoprotein: A biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations Novel Lens culinaris agglutinin-reactive fraction of a-fetoprotein: A biomarker of hepatocellular carcinoma recurrence in patients with low α-fetoprotein concentrations International Journal of Clinical Oncology, 17, 4, 373-379 International Journal of Clinical Oncology, 17, 4, 373-379 International Journal of Clinical Oncology, 17, 4, 373-379 2012 英語 公開
E. Shigematsu; T. Yamakawa; M. Taguri; S. Morita; M. Tokui; K. Miyamoto; O. Funae; Y. Takatuka; K. Kadonosono; H. Shigematsu; Y. Terauchi E. Shigematsu; T. Yamakawa; M. Taguri; S. Morita; M. Tokui; K. Miyamoto; O. Funae; Y. Takatuka; K. Kadonosono; H. Shigematsu; Y. Terauchi E. Shigematsu; T. Yamakawa; M. Taguri; S. Morita; M. Tokui; K. Miyamoto; O. Funae; Y. Takatuka; K. Kadonosono; H. Shigematsu; Y. Terauchi Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes Efficacy of ezetimibe is associated with gender and baseline lipid levels in patients with type 2 diabetes Journal of Atherosclerosis and Thrombosis, 19, 9, 846-853 Journal of Atherosclerosis and Thrombosis, 19, 9, 846-853 Journal of Atherosclerosis and Thrombosis, 19, 9, 846-853 2012 英語 公開
T. Watanabe; T. Yoshikawa; Y. Kameda; T. Aoyama; T. Hayashi; T. Ogata; H. Cho; A. Tsuburaya; S. Morita; Y. Miyashita; J. Sakamoto T. Watanabe; T. Yoshikawa; Y. Kameda; T. Aoyama; T. Hayashi; T. Ogata; H. Cho; A. Tsuburaya; S. Morita; Y. Miyashita; J. Sakamoto T. Watanabe; T. Yoshikawa; Y. Kameda; T. Aoyama; T. Hayashi; T. Ogata; H. Cho; A. Tsuburaya; S. Morita; Y. Miyashita; J. Sakamoto Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: Report of a case Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: Report of a case Pathological complete response of locally advanced gastric cancer after four courses of neoadjuvant chemotherapy with paclitaxel plus cisplatin: Report of a case Surgery Today, 42, 10, 983-987 Surgery Today, 42, 10, 983-987 Surgery Today, 42, 10, 983-987 2012 英語 公開
A. Tsuburaya; S. Morita; Y. Kodera; M. Kobayashi; K. Shitara; K. Yamaguchi; T. Yoshikawa; K. Yoshida; S. Yoshino; J.-I. Sakamoto A. Tsuburaya; S. Morita; Y. Kodera; M. Kobayashi; K. Shitara; K. Yamaguchi; T. Yoshikawa; K. Yoshida; S. Yoshino; J.-I. Sakamoto A. Tsuburaya; S. Morita; Y. Kodera; M. Kobayashi; K. Shitara; K. Yamaguchi; T. Yoshikawa; K. Yoshida; S. Yoshino; J.-I. Sakamoto A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) A randomized phase II trial to elucidate the efficacy of capecitabine plus cisplatin (XP) and S-1 plus cisplatin (SP) as a first-line treatment for advanced gastric cancer: XP ascertainment vs. SP randomized PII trial (XParTS II) BMC Cancer, 12 BMC Cancer, 12 BMC Cancer, 12 2012 英語 公開
K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; K. Kuroi; S. Ohsumi; H. Makino; N. Katsumata; M. Kuranami; K. Suemasu; T. Watanabe; F.H. Hausheer K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; K. Kuroi; S. Ohsumi; H. Makino; N. Katsumata; M. Kuranami; K. Suemasu; T. Watanabe; F.H. Hausheer K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; K. Kuroi; S. Ohsumi; H. Makino; N. Katsumata; M. Kuranami; K. Suemasu; T. Watanabe; F.H. Hausheer Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial Taxane-induced peripheral neuropathy and health-related quality of life in postoperative breast cancer patients undergoing adjuvant chemotherapy: N-SAS BC 02, a randomized clinical trial Supportive Care in Cancer, 20, 12, 3355-3364 Supportive Care in Cancer, 20, 12, 3355-3364 Supportive Care in Cancer, 20, 12, 3355-3364 2012 英語 公開
T. Ishikawa; D. Shimizu; A. Yamada; T. Sasaki; S. Morita; M. Tanabe; K. Kawachi; A. Nozawa; T. Chishima; M. Kimura; Y. Ichikawa; I. Endo T. Ishikawa; D. Shimizu; A. Yamada; T. Sasaki; S. Morita; M. Tanabe; K. Kawachi; A. Nozawa; T. Chishima; M. Kimura; Y. Ichikawa; I. Endo T. Ishikawa; D. Shimizu; A. Yamada; T. Sasaki; S. Morita; M. Tanabe; K. Kawachi; A. Nozawa; T. Chishima; M. Kimura; Y. Ichikawa; I. Endo Impacts and predictors of cytotoxic anticancer agents in different breast cancer subtypes Impacts and predictors of cytotoxic anticancer agents in different breast cancer subtypes Impacts and predictors of cytotoxic anticancer agents in different breast cancer subtypes Oncology Research, 20, 2-3, 71-79 Oncology Research, 20, 2-3, 71-79 Oncology Research, 20, 2-3, 71-79 2012 英語 公開
H. Yano; K. Tsukahara; S. Morita; T. Endo; T. Sugano; K. Hibi; H. Himeno; K. Fukui; S. Umemura; K. Kimura H. Yano; K. Tsukahara; S. Morita; T. Endo; T. Sugano; K. Hibi; H. Himeno; K. Fukui; S. Umemura; K. Kimura H. Yano; K. Tsukahara; S. Morita; T. Endo; T. Sugano; K. Hibi; H. Himeno; K. Fukui; S. Umemura; K. Kimura Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes - A prospective, randomized, multicenter study - Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes - A prospective, randomized, multicenter study - Influence of omeprazole and famotidine on the antiplatelet effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes - A prospective, randomized, multicenter study - Circulation Journal, 76, 11, 2673-2680 Circulation Journal, 76, 11, 2673-2680 Circulation Journal, 76, 11, 2673-2680 2012 英語 公開
H. Nagakura; M. Nishikawa; N. Kusano; M. Saito; S. Morita; T. Kaneko; Y. Ishigatsubo H. Nagakura; M. Nishikawa; N. Kusano; M. Saito; S. Morita; T. Kaneko; Y. Ishigatsubo H. Nagakura; M. Nishikawa; N. Kusano; M. Saito; S. Morita; T. Kaneko; Y. Ishigatsubo The impact of a negative history of smoking on survival in patients with non-small cell lung cancer detected with clinic-based screening programs The impact of a negative history of smoking on survival in patients with non-small cell lung cancer detected with clinic-based screening programs The impact of a negative history of smoking on survival in patients with non-small cell lung cancer detected with clinic-based screening programs Internal Medicine, 51, 22, 3115-3118 Internal Medicine, 51, 22, 3115-3118 Internal Medicine, 51, 22, 3115-3118 2012 英語 公開
K. Nishikawa; S. Morita; T. Matsui; M. Kobayashi; Y. Takeuchi; I. Takahashi; S. Sato; Y. Miyashita; A. Tsuburaya; J. Sakamoto; Y. Kakeji; H. Baba K. Nishikawa; S. Morita; T. Matsui; M. Kobayashi; Y. Takeuchi; I. Takahashi; S. Sato; Y. Miyashita; A. Tsuburaya; J. Sakamoto; Y. Kakeji; H. Baba K. Nishikawa; S. Morita; T. Matsui; M. Kobayashi; Y. Takeuchi; I. Takahashi; S. Sato; Y. Miyashita; A. Tsuburaya; J. Sakamoto; Y. Kakeji; H. Baba A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer A randomized phase-II trial comparing sequential and concurrent paclitaxel with oral or parenteral fluorinated pyrimidines for advanced or metastatic gastric cancer Gastric Cancer, 15, 4, 363-369 Gastric Cancer, 15, 4, 363-369 Gastric Cancer, 15, 4, 363-369 2012 英語 公開
S. Miyatake; H. Touho; N. Miyake; C. Ohba; H. Doi; H. Saitsu; M. Taguri; S. Morita; N. Matsumoto S. Miyatake; H. Touho; N. Miyake; C. Ohba; H. Doi; H. Saitsu; M. Taguri; S. Morita; N. Matsumoto S. Miyatake; H. Touho; N. Miyake; C. Ohba; H. Doi; H. Saitsu; M. Taguri; S. Morita; N. Matsumoto Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity Sibling cases of moyamoya disease having homozygous and heterozygous c.14576G>A variant in RNF213 showed varying clinical course and severity Journal of Human Genetics, 57, 12, 804-806 Journal of Human Genetics, 57, 12, 804-806 Journal of Human Genetics, 57, 12, 804-806 2012 英語 公開
A. Nakao; A. Kanzaki; T. Fujii; Y. Kodera; S. Yamada; H. Sugimoto; S. Nomoto; S. Nakamura; S. Morita; S. Takeda A. Nakao; A. Kanzaki; T. Fujii; Y. Kodera; S. Yamada; H. Sugimoto; S. Nomoto; S. Nakamura; S. Morita; S. Takeda A. Nakao; A. Kanzaki; T. Fujii; Y. Kodera; S. Yamada; H. Sugimoto; S. Nomoto; S. Nakamura; S. Morita; S. Takeda Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer Correlation between radiographic classification and pathological grade of portal vein wall invasion in pancreatic head cancer Annals of Surgery, 255, 1, 103-108 Annals of Surgery, 255, 1, 103-108 Annals of Surgery, 255, 1, 103-108 2012 英語 公開
T. Yoshikawa; M. Taguri; S. Sakuramoto; C. Kunisaki; T. Fukunaga; S. Ito; H. Cho; K. Tanabe; K. Nishikawa; T. Matsui; S. Morita; A. Tsuburaya T. Yoshikawa; M. Taguri; S. Sakuramoto; C. Kunisaki; T. Fukunaga; S. Ito; H. Cho; K. Tanabe; K. Nishikawa; T. Matsui; S. Morita; A. Tsuburaya T. Yoshikawa; M. Taguri; S. Sakuramoto; C. Kunisaki; T. Fukunaga; S. Ito; H. Cho; K. Tanabe; K. Nishikawa; T. Matsui; S. Morita; A. Tsuburaya A comparison of multimodality treatment: Two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/Docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: A randomized ph A comparison of multimodality treatment: Two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/Docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: A randomized ph A comparison of multimodality treatment: Two and four courses of neoadjuvant chemotherapy using S-1/CDDP or S-1/CDDP/Docetaxel followed by surgery and S-1 adjuvant chemotherapy for macroscopically resectable serosa-positive gastric cancer: A randomized ph Japanese Journal of Clinical Oncology, 42, 1, 74-77 Japanese Journal of Clinical Oncology, 42, 1, 74-77 Japanese Journal of Clinical Oncology, 42, 1, 74-77 2012 英語 公開
M. Kosuge; T. Ebina; K. Hibi; N. Iwahashi; S. Morita; M. Endo; N. Maejima; M. Gouhara; Z. Nagashima; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; N. Iwahashi; S. Morita; M. Endo; N. Maejima; M. Gouhara; Z. Nagashima; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; N. Iwahashi; S. Morita; M. Endo; N. Maejima; M. Gouhara; Z. Nagashima; S. Umemura; K. Kimura Implications of ST-segment elevation in leads V <sub>5</sub> and V <sub>6</sub> in patients with reperfused inferior wall acute myocardial infarction Implications of ST-segment elevation in leads V <sub>5</sub> and V <sub>6</sub> in patients with reperfused inferior wall acute myocardial infarction Implications of ST-segment elevation in leads V <sub>5</sub> and V <sub>6</sub> in patients with reperfused inferior wall acute myocardial infarction American Journal of Cardiology, 109, 3, 314-319 American Journal of Cardiology, 109, 3, 314-319 American Journal of Cardiology, 109, 3, 314-319 2012 英語 公開
A. Asai; T.T. Ishii; H. Isobe; R. Kitai; K. Ichimoto; S. Ueno; S. Nagata; S. Morita; K. Nishida; D. Shiota; A. Oi; M. Akioka; K. Shibata A. Asai; T.T. Ishii; H. Isobe; R. Kitai; K. Ichimoto; S. Ueno; S. Nagata; S. Morita; K. Nishida; D. Shiota; A. Oi; M. Akioka; K. Shibata A. Asai; T.T. Ishii; H. Isobe; R. Kitai; K. Ichimoto; S. Ueno; S. Nagata; S. Morita; K. Nishida; D. Shiota; A. Oi; M. Akioka; K. Shibata First simultaneous observation of AN Hα Moreton wave, EUV wave, and filament/prominence oscillations First simultaneous observation of AN Hα Moreton wave, EUV wave, and filament/prominence oscillations First simultaneous observation of AN Hα Moreton wave, EUV wave, and filament/prominence oscillations Astrophysical Journal Letters, 745, 2 Astrophysical Journal Letters, 745, 2 Astrophysical Journal Letters, 745, 2 2012 英語 公開
T. Fujii; M. Kanda; Y. Kodera; S. Nagai; T.T. Sahin; M. Hayashi; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao T. Fujii; M. Kanda; Y. Kodera; S. Nagai; T.T. Sahin; M. Hayashi; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao T. Fujii; M. Kanda; Y. Kodera; S. Nagai; T.T. Sahin; M. Hayashi; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: A comparative study comparing three surgical procedures Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: A comparative study comparing three surgical procedures Preservation of the pyloric ring has little value in surgery for pancreatic head cancer: A comparative study comparing three surgical procedures Annals of Surgical Oncology, 19, 1, 176-183 Annals of Surgical Oncology, 19, 1, 176-183 Annals of Surgical Oncology, 19, 1, 176-183 2012 英語 公開
C. Kunisaki; H. Makino; T. Kosaka; T. Oshima; S. Fujii; R. Takagawa; J. Kimura; H.A. Ono; H. Akiyama; M. Taguri; S. Morita; I. Endo C. Kunisaki; H. Makino; T. Kosaka; T. Oshima; S. Fujii; R. Takagawa; J. Kimura; H.A. Ono; H. Akiyama; M. Taguri; S. Morita; I. Endo C. Kunisaki; H. Makino; T. Kosaka; T. Oshima; S. Fujii; R. Takagawa; J. Kimura; H.A. Ono; H. Akiyama; M. Taguri; S. Morita; I. Endo Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: A case-control study Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: A case-control study Surgical outcomes of laparoscopy-assisted gastrectomy versus open gastrectomy for gastric cancer: A case-control study Surgical Endoscopy and Other Interventional Techniques, 26, 3, 804-810 Surgical Endoscopy and Other Interventional Techniques, 26, 3, 804-810 Surgical Endoscopy and Other Interventional Techniques, 26, 3, 804-810 2012 英語 公開
S. Fujii; K. Watanabe; M. Ota; J. Watanabe; Y. Ichikawa; S. Yamagishi; K. Tatsumi; H. Suwa; C. Kunisaki; M. Taguri; S. Morita; I. Endo S. Fujii; K. Watanabe; M. Ota; J. Watanabe; Y. Ichikawa; S. Yamagishi; K. Tatsumi; H. Suwa; C. Kunisaki; M. Taguri; S. Morita; I. Endo S. Fujii; K. Watanabe; M. Ota; J. Watanabe; Y. Ichikawa; S. Yamagishi; K. Tatsumi; H. Suwa; C. Kunisaki; M. Taguri; S. Morita; I. Endo Laparoscopic colorectal cancer surgery by a colon lifting-up technique that decreases the number of access ports: Comparison by propensity scoring of short-term and long-term outcomes with standard multiport laparoscopic surgery Laparoscopic colorectal cancer surgery by a colon lifting-up technique that decreases the number of access ports: Comparison by propensity scoring of short-term and long-term outcomes with standard multiport laparoscopic surgery Laparoscopic colorectal cancer surgery by a colon lifting-up technique that decreases the number of access ports: Comparison by propensity scoring of short-term and long-term outcomes with standard multiport laparoscopic surgery Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, 22, 1, 38-45 Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, 22, 1, 38-45 Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, 22, 1, 38-45 2012 英語 公開
M. Kubota; M. Hiramatsu; M. Yamakawa; S. Fukuhara; S. Morita; M. Iwasaki; T. Akizawa M. Kubota; M. Hiramatsu; M. Yamakawa; S. Fukuhara; S. Morita; M. Iwasaki; T. Akizawa M. Kubota; M. Hiramatsu; M. Yamakawa; S. Fukuhara; S. Morita; M. Iwasaki; T. Akizawa Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan Clinical and Experimental Nephrology, 15, 6, 884-892 Clinical and Experimental Nephrology, 15, 6, 884-892 Clinical and Experimental Nephrology, 15, 6, 884-892 2011/12 英語 公開
K. Kawaguchi; H. Ishiguro; S. Morita; S. Nakamura; S. Ohno; N. Masuda; H. Iwata; K. Aogi; K. Kuroi; M. Toi K. Kawaguchi; H. Ishiguro; S. Morita; S. Nakamura; S. Ohno; N. Masuda; H. Iwata; K. Aogi; K. Kuroi; M. Toi K. Kawaguchi; H. Ishiguro; S. Morita; S. Nakamura; S. Ohno; N. Masuda; H. Iwata; K. Aogi; K. Kuroi; M. Toi Correlation between docetaxel-induced skin toxicity and the use of steroids and H <sub>2</sub> blockers: A multi-institution survey Correlation between docetaxel-induced skin toxicity and the use of steroids and H <sub>2</sub> blockers: A multi-institution survey Correlation between docetaxel-induced skin toxicity and the use of steroids and H <sub>2</sub> blockers: A multi-institution survey Breast Cancer Research and Treatment, 130, 2, 627-634 Breast Cancer Research and Treatment, 130, 2, 627-634 Breast Cancer Research and Treatment, 130, 2, 627-634 2011/11 英語 公開
T. Akizawa; F. Gejyo; S. Nishi; Y. Iino; Y. Watanabe; M. Suzuki; A. Saito; T. Akiba; H. Hirakata; S. Fukuhara; S. Morita; M. Hiroe; Y. Hada; M. Suzuki; M. Akaishi; M. Iwasaki; Y. Tsubakihara T. Akizawa; F. Gejyo; S. Nishi; Y. Iino; Y. Watanabe; M. Suzuki; A. Saito; T. Akiba; H. Hirakata; S. Fukuhara; S. Morita; M. Hiroe; Y. Hada; M. Suzuki; M. Akaishi; M. Iwasaki; Y. Tsubakihara T. Akizawa; F. Gejyo; S. Nishi; Y. Iino; Y. Watanabe; M. Suzuki; A. Saito; T. Akiba; H. Hirakata; S. Fukuhara; S. Morita; M. Hiroe; Y. Hada; M. Suzuki; M. Akaishi; M. Iwasaki; Y. Tsubakihara Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study Positive Outcomes of High Hemoglobin Target in Patients With Chronic Kidney Disease Not on Dialysis: A Randomized Controlled Study Therapeutic Apheresis and Dialysis, 15, 5, 431-440 Therapeutic Apheresis and Dialysis, 15, 5, 431-440 Therapeutic Apheresis and Dialysis, 15, 5, 431-440 2011/10 英語 公開
S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas Impact of operative blood loss on survival in invasive ductal adenocarcinoma of the pancreas Pancreas, 40, 1, 3-9 Pancreas, 40, 1, 3-9 Pancreas, 40, 1, 3-9 2011 英語 公開
M. Yanagimachi; T. Naruto; T. Hara; M. Kikuchi; R. Hara; T. Miyamae; T. Imagawa; M. Mori; T. Kaneko; S. Morita; H. Goto; S. Yokota M. Yanagimachi; T. Naruto; T. Hara; M. Kikuchi; R. Hara; T. Miyamae; T. Imagawa; M. Mori; T. Kaneko; S. Morita; H. Goto; S. Yokota M. Yanagimachi; T. Naruto; T. Hara; M. Kikuchi; R. Hara; T. Miyamae; T. Imagawa; M. Mori; T. Kaneko; S. Morita; H. Goto; S. Yokota Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis Influence of polymorphisms within the methotrexate pathway genes on the toxicity and efficacy of methotrexate in patients with juvenile idiopathic arthritis British Journal of Clinical Pharmacology, 71, 2, 237-243 British Journal of Clinical Pharmacology, 71, 2, 237-243 British Journal of Clinical Pharmacology, 71, 2, 237-243 2011 英語 公開
T. Kariya; G. Inagawa; K. Nakamura; J. Fujimoto; Y. Aoi; S. Morita; T. Goto T. Kariya; G. Inagawa; K. Nakamura; J. Fujimoto; Y. Aoi; S. Morita; T. Goto T. Kariya; G. Inagawa; K. Nakamura; J. Fujimoto; Y. Aoi; S. Morita; T. Goto Evaluation of the Pentax-AWS <sup>®</sup> and the Macintosh laryngoscope in difficult intubation: A manikin study Evaluation of the Pentax-AWS <sup>®</sup> and the Macintosh laryngoscope in difficult intubation: A manikin study Evaluation of the Pentax-AWS <sup>®</sup> and the Macintosh laryngoscope in difficult intubation: A manikin study Acta Anaesthesiologica Scandinavica, 55, 2, 223-227 Acta Anaesthesiologica Scandinavica, 55, 2, 223-227 Acta Anaesthesiologica Scandinavica, 55, 2, 223-227 2011 英語 公開
T. Fukui; M. Tabata; M. Taguri; S. Manabe; S. Morita; S. Takanashi T. Fukui; M. Tabata; M. Taguri; S. Manabe; S. Morita; S. Takanashi T. Fukui; M. Tabata; M. Taguri; S. Manabe; S. Morita; S. Takanashi Extensive reconstruction of the left anterior descending coronary artery with an internal thoracic artery graft Extensive reconstruction of the left anterior descending coronary artery with an internal thoracic artery graft Extensive reconstruction of the left anterior descending coronary artery with an internal thoracic artery graft Annals of Thoracic Surgery, 91, 2, 445-451 Annals of Thoracic Surgery, 91, 2, 445-451 Annals of Thoracic Surgery, 91, 2, 445-451 2011 英語 公開
M. Shakudo; M. Takegami; A. Shibata; M. Kuzumaki; T. Higashi; Y. Hayashino; Y. Suzukamo; S. Morita; M. Katsuki; S. Fukuhara M. Shakudo; M. Takegami; A. Shibata; M. Kuzumaki; T. Higashi; Y. Hayashino; Y. Suzukamo; S. Morita; M. Katsuki; S. Fukuhara M. Shakudo; M. Takegami; A. Shibata; M. Kuzumaki; T. Higashi; Y. Hayashino; Y. Suzukamo; S. Morita; M. Katsuki; S. Fukuhara Effect of feedback in promoting adherence to an exercise programme: A randomized controlled trial Effect of feedback in promoting adherence to an exercise programme: A randomized controlled trial Effect of feedback in promoting adherence to an exercise programme: A randomized controlled trial Journal of Evaluation in Clinical Practice, 17, 1, 7-11 Journal of Evaluation in Clinical Practice, 17, 1, 7-11 Journal of Evaluation in Clinical Practice, 17, 1, 7-11 2011 英語 公開
Y. Kodera; M. Imano; T. Yoshikawa; N. Takahashi; A. Tsuburaya; Y. Miyashita; S. Morita; A. Nakao; J. Sakamoto; M. Sasako Y. Kodera; M. Imano; T. Yoshikawa; N. Takahashi; A. Tsuburaya; Y. Miyashita; S. Morita; A. Nakao; J. Sakamoto; M. Sasako Y. Kodera; M. Imano; T. Yoshikawa; N. Takahashi; A. Tsuburaya; Y. Miyashita; S. Morita; A. Nakao; J. Sakamoto; M. Sasako A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial) A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial) A randomized phase II trial to test the efficacy of intra-peritoneal paclitaxel for gastric cancer with high risk for the peritoneal metastasis (INPACT trial) Japanese Journal of Clinical Oncology, 41, 2, 283-286 Japanese Journal of Clinical Oncology, 41, 2, 283-286 Japanese Journal of Clinical Oncology, 41, 2, 283-286 2011 英語 公開
M. Kosuge; T. Ebina; K. Hibi; S. Morita; M. Endo; N. Maejima; N. Iwahashi; K. Okada; T. Ishikawa; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; S. Morita; M. Endo; N. Maejima; N. Iwahashi; K. Okada; T. Ishikawa; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; S. Morita; M. Endo; N. Maejima; N. Iwahashi; K. Okada; T. Ishikawa; S. Umemura; K. Kimura An early and simple predictor of severe left main and/or three-vessel disease in patients with nonst-segment elevation acute coronary syndrome An early and simple predictor of severe left main and/or three-vessel disease in patients with nonst-segment elevation acute coronary syndrome An early and simple predictor of severe left main and/or three-vessel disease in patients with nonst-segment elevation acute coronary syndrome American Journal of Cardiology, 107, 4, 495-500 American Journal of Cardiology, 107, 4, 495-500 American Journal of Cardiology, 107, 4, 495-500 2011 英語 公開
S. Kako; S. Morita; H. Sakamaki; H. Ogawa; T. Fukuda; S. Takahashi; H. Kanamori; M. Onizuka; K. Iwato; R. Suzuki; Y. Atsuta; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda S. Kako; S. Morita; H. Sakamaki; H. Ogawa; T. Fukuda; S. Takahashi; H. Kanamori; M. Onizuka; K. Iwato; R. Suzuki; Y. Atsuta; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda S. Kako; S. Morita; H. Sakamaki; H. Ogawa; T. Fukuda; S. Takahashi; H. Kanamori; M. Onizuka; K. Iwato; R. Suzuki; Y. Atsuta; T. Kyo; T. Sakura; I. Jinnai; J. Takeuchi; Y. Miyazaki; S. Miyawaki; K. Ohnishi; T. Naoe; Y. Kanda A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor A decision analysis of allogeneic hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in first remission who have an HLA-matched sibling donor Leukemia, 25, 2, 259-265 Leukemia, 25, 2, 259-265 Leukemia, 25, 2, 259-265 2011 英語 公開
S. Morita S. Morita S. Morita Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West Application of the continual reassessment method to a phase I dose-finding trial in Japanese patients: East meets West Statistics in Medicine, 30, 17, 2090-2097 Statistics in Medicine, 30, 17, 2090-2097 Statistics in Medicine, 30, 17, 2090-2097 2011 英語 公開
M. Morimoto; K. Numata; M. Kondo; H. Hidaka; J. Takada; A. Shibuya; S. Kobayashi; S. Ohkawa; C. Okuse; S. Morita; M. Taguri; K. Tanaka M. Morimoto; K. Numata; M. Kondo; H. Hidaka; J. Takada; A. Shibuya; S. Kobayashi; S. Ohkawa; C. Okuse; S. Morita; M. Taguri; K. Tanaka M. Morimoto; K. Numata; M. Kondo; H. Hidaka; J. Takada; A. Shibuya; S. Kobayashi; S. Ohkawa; C. Okuse; S. Morita; M. Taguri; K. Tanaka Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib Hepatology Research, 41, 4, 296-302 Hepatology Research, 41, 4, 296-302 Hepatology Research, 41, 4, 296-302 2011 英語 公開
B. Nakata; A. Tsuji; Y. Mitachi; N. Taenaka; T. Kamano; K. Oikawa; N. Onoda; M. Kambe; M. Takahashi; T. Shirasaka; S. Morita; J. Sakamoto; Y. Tanaka; S. Saji; K. Hirakawa B. Nakata; A. Tsuji; Y. Mitachi; N. Taenaka; T. Kamano; K. Oikawa; N. Onoda; M. Kambe; M. Takahashi; T. Shirasaka; S. Morita; J. Sakamoto; Y. Tanaka; S. Saji; K. Hirakawa B. Nakata; A. Tsuji; Y. Mitachi; N. Taenaka; T. Kamano; K. Oikawa; N. Onoda; M. Kambe; M. Takahashi; T. Shirasaka; S. Morita; J. Sakamoto; Y. Tanaka; S. Saji; K. Hirakawa Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2) Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2) Phase II trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer (JFMC27-9902 Step2) Oncology, 79, 5-6, 337-342 Oncology, 79, 5-6, 337-342 Oncology, 79, 5-6, 337-342 2011 英語 公開
H. Imamoto; K. Oba; J. Sakamoto; H. Iishi; H. Narahara; T. Yumiba; T. Morimoto; M. Nakamura; N. Oriuchi; C. Kakutani; S. Morita; H. Shiozaki H. Imamoto; K. Oba; J. Sakamoto; H. Iishi; H. Narahara; T. Yumiba; T. Morimoto; M. Nakamura; N. Oriuchi; C. Kakutani; S. Morita; H. Shiozaki H. Imamoto; K. Oba; J. Sakamoto; H. Iishi; H. Narahara; T. Yumiba; T. Morimoto; M. Nakamura; N. Oriuchi; C. Kakutani; S. Morita; H. Shiozaki Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: A multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: A multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: A multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer Gastric Cancer, 14, 1, 81-90 Gastric Cancer, 14, 1, 81-90 Gastric Cancer, 14, 1, 81-90 2011 英語 公開
I. Ogino; T. Kaneko; R. Suzuki; T. Matsui; S. Takebayashi; T. Inoue; S. Morita I. Ogino; T. Kaneko; R. Suzuki; T. Matsui; S. Takebayashi; T. Inoue; S. Morita I. Ogino; T. Kaneko; R. Suzuki; T. Matsui; S. Takebayashi; T. Inoue; S. Morita Rectal content and intrafractional prostate gland motion assessed by magnetic resonance imaging Rectal content and intrafractional prostate gland motion assessed by magnetic resonance imaging Rectal content and intrafractional prostate gland motion assessed by magnetic resonance imaging Journal of Radiation Research, 52, 2, 199-207 Journal of Radiation Research, 52, 2, 199-207 Journal of Radiation Research, 52, 2, 199-207 2011 英語 公開
M. Yanagimachi; T. Miyamae; T. Naruto; T. Hara; M. Kikuchi; R. Hara; T. Imagawa; M. Mori; T. Kaneko; H. Goto; S. Morita; N. Mizuki; A. Kimura; S. Yokota M. Yanagimachi; T. Miyamae; T. Naruto; T. Hara; M. Kikuchi; R. Hara; T. Imagawa; M. Mori; T. Kaneko; H. Goto; S. Morita; N. Mizuki; A. Kimura; S. Yokota M. Yanagimachi; T. Miyamae; T. Naruto; T. Hara; M. Kikuchi; R. Hara; T. Imagawa; M. Mori; T. Kaneko; H. Goto; S. Morita; N. Mizuki; A. Kimura; S. Yokota Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis Association of HLA-A*02:06 and HLA-DRB1*04:05 with clinical subtypes of juvenile idiopathic arthritis Journal of Human Genetics, 56, 3, 196-199 Journal of Human Genetics, 56, 3, 196-199 Journal of Human Genetics, 56, 3, 196-199 2011 英語 公開
T. Yamakawa; T. Kaneko; E. Shigematu; J. Kawaguchi; K. Kadonosono; S. Morita; Y. Terauchi T. Yamakawa; T. Kaneko; E. Shigematu; J. Kawaguchi; K. Kadonosono; S. Morita; Y. Terauchi T. Yamakawa; T. Kaneko; E. Shigematu; J. Kawaguchi; K. Kadonosono; S. Morita; Y. Terauchi Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia Glucose-lowering effect of colestimide is associated with baseline HbA1c in type 2 diabetic patients with hypercholesterolemia Endocrine Journal, 58, 3, 185-191 Endocrine Journal, 58, 3, 185-191 Endocrine Journal, 58, 3, 185-191 2011 英語 公開
C. Morizane; T. Okusaka; S. Morita; K. Tanaka; H. Ueno; S. Kondo; M. Ikeda; K. Nakachi; S. Mitsunaga C. Morizane; T. Okusaka; S. Morita; K. Tanaka; H. Ueno; S. Kondo; M. Ikeda; K. Nakachi; S. Mitsunaga C. Morizane; T. Okusaka; S. Morita; K. Tanaka; H. Ueno; S. Kondo; M. Ikeda; K. Nakachi; S. Mitsunaga Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma Construction and validation of a prognostic index for patients with metastatic pancreatic adenocarcinoma Pancreas, 40, 3, 415-421 Pancreas, 40, 3, 415-421 Pancreas, 40, 3, 415-421 2011 英語 公開
C. Kunisaki; H. Makino; T. Oshima; S. Fujii; J. Kimura; R. Takagawa; T. Kosaka; H. Akiyama; S. Morita; I. Endo C. Kunisaki; H. Makino; T. Oshima; S. Fujii; J. Kimura; R. Takagawa; T. Kosaka; H. Akiyama; S. Morita; I. Endo C. Kunisaki; H. Makino; T. Oshima; S. Fujii; J. Kimura; R. Takagawa; T. Kosaka; H. Akiyama; S. Morita; I. Endo Application of the transorally inserted anvil (OrVil™) after laparoscopy-assisted total gastrectomy Application of the transorally inserted anvil (OrVil™) after laparoscopy-assisted total gastrectomy Application of the transorally inserted anvil (OrVil™) after laparoscopy-assisted total gastrectomy Surgical Endoscopy and Other Interventional Techniques, 25, 4, 1300-1305 Surgical Endoscopy and Other Interventional Techniques, 25, 4, 1300-1305 Surgical Endoscopy and Other Interventional Techniques, 25, 4, 1300-1305 2011 英語 公開
T. Mitsuhashi; K. Hibi; M. Kosuge; S. Morita; N. Komura; I. Kusama; F. Otsuka; M. Endo; N. Iwahashi; J. Okuda; K. Tsukahara; T. Ebina; S. Umemura; K. Kimura T. Mitsuhashi; K. Hibi; M. Kosuge; S. Morita; N. Komura; I. Kusama; F. Otsuka; M. Endo; N. Iwahashi; J. Okuda; K. Tsukahara; T. Ebina; S. Umemura; K. Kimura T. Mitsuhashi; K. Hibi; M. Kosuge; S. Morita; N. Komura; I. Kusama; F. Otsuka; M. Endo; N. Iwahashi; J. Okuda; K. Tsukahara; T. Ebina; S. Umemura; K. Kimura Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes Relation between hyperinsulinemia and nonculprit plaque characteristics in nondiabetic patients with acute coronary syndromes JACC: Cardiovascular Imaging, 4, 4, 392-401 JACC: Cardiovascular Imaging, 4, 4, 392-401 JACC: Cardiovascular Imaging, 4, 4, 392-401 2011 英語 公開
Y. Sakuma; J. Ishitoya; M. Komatsu; O. Shiono; M. Hirama; Y. Yamashita; T. Kaneko; S. Morita; M. Tsukuda Y. Sakuma; J. Ishitoya; M. Komatsu; O. Shiono; M. Hirama; Y. Yamashita; T. Kaneko; S. Morita; M. Tsukuda Y. Sakuma; J. Ishitoya; M. Komatsu; O. Shiono; M. Hirama; Y. Yamashita; T. Kaneko; S. Morita; M. Tsukuda New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis New clinical diagnostic criteria for eosinophilic chronic rhinosinusitis Auris Nasus Larynx, 38, 5, 583-588 Auris Nasus Larynx, 38, 5, 583-588 Auris Nasus Larynx, 38, 5, 583-588 2011 英語 公開
K. Tsukahara; K. Kimura; S. Morita; T. Ebina; M. Kosuge; K. Hibi; N. Iwahashi; M. Endo; N. Maejima; T. Sugano; S. Umemura K. Tsukahara; K. Kimura; S. Morita; T. Ebina; M. Kosuge; K. Hibi; N. Iwahashi; M. Endo; N. Maejima; T. Sugano; S. Umemura K. Tsukahara; K. Kimura; S. Morita; T. Ebina; M. Kosuge; K. Hibi; N. Iwahashi; M. Endo; N. Maejima; T. Sugano; S. Umemura Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects Impact of concomitant use of proton-pump inhibitors and thienopyridine derivatives on the antiplatelet effects Journal of Cardiology, 57, 3, 275-282 Journal of Cardiology, 57, 3, 275-282 Journal of Cardiology, 57, 3, 275-282 2011 英語 公開
S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancer Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancer Prognostic implications of intraoperative radiotherapy for unresectable pancreatic cancer Pancreatology, 11, 1, 68-75 Pancreatology, 11, 1, 68-75 Pancreatology, 11, 1, 68-75 2011 英語 公開
M. Nakagawa; C. Kawanishi; T. Yamada; K. Sugiura; Y. Iwamoto; R. Sato; S. Morita; T. Odawara; Y. Hirayasu M. Nakagawa; C. Kawanishi; T. Yamada; K. Sugiura; Y. Iwamoto; R. Sato; S. Morita; T. Odawara; Y. Hirayasu M. Nakagawa; C. Kawanishi; T. Yamada; K. Sugiura; Y. Iwamoto; R. Sato; S. Morita; T. Odawara; Y. Hirayasu Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan Comparison of characteristics of suicide attempters with schizophrenia spectrum disorders and those with mood disorders in Japan Psychiatry Research, 188, 1, 78-82 Psychiatry Research, 188, 1, 78-82 Psychiatry Research, 188, 1, 78-82 2011 英語 公開
H. Makino; C. Kunisaki; T. Kosaka; H. Akiyama; S. Morita; I. Endo H. Makino; C. Kunisaki; T. Kosaka; H. Akiyama; S. Morita; I. Endo H. Makino; C. Kunisaki; T. Kosaka; H. Akiyama; S. Morita; I. Endo Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer Perioperative use of a neutrophil elastase inhibitor in video-assisted thoracoscopic oesophagectomy for cancer British Journal of Surgery, 98, 7, 975-982 British Journal of Surgery, 98, 7, 975-982 British Journal of Surgery, 98, 7, 975-982 2011 英語 公開
C. Kunisaki; M. Takahashi; H. Makino; T. Oshima; S. Fujii; R. Takagawa; J. Kimura; T. Kosaka; H.A. Ono; H. Akiyama; K. Kameda; F. Kito; S. Morita; I. Endo C. Kunisaki; M. Takahashi; H. Makino; T. Oshima; S. Fujii; R. Takagawa; J. Kimura; T. Kosaka; H.A. Ono; H. Akiyama; K. Kameda; F. Kito; S. Morita; I. Endo C. Kunisaki; M. Takahashi; H. Makino; T. Oshima; S. Fujii; R. Takagawa; J. Kimura; T. Kosaka; H.A. Ono; H. Akiyama; K. Kameda; F. Kito; S. Morita; I. Endo Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer Phase II study of biweekly docetaxel and S-1 combination chemotherapy as first-line treatment for advanced gastric cancer Cancer Chemotherapy and Pharmacology, 67, 6, 1363-1368 Cancer Chemotherapy and Pharmacology, 67, 6, 1363-1368 Cancer Chemotherapy and Pharmacology, 67, 6, 1363-1368 2011 英語 公開
P. Mathew; S. Wen; S. Morita; P.F. Thall P. Mathew; S. Wen; S. Morita; P.F. Thall P. Mathew; S. Wen; S. Morita; P.F. Thall Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases Placental growth factor and soluble c-kit receptor dynamics characterize the cytokine signature of imatinib in prostate cancer and bone metastases Journal of Interferon and Cytokine Research, 31, 7, 539-544 Journal of Interferon and Cytokine Research, 31, 7, 539-544 Journal of Interferon and Cytokine Research, 31, 7, 539-544 2011 英語 公開
M. Inoue; S. Morita; Y. Watanabe; T. Kaneko; S. Yamane; S. Kobayashi; A. Arakawa; K. Kadonosono M. Inoue; S. Morita; Y. Watanabe; T. Kaneko; S. Yamane; S. Kobayashi; A. Arakawa; K. Kadonosono M. Inoue; S. Morita; Y. Watanabe; T. Kaneko; S. Yamane; S. Kobayashi; A. Arakawa; K. Kadonosono Preoperative inner segment/outer segment junction in spectral-domain optical coherence tomography as a prognostic factor in epiretinal membrane surgery Preoperative inner segment/outer segment junction in spectral-domain optical coherence tomography as a prognostic factor in epiretinal membrane surgery Preoperative inner segment/outer segment junction in spectral-domain optical coherence tomography as a prognostic factor in epiretinal membrane surgery Retina, 31, 7, 1366-1372 Retina, 31, 7, 1366-1372 Retina, 31, 7, 1366-1372 2011 英語 公開
M. Kanda; T. Fujii; S. Nagai; Y. Kodera; A. Kanzaki; T.T. Sahin; M. Hayashi; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao M. Kanda; T. Fujii; S. Nagai; Y. Kodera; A. Kanzaki; T.T. Sahin; M. Hayashi; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao M. Kanda; T. Fujii; S. Nagai; Y. Kodera; A. Kanzaki; T.T. Sahin; M. Hayashi; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao Pattern of lymph node metastasis spread in pancreatic cancer Pattern of lymph node metastasis spread in pancreatic cancer Pattern of lymph node metastasis spread in pancreatic cancer Pancreas, 40, 6, 951-955 Pancreas, 40, 6, 951-955 Pancreas, 40, 6, 951-955 2011 英語 公開
S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; M. Hayashi; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; M. Hayashi; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao S. Nagai; T. Fujii; Y. Kodera; M. Kanda; T.T. Sahin; A. Kanzaki; M. Hayashi; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; A. Nakao Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula Recurrence pattern and prognosis of pancreatic cancer after pancreatic fistula Annals of Surgical Oncology, 18, 8, 2329-2337 Annals of Surgical Oncology, 18, 8, 2329-2337 Annals of Surgical Oncology, 18, 8, 2329-2337 2011 英語 公開
T. Hirama; T. Yamaguchi; H. Miyazawa; T. Tanaka; G. Hashikita; E. Kishi; Y. Tachi; S. Takahashi; K. Kodama; H. Egashira; A. Yokote; K. Kobayashi; M. Nagata; T. Ishii; M. Nemoto; M. Tanaka; K. Fukunaga; S. Morita; M. Kanazawa; K. Hagiwara T. Hirama; T. Yamaguchi; H. Miyazawa; T. Tanaka; G. Hashikita; E. Kishi; Y. Tachi; S. Takahashi; K. Kodama; H. Egashira; A. Yokote; K. Kobayashi; M. Nagata; T. Ishii; M. Nemoto; M. Tanaka; K. Fukunaga; S. Morita; M. Kanazawa; K. Hagiwara T. Hirama; T. Yamaguchi; H. Miyazawa; T. Tanaka; G. Hashikita; E. Kishi; Y. Tachi; S. Takahashi; K. Kodama; H. Egashira; A. Yokote; K. Kobayashi; M. Nagata; T. Ishii; M. Nemoto; M. Tanaka; K. Fukunaga; S. Morita; M. Kanazawa; K. Hagiwara Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis Prediction of the pathogens that are the cause of pneumonia by the battlefield hypothesis PLoS ONE, 6, 9 PLoS ONE, 6, 9 PLoS ONE, 6, 9 2011 英語 公開
T.T. Sahin; T. Fujii; M. Kanda; S. Nagai; Y. Kodera; A. Kanzaki; K. Yamamura; H. Sugimoto; H. Kasuya; S. Nomoto; S. Takeda; S. Morita; A. Nakao T.T. Sahin; T. Fujii; M. Kanda; S. Nagai; Y. Kodera; A. Kanzaki; K. Yamamura; H. Sugimoto; H. Kasuya; S. Nomoto; S. Takeda; S. Morita; A. Nakao T.T. Sahin; T. Fujii; M. Kanda; S. Nagai; Y. Kodera; A. Kanzaki; K. Yamamura; H. Sugimoto; H. Kasuya; S. Nomoto; S. Takeda; S. Morita; A. Nakao Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas Prognostic implications of lymph node metastases in carcinoma of the body and tail of the pancreas Pancreas, 40, 7, 1029-1033 Pancreas, 40, 7, 1029-1033 Pancreas, 40, 7, 1029-1033 2011 英語 公開
A. Hata; N. Katakami; H. Yoshioka; S. Fujita; K. Kunimasa; S. Nanjo; K. Otsuka; R. Kaji; K. Tomii; M. Iwasaku; A. Nishiyama; H. Hayashi; S. Morita; T. Ishida A. Hata; N. Katakami; H. Yoshioka; S. Fujita; K. Kunimasa; S. Nanjo; K. Otsuka; R. Kaji; K. Tomii; M. Iwasaku; A. Nishiyama; H. Hayashi; S. Morita; T. Ishida A. Hata; N. Katakami; H. Yoshioka; S. Fujita; K. Kunimasa; S. Nanjo; K. Otsuka; R. Kaji; K. Tomii; M. Iwasaku; A. Nishiyama; H. Hayashi; S. Morita; T. Ishida Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection Erlotinib after gefitinib failure in relapsed non-small cell lung cancer: Clinical benefit with optimal patient selection Lung Cancer, 74, 2, 268-273 Lung Cancer, 74, 2, 268-273 Lung Cancer, 74, 2, 268-273 2011 英語 公開
T. Fujii; M. Kanda; Y. Kodera; S. Nagai; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Morita; S. Takeda; A. Nakao T. Fujii; M. Kanda; Y. Kodera; S. Nagai; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Morita; S. Takeda; A. Nakao T. Fujii; M. Kanda; Y. Kodera; S. Nagai; T.T. Sahin; A. Kanzaki; S. Yamada; H. Sugimoto; S. Nomoto; S. Morita; S. Takeda; A. Nakao Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic head Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic head Comparison of pancreatic head resection with segmental duodenectomy and pylorus-preserving pancreatoduodenectomy for benign and low-grade malignant neoplasms of the pancreatic head Pancreas, 40, 8, 1258-1263 Pancreas, 40, 8, 1258-1263 Pancreas, 40, 8, 1258-1263 2011 英語 公開
S. Kato; K. Kubota; T. Shimamura; Y. Shinohara; N. Kobayashi; S. Watanabe; M. Yoneda; M. Inamori; F. Nakamura; H. Ishiguro; N. Nakaigawa; Y. Nagashima; M. Taguri; Y. Kubota; Y. Goshima; S. Morita; I. Endo; S. Maeda; A. Nakajima; H. Nakagama S. Kato; K. Kubota; T. Shimamura; Y. Shinohara; N. Kobayashi; S. Watanabe; M. Yoneda; M. Inamori; F. Nakamura; H. Ishiguro; N. Nakaigawa; Y. Nagashima; M. Taguri; Y. Kubota; Y. Goshima; S. Morita; I. Endo; S. Maeda; A. Nakajima; H. Nakagama S. Kato; K. Kubota; T. Shimamura; Y. Shinohara; N. Kobayashi; S. Watanabe; M. Yoneda; M. Inamori; F. Nakamura; H. Ishiguro; N. Nakaigawa; Y. Nagashima; M. Taguri; Y. Kubota; Y. Goshima; S. Morita; I. Endo; S. Maeda; A. Nakajima; H. Nakagama Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer Semaphorin 4D, a lymphocyte semaphorin, enhances tumor cell motility through binding its receptor, plexinB1, in pancreatic cancer Cancer Science, 102, 11, 2029-2037 Cancer Science, 102, 11, 2029-2037 Cancer Science, 102, 11, 2029-2037 2011 英語 公開
K. Hirasawa; A. Kokawa; H. Oka; S. Yahara; T. Sasaki; A. Nozawa; M. Morimoto; K. Numata; M. Taguri; S. Morita; S. Maeda; K. Tanaka K. Hirasawa; A. Kokawa; H. Oka; S. Yahara; T. Sasaki; A. Nozawa; M. Morimoto; K. Numata; M. Taguri; S. Morita; S. Maeda; K. Tanaka K. Hirasawa; A. Kokawa; H. Oka; S. Yahara; T. Sasaki; A. Nozawa; M. Morimoto; K. Numata; M. Taguri; S. Morita; S. Maeda; K. Tanaka Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection Risk assessment chart for curability of early gastric cancer with endoscopic submucosal dissection Gastrointestinal Endoscopy, 74, 6, 1268-1275 Gastrointestinal Endoscopy, 74, 6, 1268-1275 Gastrointestinal Endoscopy, 74, 6, 1268-1275 2011 英語 公開
X. Wang; R. Akasaka; C. Takemoto; S. Morita; M. Yamaguchi; T. Terada; M. Shirozu; S. Yokoyama; S. Chen; S. Si; Y. Xie X. Wang; R. Akasaka; C. Takemoto; S. Morita; M. Yamaguchi; T. Terada; M. Shirozu; S. Yokoyama; S. Chen; S. Si; Y. Xie X. Wang; R. Akasaka; C. Takemoto; S. Morita; M. Yamaguchi; T. Terada; M. Shirozu; S. Yokoyama; S. Chen; S. Si; Y. Xie Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3 Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3 Overexpression, purification, crystallization and preliminary crystallographic studies of a hyperthermophilic adenylosuccinate synthetase from Pyrococcus horikoshii OT3 Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 67, 12, 1551-1555 Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 67, 12, 1551-1555 Acta Crystallographica Section F: Structural Biology and Crystallization Communications, 67, 12, 1551-1555 2011 英語 公開
M. Ito; T. Kaneko; H. Goto; N. Yamaguchi; S. Fujisawa; S. Ono; S. Morita; N. Miyazawa; H. Kanamori; Y. Watanuki; Y. Ishigatsubo M. Ito; T. Kaneko; H. Goto; N. Yamaguchi; S. Fujisawa; S. Ono; S. Morita; N. Miyazawa; H. Kanamori; Y. Watanuki; Y. Ishigatsubo M. Ito; T. Kaneko; H. Goto; N. Yamaguchi; S. Fujisawa; S. Ono; S. Morita; N. Miyazawa; H. Kanamori; Y. Watanuki; Y. Ishigatsubo Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP Clinical efficacy of carbapenems on hospital-acquired pneumonia in accordance with the Japanese Respiratory Society Guidelines for management of HAP Journal of Infection and Chemotherapy, 17, 6, 770-775 Journal of Infection and Chemotherapy, 17, 6, 770-775 Journal of Infection and Chemotherapy, 17, 6, 770-775 2011 英語 公開
M. Yanagimachi; H. Goto; T. Miyamae; K. Kadota; T. Imagawa; M. Mori; H. Sato; R. Yanagisawa; T. Kaneko; S. Morita; E. Ishii; S. Yokota M. Yanagimachi; H. Goto; T. Miyamae; K. Kadota; T. Imagawa; M. Mori; H. Sato; R. Yanagisawa; T. Kaneko; S. Morita; E. Ishii; S. Yokota M. Yanagimachi; H. Goto; T. Miyamae; K. Kadota; T. Imagawa; M. Mori; H. Sato; R. Yanagisawa; T. Kaneko; S. Morita; E. Ishii; S. Yokota Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children Association of IRF5 polymorphisms with susceptibility to hemophagocytic lymphohistiocytosis in children Journal of Clinical Immunology, 31, 6, 946-951 Journal of Clinical Immunology, 31, 6, 946-951 Journal of Clinical Immunology, 31, 6, 946-951 2011 英語 公開
T. Nakayama; S. Morita; T. Takashima; S. Kamigaki; K. Yoshidome; T. Ito; T. Taguchi; J. Sakamoto; S. Noguchi T. Nakayama; S. Morita; T. Takashima; S. Kamigaki; K. Yoshidome; T. Ito; T. Taguchi; J. Sakamoto; S. Noguchi T. Nakayama; S. Morita; T. Takashima; S. Kamigaki; K. Yoshidome; T. Ito; T. Taguchi; J. Sakamoto; S. Noguchi Phase I study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer Phase I study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer Phase I study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer Anticancer Research, 31, 9, 3035-3039 Anticancer Research, 31, 9, 3035-3039 Anticancer Research, 31, 9, 3035-3039 2011 英語 公開
H. Kuwabara; H. Takahashi; Y. Hattori; R. Ohshima; M. Hagihara; R. Sakai; T. Kaneko; S. Morita; Y. Ishigatsubo; S. Fujisawa H. Kuwabara; H. Takahashi; Y. Hattori; R. Ohshima; M. Hagihara; R. Sakai; T. Kaneko; S. Morita; Y. Ishigatsubo; S. Fujisawa H. Kuwabara; H. Takahashi; Y. Hattori; R. Ohshima; M. Hagihara; R. Sakai; T. Kaneko; S. Morita; Y. Ishigatsubo; S. Fujisawa Assessment of adherence to imatinib therapy by questionnaire survey in patients with chronic myeloid leukemia Assessment of adherence to imatinib therapy by questionnaire survey in patients with chronic myeloid leukemia Assessment of adherence to imatinib therapy by questionnaire survey in patients with chronic myeloid leukemia Yokohama Medical Journal, 62, 4, 495-500 Yokohama Medical Journal, 62, 4, 495-500 Yokohama Medical Journal, 62, 4, 495-500 2011 英語 公開
H. Hirakata; Y. Tsubakihara; F. Gejyo; S. Nishi; Y. Iino; Y. Watanabe; M. Suzuki; A. Saito; T. Akiba; D. Inaguma; S. Fukuhara; S. Morita; M. Hiroe; Y. Hada; M. Suzuki; M. Akaishi; K. Aonuma; T. Akizawa H. Hirakata; Y. Tsubakihara; F. Gejyo; S. Nishi; Y. Iino; Y. Watanabe; M. Suzuki; A. Saito; T. Akiba; D. Inaguma; S. Fukuhara; S. Morita; M. Hiroe; Y. Hada; M. Suzuki; M. Akaishi; K. Aonuma; T. Akizawa H. Hirakata; Y. Tsubakihara; F. Gejyo; S. Nishi; Y. Iino; Y. Watanabe; M. Suzuki; A. Saito; T. Akiba; D. Inaguma; S. Fukuhara; S. Morita; M. Hiroe; Y. Hada; M. Suzuki; M. Akaishi; K. Aonuma; T. Akizawa Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients Maintaining high hemoglobin levels improved the left ventricular mass index and quality of life scores in pre-dialysis Japanese chronic kidney disease patients Clinical and Experimental Nephrology, 14, 1, 28-35 Clinical and Experimental Nephrology, 14, 1, 28-35 Clinical and Experimental Nephrology, 14, 1, 28-35 2010/02 英語 公開
T. Tanaka; M. Matsuoka; A. Sutani; A. Gemma; M. Maemondo; A. Inoue; S. Okinaga; M. Nagashima; S. Oizumi; K. Uematsu; Y. Nagai; G. Moriyama; H. Miyazawa; K. Ikebuchi; S. Morita; K. Kobayashi; K. Hagiwara T. Tanaka; M. Matsuoka; A. Sutani; A. Gemma; M. Maemondo; A. Inoue; S. Okinaga; M. Nagashima; S. Oizumi; K. Uematsu; Y. Nagai; G. Moriyama; H. Miyazawa; K. Ikebuchi; S. Morita; K. Kobayashi; K. Hagiwara T. Tanaka; M. Matsuoka; A. Sutani; A. Gemma; M. Maemondo; A. Inoue; S. Okinaga; M. Nagashima; S. Oizumi; K. Uematsu; Y. Nagai; G. Moriyama; H. Miyazawa; K. Ikebuchi; S. Morita; K. Kobayashi; K. Hagiwara Frequency of and variables associated with the EGFR mutation and its subtypes Frequency of and variables associated with the EGFR mutation and its subtypes Frequency of and variables associated with the EGFR mutation and its subtypes International Journal of Cancer, 126, 3, 651-655 International Journal of Cancer, 126, 3, 651-655 International Journal of Cancer, 126, 3, 651-655 2010 英語 公開
S. Morita; P.F. Thall; B.N. Bekele; P. Mathew S. Morita; P.F. Thall; B.N. Bekele; P. Mathew S. Morita; P.F. Thall; B.N. Bekele; P. Mathew A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer A Bayesian hierarchical mixture model for platelet-derived growth factor receptor phosphorylation to improve estimation of progression-free survival in prostate cancer Journal of the Royal Statistical Society. Series C: Applied Statistics, 59, 1, 19-34 Journal of the Royal Statistical Society. Series C: Applied Statistics, 59, 1, 19-34 Journal of the Royal Statistical Society. Series C: Applied Statistics, 59, 1, 19-34 2010 英語 公開
T. Mitsudomi; S. Morita; Y. Yatabe; S. Negoro; I. Okamoto; J. Tsurutani; T. Seto; M. Satouchi; H. Tada; T. Hirashima; K. Asami; N. Katakami; M. Takada; H. Yoshioka; K. Shibata; S. Kudoh; E. Shimizu; H. Saito; S. Toyooka; K. Nakagawa; M. Fukuoka T. Mitsudomi; S. Morita; Y. Yatabe; S. Negoro; I. Okamoto; J. Tsurutani; T. Seto; M. Satouchi; H. Tada; T. Hirashima; K. Asami; N. Katakami; M. Takada; H. Yoshioka; K. Shibata; S. Kudoh; E. Shimizu; H. Saito; S. Toyooka; K. Nakagawa; M. Fukuoka T. Mitsudomi; S. Morita; Y. Yatabe; S. Negoro; I. Okamoto; J. Tsurutani; T. Seto; M. Satouchi; H. Tada; T. Hirashima; K. Asami; N. Katakami; M. Takada; H. Yoshioka; K. Shibata; S. Kudoh; E. Shimizu; H. Saito; S. Toyooka; K. Nakagawa; M. Fukuoka Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial The Lancet Oncology, 11, 2, 121-128 The Lancet Oncology, 11, 2, 121-128 The Lancet Oncology, 11, 2, 121-128 2010 英語 公開
S. Manabe; T. Fukui; T. Shimokawa; M. Tabata; Y. Katayama; S. Morita; S. Takanashi S. Manabe; T. Fukui; T. Shimokawa; M. Tabata; Y. Katayama; S. Morita; S. Takanashi S. Manabe; T. Fukui; T. Shimokawa; M. Tabata; Y. Katayama; S. Morita; S. Takanashi Increased Graft Occlusion or String Sign in Composite Arterial Grafting for Mildly Stenosed Target Vessels Increased Graft Occlusion or String Sign in Composite Arterial Grafting for Mildly Stenosed Target Vessels Increased Graft Occlusion or String Sign in Composite Arterial Grafting for Mildly Stenosed Target Vessels Annals of Thoracic Surgery, 89, 3, 683-687 Annals of Thoracic Surgery, 89, 3, 683-687 Annals of Thoracic Surgery, 89, 3, 683-687 2010 英語 公開
M. Kanda; T. Fujii; T.T. Sahin; A. Kanzaki; S. Nagai; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; Y. Kodera; S. Morita; A. Nakao M. Kanda; T. Fujii; T.T. Sahin; A. Kanzaki; S. Nagai; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; Y. Kodera; S. Morita; A. Nakao M. Kanda; T. Fujii; T.T. Sahin; A. Kanzaki; S. Nagai; S. Yamada; H. Sugimoto; S. Nomoto; S. Takeda; Y. Kodera; S. Morita; A. Nakao Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas Annals of Surgery, 251, 3, 483-487 Annals of Surgery, 251, 3, 483-487 Annals of Surgery, 251, 3, 483-487 2010 英語 公開
L.S. Heng; H. Yatsuya; S. Morita; J. Sakamoto L.S. Heng; H. Yatsuya; S. Morita; J. Sakamoto L.S. Heng; H. Yatsuya; S. Morita; J. Sakamoto Vaginal douching in cambodian women: Its prevalence and association with vaginal candidiasis Vaginal douching in cambodian women: Its prevalence and association with vaginal candidiasis Vaginal douching in cambodian women: Its prevalence and association with vaginal candidiasis Journal of Epidemiology, 20, 1, 70-76 Journal of Epidemiology, 20, 1, 70-76 Journal of Epidemiology, 20, 1, 70-76 2010 英語 公開
M. Toi; J. Sperinde; W. Huang; S. Saji; J. Winslow; X. Jin; Y. Tan; S. Ohno; S. Nakamura; H. Iwata; N. Masuda; K. Aogi; S. Morita; C. Petropoulos; M. Bates M. Toi; J. Sperinde; W. Huang; S. Saji; J. Winslow; X. Jin; Y. Tan; S. Ohno; S. Nakamura; H. Iwata; N. Masuda; K. Aogi; S. Morita; C. Petropoulos; M. Bates M. Toi; J. Sperinde; W. Huang; S. Saji; J. Winslow; X. Jin; Y. Tan; S. Ohno; S. Nakamura; H. Iwata; N. Masuda; K. Aogi; S. Morita; C. Petropoulos; M. Bates Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer Differential survival following trastuzumab treatment based on quantitative HER2 expression and HER2 homodimers in a clinic-based cohort of patients with metastatic breast cancer BMC Cancer, 10 BMC Cancer, 10 BMC Cancer, 10 2010 英語 公開
T. Fukui; M. Tabata; S. Manabe; T. Shimokawa; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Manabe; T. Shimokawa; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Manabe; T. Shimokawa; S. Morita; S. Takanashi Angiographic outcomes of right internal thoracic artery grafts in situ or as free grafts in coronary artery bypass grafting Angiographic outcomes of right internal thoracic artery grafts in situ or as free grafts in coronary artery bypass grafting Angiographic outcomes of right internal thoracic artery grafts in situ or as free grafts in coronary artery bypass grafting Journal of Thoracic and Cardiovascular Surgery, 139, 4, 868-873 Journal of Thoracic and Cardiovascular Surgery, 139, 4, 868-873 Journal of Thoracic and Cardiovascular Surgery, 139, 4, 868-873 2010 英語 公開
S. Morita; P.F. Thall; P. Müller S. Morita; P.F. Thall; P. Müller S. Morita; P.F. Thall; P. Müller Evaluating the impact of prior assumptions in Bayesian biostatistics Evaluating the impact of prior assumptions in Bayesian biostatistics Evaluating the impact of prior assumptions in Bayesian biostatistics Statistics in Biosciences, 2, 1, 1-17 Statistics in Biosciences, 2, 1, 1-17 Statistics in Biosciences, 2, 1, 1-17 2010 英語 公開
A. Nozaki; M. Morimoto; M. Kondo; T. Oshima; K. Numata; S. Fujisawa; T. Kaneko; E. Miyajima; S. Morita; K. Mori; M. Ikeda; N. Kato; K. Tanaka A. Nozaki; M. Morimoto; M. Kondo; T. Oshima; K. Numata; S. Fujisawa; T. Kaneko; E. Miyajima; S. Morita; K. Mori; M. Ikeda; N. Kato; K. Tanaka A. Nozaki; M. Morimoto; M. Kondo; T. Oshima; K. Numata; S. Fujisawa; T. Kaneko; E. Miyajima; S. Morita; K. Mori; M. Ikeda; N. Kato; K. Tanaka Hydroxyurea as an inhibitor of hepatitis C virus RNA replication Hydroxyurea as an inhibitor of hepatitis C virus RNA replication Hydroxyurea as an inhibitor of hepatitis C virus RNA replication Archives of Virology, 155, 4, 601-605 Archives of Virology, 155, 4, 601-605 Archives of Virology, 155, 4, 601-605 2010 英語 公開
K. Tsukahara; K. Kimura; S. Morita; T. Ebina; M. Kosuge; K. Hibi; J. Okuda; N. Iwahashi; N. Maejima; T. Nakachi; F. Ohtsuka; K. Hashiba; Y. Tahara; T. Sugano; S. Umemura K. Tsukahara; K. Kimura; S. Morita; T. Ebina; M. Kosuge; K. Hibi; J. Okuda; N. Iwahashi; N. Maejima; T. Nakachi; F. Ohtsuka; K. Hashiba; Y. Tahara; T. Sugano; S. Umemura K. Tsukahara; K. Kimura; S. Morita; T. Ebina; M. Kosuge; K. Hibi; J. Okuda; N. Iwahashi; N. Maejima; T. Nakachi; F. Ohtsuka; K. Hashiba; Y. Tahara; T. Sugano; S. Umemura Impact of high-responsiveness to dual antiplatelet therapy on bleeding complications in patients receiving drug-eluting stents Impact of high-responsiveness to dual antiplatelet therapy on bleeding complications in patients receiving drug-eluting stents Impact of high-responsiveness to dual antiplatelet therapy on bleeding complications in patients receiving drug-eluting stents Circulation Journal, 74, 4, 679-685 Circulation Journal, 74, 4, 679-685 Circulation Journal, 74, 4, 679-685 2010 英語 公開
T. Yoshikawa; A. Tsuburaya; S. Morita; Y. Kodera; S. Ito; H. Cho; Y. Miyashita; J. Sakamoto T. Yoshikawa; A. Tsuburaya; S. Morita; Y. Kodera; S. Ito; H. Cho; Y. Miyashita; J. Sakamoto T. Yoshikawa; A. Tsuburaya; S. Morita; Y. Kodera; S. Ito; H. Cho; Y. Miyashita; J. Sakamoto A comparison of multimodality treatment: Two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized phase II trial (COMPASS) A comparison of multimodality treatment: Two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized phase II trial (COMPASS) A comparison of multimodality treatment: Two or four courses of paclitaxel plus cisplatin or S-1 plus cisplatin followed by surgery for locally advanced gastric cancer, a randomized phase II trial (COMPASS) Japanese Journal of Clinical Oncology, 40, 4, 369-372 Japanese Journal of Clinical Oncology, 40, 4, 369-372 Japanese Journal of Clinical Oncology, 40, 4, 369-372 2010 英語 公開
K. Tsushima; S. Sone; K. Fujimoto; K. Kubo; S. Morita; M. Takegami; S. Fukuhara K. Tsushima; S. Sone; K. Fujimoto; K. Kubo; S. Morita; M. Takegami; S. Fukuhara K. Tsushima; S. Sone; K. Fujimoto; K. Kubo; S. Morita; M. Takegami; S. Fukuhara Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography Identification of occult parechymal disease such as emphysema or airway disease using screening computed tomography COPD: Journal of Chronic Obstructive Pulmonary Disease, 7, 2, 117-125 COPD: Journal of Chronic Obstructive Pulmonary Disease, 7, 2, 117-125 COPD: Journal of Chronic Obstructive Pulmonary Disease, 7, 2, 117-125 2010 英語 公開
W. Luo; K. Numata; M. Morimoto; A. Nozaki; M. Ueda; M. Kondo; S. Morita; K. Tanaka W. Luo; K. Numata; M. Morimoto; A. Nozaki; M. Ueda; M. Kondo; S. Morita; K. Tanaka W. Luo; K. Numata; M. Morimoto; A. Nozaki; M. Ueda; M. Kondo; S. Morita; K. Tanaka Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies Differentiation of focal liver lesions using three-dimensional ultrasonography: Retrospective and prospective studies World Journal of Gastroenterology, 16, 17, 2109-2119 World Journal of Gastroenterology, 16, 17, 2109-2119 World Journal of Gastroenterology, 16, 17, 2109-2119 2010 英語 公開
M. Kosuge; T. Ebina; K. Hibi; S. Morita; J. Okuda; N. Iwahashi; K. Tsukahara; T. Nakachi; M. Kiyokuni; T. Ishikawa; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; S. Morita; J. Okuda; N. Iwahashi; K. Tsukahara; T. Nakachi; M. Kiyokuni; T. Ishikawa; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; S. Morita; J. Okuda; N. Iwahashi; K. Tsukahara; T. Nakachi; M. Kiyokuni; T. Ishikawa; S. Umemura; K. Kimura Simple and Accurate Electrocardiographic Criteria to Differentiate Takotsubo Cardiomyopathy From Anterior Acute Myocardial Infarction Simple and Accurate Electrocardiographic Criteria to Differentiate Takotsubo Cardiomyopathy From Anterior Acute Myocardial Infarction Simple and Accurate Electrocardiographic Criteria to Differentiate Takotsubo Cardiomyopathy From Anterior Acute Myocardial Infarction Journal of the American College of Cardiology, 55, 22, 2514-2516 Journal of the American College of Cardiology, 55, 22, 2514-2516 Journal of the American College of Cardiology, 55, 22, 2514-2516 2010 英語 公開
M. Maemondo; A. Inoue; K. Kobayashi; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; M. Harada; H. Yoshizawa; I. Kinoshita; Y. Fujita; S. Okinaga; H. Hirano; K. Yoshimori; T. Harada; T. Ogura; M. Ando; H. Miyazawa; T. Tanaka; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa M. Maemondo; A. Inoue; K. Kobayashi; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; M. Harada; H. Yoshizawa; I. Kinoshita; Y. Fujita; S. Okinaga; H. Hirano; K. Yoshimori; T. Harada; T. Ogura; M. Ando; H. Miyazawa; T. Tanaka; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa M. Maemondo; A. Inoue; K. Kobayashi; S. Sugawara; S. Oizumi; H. Isobe; A. Gemma; M. Harada; H. Yoshizawa; I. Kinoshita; Y. Fujita; S. Okinaga; H. Hirano; K. Yoshimori; T. Harada; T. Ogura; M. Ando; H. Miyazawa; T. Tanaka; Y. Saijo; K. Hagiwara; S. Morita; T. Nukiwa Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR New England Journal of Medicine, 362, 25, 2380-2388 New England Journal of Medicine, 362, 25, 2380-2388 New England Journal of Medicine, 362, 25, 2380-2388 2010 英語 公開
T. Ishikawa; D. Shimizu; T. Sasaki; S. Morita; M. Tanabe; I. Ota; K. Kawachi; A. Nozawa; T. Chishima; Y. Ichikawa; I. Endo; H. Shimada T. Ishikawa; D. Shimizu; T. Sasaki; S. Morita; M. Tanabe; I. Ota; K. Kawachi; A. Nozawa; T. Chishima; Y. Ichikawa; I. Endo; H. Shimada T. Ishikawa; D. Shimizu; T. Sasaki; S. Morita; M. Tanabe; I. Ota; K. Kawachi; A. Nozawa; T. Chishima; Y. Ichikawa; I. Endo; H. Shimada A human epidermal growth factor receptor 2 expression-based approach to neoadjuvant chemotherapy for operable breast cancer A human epidermal growth factor receptor 2 expression-based approach to neoadjuvant chemotherapy for operable breast cancer A human epidermal growth factor receptor 2 expression-based approach to neoadjuvant chemotherapy for operable breast cancer Japanese Journal of Clinical Oncology, 40, 7, 620-626 Japanese Journal of Clinical Oncology, 40, 7, 620-626 Japanese Journal of Clinical Oncology, 40, 7, 620-626 2010 英語 公開
T. Fujii; K. Kato; Y. Kodera; M. Kanda; S. Nagai; S. Yamada; A. Kanzaki; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; S. Nakamura; A. Nakao T. Fujii; K. Kato; Y. Kodera; M. Kanda; S. Nagai; S. Yamada; A. Kanzaki; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; S. Nakamura; A. Nakao T. Fujii; K. Kato; Y. Kodera; M. Kanda; S. Nagai; S. Yamada; A. Kanzaki; H. Sugimoto; S. Nomoto; S. Takeda; S. Morita; S. Nakamura; A. Nakao Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas Prognostic impact of pancreatic margin status in the intraductal papillary mucinous neoplasms of the pancreas Surgery, 148, 2, 285-290 Surgery, 148, 2, 285-290 Surgery, 148, 2, 285-290 2010 英語 公開
K. Muro; N. Boku; Y. Shimada; A. Tsuji; S. Sameshima; H. Baba; T. Satoh; T. Denda; K. Ina; T. Nishina; K. Yamaguchi; H. Takiuchi; T. Esaki; S. Tokunaga; H. Kuwano; Y. Komatsu; M. Watanabe; I. Hyodo; S. Morita; K. Sugihara K. Muro; N. Boku; Y. Shimada; A. Tsuji; S. Sameshima; H. Baba; T. Satoh; T. Denda; K. Ina; T. Nishina; K. Yamaguchi; H. Takiuchi; T. Esaki; S. Tokunaga; H. Kuwano; Y. Komatsu; M. Watanabe; I. Hyodo; S. Morita; K. Sugihara K. Muro; N. Boku; Y. Shimada; A. Tsuji; S. Sameshima; H. Baba; T. Satoh; T. Denda; K. Ina; T. Nishina; K. Yamaguchi; H. Takiuchi; T. Esaki; S. Tokunaga; H. Kuwano; Y. Komatsu; M. Watanabe; I. Hyodo; S. Morita; K. Sugihara Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: A randomised phase 2/3 non-inferiority study (FIRIS study) Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: A randomised phase 2/3 non-inferiority study (FIRIS study) Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: A randomised phase 2/3 non-inferiority study (FIRIS study) The Lancet Oncology, 11, 9, 853-860 The Lancet Oncology, 11, 9, 853-860 The Lancet Oncology, 11, 9, 853-860 2010 英語 公開
M. Kobayashi; N. Hirawa; S. Morita; K. Yatsu; Y. Kobayashi; Y. Yamamoto; S. Saka; Y. Toya; G. Yasuda; S. Umemura M. Kobayashi; N. Hirawa; S. Morita; K. Yatsu; Y. Kobayashi; Y. Yamamoto; S. Saka; Y. Toya; G. Yasuda; S. Umemura M. Kobayashi; N. Hirawa; S. Morita; K. Yatsu; Y. Kobayashi; Y. Yamamoto; S. Saka; Y. Toya; G. Yasuda; S. Umemura Silent brain infarction and rapid decline of kidney function in patients with CKD: A prospective cohort study Silent brain infarction and rapid decline of kidney function in patients with CKD: A prospective cohort study Silent brain infarction and rapid decline of kidney function in patients with CKD: A prospective cohort study American Journal of Kidney Diseases, 56, 3, 468-476 American Journal of Kidney Diseases, 56, 3, 468-476 American Journal of Kidney Diseases, 56, 3, 468-476 2010 英語 公開
Y. Oji; Y. Oka; S. Nishida; A. Tsuboi; M. Kawakami; T. Shirakata; K. Takahashi; A. Murao; H. Nakajima; M. Narita; M. Takahashi; S. Morita; J. Sakamoto; T. Tanaka; I. Kawase; N. Hosen; H. Sugiyama Y. Oji; Y. Oka; S. Nishida; A. Tsuboi; M. Kawakami; T. Shirakata; K. Takahashi; A. Murao; H. Nakajima; M. Narita; M. Takahashi; S. Morita; J. Sakamoto; T. Tanaka; I. Kawase; N. Hosen; H. Sugiyama Y. Oji; Y. Oka; S. Nishida; A. Tsuboi; M. Kawakami; T. Shirakata; K. Takahashi; A. Murao; H. Nakajima; M. Narita; M. Takahashi; S. Morita; J. Sakamoto; T. Tanaka; I. Kawase; N. Hosen; H. Sugiyama WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient WT1 peptide vaccine induces reduction in minimal residual disease in an Imatinib-treated CML patient European Journal of Haematology, 85, 4, 358-360 European Journal of Haematology, 85, 4, 358-360 European Journal of Haematology, 85, 4, 358-360 2010 英語 公開
Y. Ueda; H. Yamagishi; D. Ichikawa; K. Okamoto; E. Otsuji; J. Morii; K. Koizumi; N. Kakihara; M. Shimotsuma; T. Yamashita; F. Taniguchi; H. Aragane; H. Nishi; Y. Itokawa; S. Morita; J. Sakamoto Y. Ueda; H. Yamagishi; D. Ichikawa; K. Okamoto; E. Otsuji; J. Morii; K. Koizumi; N. Kakihara; M. Shimotsuma; T. Yamashita; F. Taniguchi; H. Aragane; H. Nishi; Y. Itokawa; S. Morita; J. Sakamoto Y. Ueda; H. Yamagishi; D. Ichikawa; K. Okamoto; E. Otsuji; J. Morii; K. Koizumi; N. Kakihara; M. Shimotsuma; T. Yamashita; F. Taniguchi; H. Aragane; H. Nishi; Y. Itokawa; S. Morita; J. Sakamoto Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer Multicenter phase II study of weekly paclitaxel plus S-1 combination chemotherapy in patients with advanced gastric cancer Gastric Cancer, 13, 3, 149-154 Gastric Cancer, 13, 3, 149-154 Gastric Cancer, 13, 3, 149-154 2010 英語 公開
T. Fukui; M. Tabata; S. Manabe; T. Shimokawa; J. Shimizu; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Manabe; T. Shimokawa; J. Shimizu; S. Morita; S. Takanashi T. Fukui; M. Tabata; S. Manabe; T. Shimokawa; J. Shimizu; S. Morita; S. Takanashi Off-pump bilateral internal thoracic artery grafting in patients with left main disease Off-pump bilateral internal thoracic artery grafting in patients with left main disease Off-pump bilateral internal thoracic artery grafting in patients with left main disease Journal of Thoracic and Cardiovascular Surgery, 140, 5, 1040-1045 Journal of Thoracic and Cardiovascular Surgery, 140, 5, 1040-1045 Journal of Thoracic and Cardiovascular Surgery, 140, 5, 1040-1045 2010 英語 公開
Y. Kodera; M. Fujiwara; N. Ohashi; G. Nakayama; M. Koike; S. Morita; A. Nakao Y. Kodera; M. Fujiwara; N. Ohashi; G. Nakayama; M. Koike; S. Morita; A. Nakao Y. Kodera; M. Fujiwara; N. Ohashi; G. Nakayama; M. Koike; S. Morita; A. Nakao Laparoscopic surgery for gastric cancer: A collective review with meta-analysis of randomized trials Laparoscopic surgery for gastric cancer: A collective review with meta-analysis of randomized trials Laparoscopic surgery for gastric cancer: A collective review with meta-analysis of randomized trials Journal of the American College of Surgeons, 211, 5, 677-686 Journal of the American College of Surgeons, 211, 5, 677-686 Journal of the American College of Surgeons, 211, 5, 677-686 2010 英語 公開
U. Tateishi; S. Morita; M. Taguri; K. Shizukuishi; R. Minamimoto; M. Kawaguchi; T. Murano; T. Terauchi; T. Inoue; E.E. Kim U. Tateishi; S. Morita; M. Taguri; K. Shizukuishi; R. Minamimoto; M. Kawaguchi; T. Murano; T. Terauchi; T. Inoue; E.E. Kim U. Tateishi; S. Morita; M. Taguri; K. Shizukuishi; R. Minamimoto; M. Kawaguchi; T. Murano; T. Terauchi; T. Inoue; E.E. Kim A meta-analysis of <sup>18</sup>F-Fluoride positron emission tomography for assessment of metastatic bone tumor A meta-analysis of <sup>18</sup>F-Fluoride positron emission tomography for assessment of metastatic bone tumor A meta-analysis of <sup>18</sup>F-Fluoride positron emission tomography for assessment of metastatic bone tumor Annals of Nuclear Medicine, 24, 7, 523-531 Annals of Nuclear Medicine, 24, 7, 523-531 Annals of Nuclear Medicine, 24, 7, 523-531 2010 英語 公開
G. Miyashita; T. Higuchi; N. Oriuchi; Y. Arisaka; H. Hanaoka; H. Tominaga; S. Morita; M. Miyakubo; T. Ishikita; Y. Nakasone; A. Negishi; S. Yokoo; K. Endo G. Miyashita; T. Higuchi; N. Oriuchi; Y. Arisaka; H. Hanaoka; H. Tominaga; S. Morita; M. Miyakubo; T. Ishikita; Y. Nakasone; A. Negishi; S. Yokoo; K. Endo G. Miyashita; T. Higuchi; N. Oriuchi; Y. Arisaka; H. Hanaoka; H. Tominaga; S. Morita; M. Miyakubo; T. Ishikita; Y. Nakasone; A. Negishi; S. Yokoo; K. Endo <sup>18</sup>F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with <sup>18</sup>F-FDG PET and immunohistochemistry <sup>18</sup>F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with <sup>18</sup>F-FDG PET and immunohistochemistry <sup>18</sup>F-FAMT uptake correlates with tumor proliferative activity in oral squamous cell carcinoma: Comparative study with <sup>18</sup>F-FDG PET and immunohistochemistry Annals of Nuclear Medicine, 24, 8, 579-584 Annals of Nuclear Medicine, 24, 8, 579-584 Annals of Nuclear Medicine, 24, 8, 579-584 2010 英語 公開
S. Manabe; T. Fukui; M. Tabata; T. Shimokawa; S. Morita; S. Takanashi S. Manabe; T. Fukui; M. Tabata; T. Shimokawa; S. Morita; S. Takanashi S. Manabe; T. Fukui; M. Tabata; T. Shimokawa; S. Morita; S. Takanashi Arterial graft deterioration one year after coronary artery bypass grafting Arterial graft deterioration one year after coronary artery bypass grafting Arterial graft deterioration one year after coronary artery bypass grafting Journal of Thoracic and Cardiovascular Surgery, 140, 6, 1306-1311 Journal of Thoracic and Cardiovascular Surgery, 140, 6, 1306-1311 Journal of Thoracic and Cardiovascular Surgery, 140, 6, 1306-1311 2010 英語 公開
M. Inoue; S. Morita; Y. Watanabe; T. Kaneko; S. Yamane; S. Kobayashi; A. Arakawa; K. Kadonosono M. Inoue; S. Morita; Y. Watanabe; T. Kaneko; S. Yamane; S. Kobayashi; A. Arakawa; K. Kadonosono M. Inoue; S. Morita; Y. Watanabe; T. Kaneko; S. Yamane; S. Kobayashi; A. Arakawa; K. Kadonosono Inner segment/outer segment junction assessed by spectral-domain optical coherence tomography in patients with idiopathic epiretinal membrane Inner segment/outer segment junction assessed by spectral-domain optical coherence tomography in patients with idiopathic epiretinal membrane Inner segment/outer segment junction assessed by spectral-domain optical coherence tomography in patients with idiopathic epiretinal membrane American Journal of Ophthalmology, 150, 6, 834-839 American Journal of Ophthalmology, 150, 6, 834-839 American Journal of Ophthalmology, 150, 6, 834-839 2010 英語 公開
M. Morimoto; K. Numata; M. Kondou; A. Nozaki; S. Morita; K. Tanaka M. Morimoto; K. Numata; M. Kondou; A. Nozaki; S. Morita; K. Tanaka M. Morimoto; K. Numata; M. Kondou; A. Nozaki; S. Morita; K. Tanaka Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: A randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization Cancer, 116, 23, 5452-5460 Cancer, 116, 23, 5452-5460 Cancer, 116, 23, 5452-5460 2010 英語 公開
A. Nozaki; K. Numata; M. Morimoto; M. Kondo; K. Sugimori; S. Morita; E. Miyajima; M. Ikeda; N. Kato; S. Maeda; K. Tanaka A. Nozaki; K. Numata; M. Morimoto; M. Kondo; K. Sugimori; S. Morita; E. Miyajima; M. Ikeda; N. Kato; S. Maeda; K. Tanaka A. Nozaki; K. Numata; M. Morimoto; M. Kondo; K. Sugimori; S. Morita; E. Miyajima; M. Ikeda; N. Kato; S. Maeda; K. Tanaka Hydroxyurea suppresses HCV replication in humans: A Phase I trial of oral hydroxyurea in chronic hepatitis C patients Hydroxyurea suppresses HCV replication in humans: A Phase I trial of oral hydroxyurea in chronic hepatitis C patients Hydroxyurea suppresses HCV replication in humans: A Phase I trial of oral hydroxyurea in chronic hepatitis C patients Antiviral Therapy, 15, 8, 1179-1183 Antiviral Therapy, 15, 8, 1179-1183 Antiviral Therapy, 15, 8, 1179-1183 2010 英語 公開
I. Okamoto; H. Yoshioka; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; K. Asami; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; M. Miyazaki; K. Tamura; T. Kurata; M. Fukuoka; K. Nakagawa I. Okamoto; H. Yoshioka; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; K. Asami; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; M. Miyazaki; K. Tamura; T. Kurata; M. Fukuoka; K. Nakagawa I. Okamoto; H. Yoshioka; S. Morita; M. Ando; K. Takeda; T. Seto; N. Yamamoto; H. Saka; K. Asami; T. Hirashima; S. Kudoh; M. Satouchi; N. Ikeda; Y. Iwamoto; T. Sawa; M. Miyazaki; K. Tamura; T. Kurata; M. Fukuoka; K. Nakagawa Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: Results of a west Japan oncology group study Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: Results of a west Japan oncology group study Phase III trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small-cell lung cancer: Results of a west Japan oncology group study Journal of Clinical Oncology, 28, 36, 5240-5246 Journal of Clinical Oncology, 28, 36, 5240-5246 Journal of Clinical Oncology, 28, 36, 5240-5246 2010 英語 公開
I. Ota; A. Sakurai; Yu. Toyoda; S. Morita; T. Sasaki; T. Chishima; M. Yamakado; Y. Kawai; T. Ishidao; A. Lezhava; K.-I. Yoshiura; S. Togo; Y. Hayashizaki; T. Ishikawa; T. Ishikawa; I. Endo; H. Shimada I. Ota; A. Sakurai; Yu. Toyoda; S. Morita; T. Sasaki; T. Chishima; M. Yamakado; Y. Kawai; T. Ishidao; A. Lezhava; K.-I. Yoshiura; S. Togo; Y. Hayashizaki; T. Ishikawa; T. Ishikawa; I. Endo; H. Shimada I. Ota; A. Sakurai; Yu. Toyoda; S. Morita; T. Sasaki; T. Chishima; M. Yamakado; Y. Kawai; T. Ishidao; A. Lezhava; K.-I. Yoshiura; S. Togo; Y. Hayashizaki; T. Ishikawa; T. Ishikawa; I. Endo; H. Shimada Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11 Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11 Association between breast cancer risk and the wild-type allele of human ABC transporter ABCC11 Anticancer Research, 30, 12, 5189-5194 Anticancer Research, 30, 12, 5189-5194 Anticancer Research, 30, 12, 5189-5194 2010 英語 公開
S. Morita; K. Shibata; S. Ueno; K. Ichimoto; R. Kitai; K.-I. Otsuji S. Morita; K. Shibata; S. Ueno; K. Ichimoto; R. Kitai; K.-I. Otsuji S. Morita; K. Shibata; S. Ueno; K. Ichimoto; R. Kitai; K.-I. Otsuji Observations of chromospheric anemone jets with hinode Ca II broadband filtergraph and hida Ca II spectroheliograph Observations of chromospheric anemone jets with hinode Ca II broadband filtergraph and hida Ca II spectroheliograph Observations of chromospheric anemone jets with hinode Ca II broadband filtergraph and hida Ca II spectroheliograph Publications of the Astronomical Society of Japan, 62, 4, 901-920 Publications of the Astronomical Society of Japan, 62, 4, 901-920 Publications of the Astronomical Society of Japan, 62, 4, 901-920 2010 英語 公開
T. Akizawa; Y. Asano; S. Morita; T. Wakita; Y. Onishi; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; K. Kurokawa T. Akizawa; Y. Asano; S. Morita; T. Wakita; Y. Onishi; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; K. Kurokawa T. Akizawa; Y. Asano; S. Morita; T. Wakita; Y. Onishi; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; K. Kurokawa Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial Effect of a Carbonaceous Oral Adsorbent on the Progression of CKD: A Multicenter, Randomized, Controlled Trial American Journal of Kidney Diseases, 54, 3, 459-467 American Journal of Kidney Diseases, 54, 3, 459-467 American Journal of Kidney Diseases, 54, 3, 459-467 2009/09 英語 公開
T. Fukui; T. Shimokawa; S. Manabe; S. Morita; S. Takanashi T. Fukui; T. Shimokawa; S. Manabe; S. Morita; S. Takanashi T. Fukui; T. Shimokawa; S. Manabe; S. Morita; S. Takanashi Prior Inferior Myocardial Infarction Has Worse Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Than Prior Anterior Myocardial Infarction Prior Inferior Myocardial Infarction Has Worse Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Than Prior Anterior Myocardial Infarction Prior Inferior Myocardial Infarction Has Worse Early Outcomes in Patients Undergoing Coronary Artery Bypass Grafting Than Prior Anterior Myocardial Infarction Annals of Thoracic Surgery, 87, 2, 475-480 Annals of Thoracic Surgery, 87, 2, 475-480 Annals of Thoracic Surgery, 87, 2, 475-480 2009 英語 公開
M. Kosuge; K. Kimura; S. Morita; S. Kojima; T. Sakamoto; M. Ishihara; Y. Asada; C. Tei; S. Miyazaki; M. Sonoda; K. Tsuchihashi; M. Yamagishi; M. Shirai; H. Hiraoka; T. Honda; Y. Ogata; H. Ogawa M. Kosuge; K. Kimura; S. Morita; S. Kojima; T. Sakamoto; M. Ishihara; Y. Asada; C. Tei; S. Miyazaki; M. Sonoda; K. Tsuchihashi; M. Yamagishi; M. Shirai; H. Hiraoka; T. Honda; Y. Ogata; H. Ogawa M. Kosuge; K. Kimura; S. Morita; S. Kojima; T. Sakamoto; M. Ishihara; Y. Asada; C. Tei; S. Miyazaki; M. Sonoda; K. Tsuchihashi; M. Yamagishi; M. Shirai; H. Hiraoka; T. Honda; Y. Ogata; H. Ogawa Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction Combined Prognostic Utility of White Blood Cell Count, Plasma Glucose, and Glomerular Filtration Rate in Patients Undergoing Primary Stent Placement for Acute Myocardial Infarction American Journal of Cardiology, 103, 3, 322-327 American Journal of Cardiology, 103, 3, 322-327 American Journal of Cardiology, 103, 3, 322-327 2009 英語 公開
Y. Shingu; N. Shiiya; T. Ooka; T. Tachibana; S. Kubota; S. Morita; Y. Matsui Y. Shingu; N. Shiiya; T. Ooka; T. Tachibana; S. Kubota; S. Morita; Y. Matsui Y. Shingu; N. Shiiya; T. Ooka; T. Tachibana; S. Kubota; S. Morita; Y. Matsui Augmentation Index Is Elevated in Aortic Aneurysm and Dissection Augmentation Index Is Elevated in Aortic Aneurysm and Dissection Augmentation Index Is Elevated in Aortic Aneurysm and Dissection Annals of Thoracic Surgery, 87, 5, 1373-1377 Annals of Thoracic Surgery, 87, 5, 1373-1377 Annals of Thoracic Surgery, 87, 5, 1373-1377 2009 英語 公開
W. Luo; K. Numata; M. Morimoto; M. Kondo; S. Takebayashi; M. Okada; S. Morita; K. Tanaka W. Luo; K. Numata; M. Morimoto; M. Kondo; S. Takebayashi; M. Okada; S. Morita; K. Tanaka W. Luo; K. Numata; M. Morimoto; M. Kondo; S. Takebayashi; M. Okada; S. Morita; K. Tanaka Focal liver tumors: Characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT Focal liver tumors: Characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT Focal liver tumors: Characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT Radiology, 251, 1, 287-295 Radiology, 251, 1, 287-295 Radiology, 251, 1, 287-295 2009 英語 公開
Y. Kamiya; T. Kikuchi; G. Inagawa; H. Miyazaki; M. Miura; S. Morita; T. Goto Y. Kamiya; T. Kikuchi; G. Inagawa; H. Miyazaki; M. Miura; S. Morita; T. Goto Y. Kamiya; T. Kikuchi; G. Inagawa; H. Miyazaki; M. Miura; S. Morita; T. Goto Lidocaine concentration in cerebrospinal fluid after epidural administration: A comparison between epidural and combined spinal-epidural anesthesia Lidocaine concentration in cerebrospinal fluid after epidural administration: A comparison between epidural and combined spinal-epidural anesthesia Lidocaine concentration in cerebrospinal fluid after epidural administration: A comparison between epidural and combined spinal-epidural anesthesia Anesthesiology, 110, 5, 1127-1132 Anesthesiology, 110, 5, 1127-1132 Anesthesiology, 110, 5, 1127-1132 2009 英語 公開
M. Kosuge; T. Ebina; K. Hibi; S. Morita; N. Komura; K. Hashiba; M. Kiyokuni; N. Nakayama; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; S. Morita; N. Komura; K. Hashiba; M. Kiyokuni; N. Nakayama; S. Umemura; K. Kimura M. Kosuge; T. Ebina; K. Hibi; S. Morita; N. Komura; K. Hashiba; M. Kiyokuni; N. Nakayama; S. Umemura; K. Kimura Early, accurate, non-invasive predictors of left main or 3-vessel disease in patients with non-ST-segment elevation acute coronary syndrome Early, accurate, non-invasive predictors of left main or 3-vessel disease in patients with non-ST-segment elevation acute coronary syndrome Early, accurate, non-invasive predictors of left main or 3-vessel disease in patients with non-ST-segment elevation acute coronary syndrome Circulation Journal, 73, 6, 1105-1110 Circulation Journal, 73, 6, 1105-1110 Circulation Journal, 73, 6, 1105-1110 2009 英語 公開
M. Nakagawa; C. Kawanishi; T. Yamada; Y. Iwamoto; R. Sato; H. Hasegawa; S. Morita; T. Odawara; Y. Hirayasu M. Nakagawa; C. Kawanishi; T. Yamada; Y. Iwamoto; R. Sato; H. Hasegawa; S. Morita; T. Odawara; Y. Hirayasu M. Nakagawa; C. Kawanishi; T. Yamada; Y. Iwamoto; R. Sato; H. Hasegawa; S. Morita; T. Odawara; Y. Hirayasu Characteristics of suicide attempters with family history of suicide attempt: A retrospective chart review Characteristics of suicide attempters with family history of suicide attempt: A retrospective chart review Characteristics of suicide attempters with family history of suicide attempt: A retrospective chart review BMC Psychiatry, 9 BMC Psychiatry, 9 BMC Psychiatry, 9 2009 英語 公開
S. Morita; I. Okamoto; K. Kobayashi; K. Yamazaki; H. Asahina; A. Inoue; K. Hagiwara; N. Sunaga; N. Yanagitani; T. Hida; K. Yoshida; T. Hirashima; K. Yasumoto; K. Sugio; T. Mitsudomi; M. Fukuoka; T. Nukiwa S. Morita; I. Okamoto; K. Kobayashi; K. Yamazaki; H. Asahina; A. Inoue; K. Hagiwara; N. Sunaga; N. Yanagitani; T. Hida; K. Yoshida; T. Hirashima; K. Yasumoto; K. Sugio; T. Mitsudomi; M. Fukuoka; T. Nukiwa S. Morita; I. Okamoto; K. Kobayashi; K. Yamazaki; H. Asahina; A. Inoue; K. Hagiwara; N. Sunaga; N. Yanagitani; T. Hida; K. Yoshida; T. Hirashima; K. Yasumoto; K. Sugio; T. Mitsudomi; M. Fukuoka; T. Nukiwa Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations Combined survival analysis of prospective clinical trials of gefitinib for non-small cell lung cancer with EGFR mutations Clinical Cancer Research, 15, 13, 4493-4498 Clinical Cancer Research, 15, 13, 4493-4498 Clinical Cancer Research, 15, 13, 4493-4498 2009 英語 公開
S. Ohsumi; K. Shimozuma; S. Morita; F. Hara; D. Takabatake; S. Takashima; N. Taira; K. Aogi; S. Takashima S. Ohsumi; K. Shimozuma; S. Morita; F. Hara; D. Takabatake; S. Takashima; N. Taira; K. Aogi; S. Takashima S. Ohsumi; K. Shimozuma; S. Morita; F. Hara; D. Takabatake; S. Takashima; N. Taira; K. Aogi; S. Takashima Factors associated with health-related quality-of-life in breast cancer survivors: Influence of the type of surgery Factors associated with health-related quality-of-life in breast cancer survivors: Influence of the type of surgery Factors associated with health-related quality-of-life in breast cancer survivors: Influence of the type of surgery Japanese Journal of Clinical Oncology, 39, 8, 491-496 Japanese Journal of Clinical Oncology, 39, 8, 491-496 Japanese Journal of Clinical Oncology, 39, 8, 491-496 2009 英語 公開
T. Shimokawa; H. Kasegawa; S. Matsuyama; H. Seki; S. Manabe; T. Fukui; S. Morita; S. Takanashi T. Shimokawa; H. Kasegawa; S. Matsuyama; H. Seki; S. Manabe; T. Fukui; S. Morita; S. Takanashi T. Shimokawa; H. Kasegawa; S. Matsuyama; H. Seki; S. Manabe; T. Fukui; S. Morita; S. Takanashi Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis Long-Term Outcome of Mitral Valve Repair for Infective Endocarditis Annals of Thoracic Surgery, 88, 3, 733-739 Annals of Thoracic Surgery, 88, 3, 733-739 Annals of Thoracic Surgery, 88, 3, 733-739 2009 英語 公開
K. Kato; S. Yamada; H. Sugimoto; N. Kanazumi; S. Nomoto; S. Takeda; Y. Kodera; S. Morita; A. Nakao K. Kato; S. Yamada; H. Sugimoto; N. Kanazumi; S. Nomoto; S. Takeda; Y. Kodera; S. Morita; A. Nakao K. Kato; S. Yamada; H. Sugimoto; N. Kanazumi; S. Nomoto; S. Takeda; Y. Kodera; S. Morita; A. Nakao Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: Influence of resection margin status on survival Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: Influence of resection margin status on survival Prognostic factors for survival after extended pancreatectomy for pancreatic head cancer: Influence of resection margin status on survival Pancreas, 38, 6, 606-612 Pancreas, 38, 6, 606-612 Pancreas, 38, 6, 606-612 2009 英語 公開
M. Kanai; S. Morita; S. Matsumoto; T. Nishimura; E. Hatano; S. Yazumi; T. Sasaki; H. Yasuda; T. Kitano; A. Misawa; H. Ishiguro; K. Yanagihara; I. Ikai; R. Doi; M. Fukushima M. Kanai; S. Morita; S. Matsumoto; T. Nishimura; E. Hatano; S. Yazumi; T. Sasaki; H. Yasuda; T. Kitano; A. Misawa; H. Ishiguro; K. Yanagihara; I. Ikai; R. Doi; M. Fukushima M. Kanai; S. Morita; S. Matsumoto; T. Nishimura; E. Hatano; S. Yazumi; T. Sasaki; H. Yasuda; T. Kitano; A. Misawa; H. Ishiguro; K. Yanagihara; I. Ikai; R. Doi; M. Fukushima A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia A history of smoking is inversely correlated with the incidence of gemcitabine-induced neutropenia Annals of Oncology, 20, 8, 1397-1401 Annals of Oncology, 20, 8, 1397-1401 Annals of Oncology, 20, 8, 1397-1401 2009 英語 公開
M. Kosuge; T. Ishikawa; S. Morita; T. Ebina; K. Hibi; N. Maejima; S. Umemura; K. Kimura M. Kosuge; T. Ishikawa; S. Morita; T. Ebina; K. Hibi; N. Maejima; S. Umemura; K. Kimura M. Kosuge; T. Ishikawa; S. Morita; T. Ebina; K. Hibi; N. Maejima; S. Umemura; K. Kimura Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardial infarction Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardial infarction Posterior wall involvement attenuates predictive value of ST-segment elevation in lead V4R for right ventricular involvement in inferior acute myocardial infarction Journal of Cardiology, 54, 3, 386-393 Journal of Cardiology, 54, 3, 386-393 Journal of Cardiology, 54, 3, 386-393 2009 英語 公開
T. Kono; H. Mishima; M. Shimada; S. Morita; J. Sakamoto T. Kono; H. Mishima; M. Shimada; S. Morita; J. Sakamoto T. Kono; H. Mishima; M. Shimada; S. Morita; J. Sakamoto Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: A placebo-controlled double-blind randomized phase II study (the GONE Study) Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: A placebo-controlled double-blind randomized phase II study (the GONE Study) Preventive effect of goshajinkigan on peripheral neurotoxicity of FOLFOX therapy: A placebo-controlled double-blind randomized phase II study (the GONE Study) Japanese Journal of Clinical Oncology, 39, 12, 847-849 Japanese Journal of Clinical Oncology, 39, 12, 847-849 Japanese Journal of Clinical Oncology, 39, 12, 847-849 2009 英語 公開
K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; K. Kuroi; S. Ohsumi; H. Makino; H. Mukai; N. Katsumata; Y. Sunada; T. Watanabe; F.H. Hausheer K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; K. Kuroi; S. Ohsumi; H. Makino; H. Mukai; N. Katsumata; Y. Sunada; T. Watanabe; F.H. Hausheer K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; K. Kuroi; S. Ohsumi; H. Makino; H. Mukai; N. Katsumata; Y. Sunada; T. Watanabe; F.H. Hausheer Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02 Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02 Feasibility and validity of the Patient Neurotoxicity Questionnaire during taxane chemotherapy in a phase III randomized trial in patients with breast cancer: N-SAS BC 02 Supportive Care in Cancer, 17, 12, 1483-1491 Supportive Care in Cancer, 17, 12, 1483-1491 Supportive Care in Cancer, 17, 12, 1483-1491 2009 英語 公開
K. Kuroi; K. Shimozuma; Y. Ohashi; K. Hisamatsu; N. Masuda; A. Takeuchi; T. Aranishi; S. Morita; S. Ohsumi; F.H. Hausheer K. Kuroi; K. Shimozuma; Y. Ohashi; K. Hisamatsu; N. Masuda; A. Takeuchi; T. Aranishi; S. Morita; S. Ohsumi; F.H. Hausheer K. Kuroi; K. Shimozuma; Y. Ohashi; K. Hisamatsu; N. Masuda; A. Takeuchi; T. Aranishi; S. Morita; S. Ohsumi; F.H. Hausheer Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study) Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study) Prospective assessment of chemotherapy-induced peripheral neuropathy due to weekly paclitaxel in patients with advanced or metastatic breast cancer (CSP-HOR 02 study) Supportive Care in Cancer, 17, 8, 1071-1080 Supportive Care in Cancer, 17, 8, 1071-1080 Supportive Care in Cancer, 17, 8, 1071-1080 2009 英語 公開
S. Ueno; K. Shibata; R. Kitai; K. Ichimoto; S. Nagata; H. Isobe; G. Kimura; Y. Nakatani; M. Kadota; H. Komori; T.T. Ishii; S. Morita; K. Otsuji S. Ueno; K. Shibata; R. Kitai; K. Ichimoto; S. Nagata; H. Isobe; G. Kimura; Y. Nakatani; M. Kadota; H. Komori; T.T. Ishii; S. Morita; K. Otsuji S. Ueno; K. Shibata; R. Kitai; K. Ichimoto; S. Nagata; H. Isobe; G. Kimura; Y. Nakatani; M. Kadota; H. Komori; T.T. Ishii; S. Morita; K. Otsuji The CHAIN-project and installation of flare monitoring telescopes in developing countries The CHAIN-project and installation of flare monitoring telescopes in developing countries The CHAIN-project and installation of flare monitoring telescopes in developing countries Data Science Journal, 8, S51-S58 Data Science Journal, 8, S51-S58 Data Science Journal, 8, S51-S58 2009 英語 公開
K. Nakao; H. Makino; S. Morita; Y. Takahashi; T. Akizawa; A. Saito; Y. Asano; K. Kurokawa; S. Fukuhara; T. Akiba K. Nakao; H. Makino; S. Morita; Y. Takahashi; T. Akizawa; A. Saito; Y. Asano; K. Kurokawa; S. Fukuhara; T. Akiba K. Nakao; H. Makino; S. Morita; Y. Takahashi; T. Akizawa; A. Saito; Y. Asano; K. Kurokawa; S. Fukuhara; T. Akiba β-Blocker prescription and outcomes in hemodialysis patients from the japan dialysis outcomes and practice patterns study β-Blocker prescription and outcomes in hemodialysis patients from the japan dialysis outcomes and practice patterns study β-Blocker prescription and outcomes in hemodialysis patients from the japan dialysis outcomes and practice patterns study Nephron - Clinical Practice, 113, 3, C132-C139 Nephron - Clinical Practice, 113, 3, C132-C139 Nephron - Clinical Practice, 113, 3, C132-C139 2009 英語 公開
S. Nalongsack; Y. Yoshida; S. Morita; K. Sosouphanh; J. Sakamoto S. Nalongsack; Y. Yoshida; S. Morita; K. Sosouphanh; J. Sakamoto S. Nalongsack; Y. Yoshida; S. Morita; K. Sosouphanh; J. Sakamoto Knowledge, attitude and practice regarding dengue among people in Pakse, Laos. Knowledge, attitude and practice regarding dengue among people in Pakse, Laos. Knowledge, attitude and practice regarding dengue among people in Pakse, Laos. Nagoya journal of medical science, 71, 1-2, 29-37 Nagoya journal of medical science, 71, 1-2, 29-37 Nagoya journal of medical science, 71, 1-2, 29-37 2009 英語 公開
M. Harun-Or-Rashid; U.F. Khatun; Y. Yoshida; S. Morita; N. Chowdhury; J. Sakamoto M. Harun-Or-Rashid; U.F. Khatun; Y. Yoshida; S. Morita; N. Chowdhury; J. Sakamoto M. Harun-Or-Rashid; U.F. Khatun; Y. Yoshida; S. Morita; N. Chowdhury; J. Sakamoto Iron and iodine deficiencies among under-2 children, adolescent girls, and pregnant women of Bangladesh: association with common diseases. Iron and iodine deficiencies among under-2 children, adolescent girls, and pregnant women of Bangladesh: association with common diseases. Iron and iodine deficiencies among under-2 children, adolescent girls, and pregnant women of Bangladesh: association with common diseases. Nagoya journal of medical science, 71, 1-2, 39-49 Nagoya journal of medical science, 71, 1-2, 39-49 Nagoya journal of medical science, 71, 1-2, 39-49 2009 英語 公開
T. Ishikawa; S. Shimizu; K. Katayama; T. Chishima; Y. Hamaguchi; T. Doi; M. Tanabe; A. Kasahara; N. Yamaguchi; K. Narui; I. Ohta; C. Matsumoto; D. Shimizu; A. Kito; T. Suda; M. Inaba; T. Asaga; N. Momiyama; Y. Ichikawa; M. Yoshimoto; S. Morita; H. Shimada T. Ishikawa; S. Shimizu; K. Katayama; T. Chishima; Y. Hamaguchi; T. Doi; M. Tanabe; A. Kasahara; N. Yamaguchi; K. Narui; I. Ohta; C. Matsumoto; D. Shimizu; A. Kito; T. Suda; M. Inaba; T. Asaga; N. Momiyama; Y. Ichikawa; M. Yoshimoto; S. Morita; H. Shimada T. Ishikawa; S. Shimizu; K. Katayama; T. Chishima; Y. Hamaguchi; T. Doi; M. Tanabe; A. Kasahara; N. Yamaguchi; K. Narui; I. Ohta; C. Matsumoto; D. Shimizu; A. Kito; T. Suda; M. Inaba; T. Asaga; N. Momiyama; Y. Ichikawa; M. Yoshimoto; S. Morita; H. Shimada Feasibility of AC/EC followed by weekly paclitaxel in node-positive breast cancer in Japan Feasibility of AC/EC followed by weekly paclitaxel in node-positive breast cancer in Japan Feasibility of AC/EC followed by weekly paclitaxel in node-positive breast cancer in Japan Anticancer Research, 29, 5, 1515-1520 Anticancer Research, 29, 5, 1515-1520 Anticancer Research, 29, 5, 1515-1520 2009 英語 公開
S. Ohno; S. Kyo; S. Myojo; S. Dohi; J. Ishizaki; K.-I. Miyamoto; S. Morita; J.-I. Sakamoto; T. Enomoto; T. Kimura; Y. Oka; A. Tsuboi; H. Sugiyama; M. Inoue S. Ohno; S. Kyo; S. Myojo; S. Dohi; J. Ishizaki; K.-I. Miyamoto; S. Morita; J.-I. Sakamoto; T. Enomoto; T. Kimura; Y. Oka; A. Tsuboi; H. Sugiyama; M. Inoue S. Ohno; S. Kyo; S. Myojo; S. Dohi; J. Ishizaki; K.-I. Miyamoto; S. Morita; J.-I. Sakamoto; T. Enomoto; T. Kimura; Y. Oka; A. Tsuboi; H. Sugiyama; M. Inoue Wilms\\' tumor 1 (WTl) peptide immunotherapy for gynecological malignancy Wilms\\' tumor 1 (WTl) peptide immunotherapy for gynecological malignancy Wilms\\' tumor 1 (WTl) peptide immunotherapy for gynecological malignancy Anticancer Research, 29, 11, 4779-4784 Anticancer Research, 29, 11, 4779-4784 Anticancer Research, 29, 11, 4779-4784 2009 英語 公開
S. Fukuhara; T. Akizawa; S. Morita; S. Koshikawa; H. Ishida; N. Itami; S. Miyagata; S. Yumita; H. Kawaguchi; R. Aoyagi; A. Tsuchida; N. Matsui; T. Sato; Y. Kannou; Y. Ishida; K. Oguchi; Y. Komatsu; Y. Chida; K. Matsuzaki; F. Takeda; K. Takao; N. Takagi; S. Takeuchi; H. Ogura; N. Ishida; J. Takahashi; F. Nakayama; T. Mineno; Y. Kawade; H. Murai; H. Seno; Y. Sato; K. Horikawa; R. Miyazaki; S. Okuno; T. Yamakawa; S. Hayashida; N. Takasugi; K. Fujiwara; M. Fukushima; S. Obayashi; T. Mizuguchi; K. Yuasa; S. Miyake; A. Shiroozu; H. Higashi; H. Kumagai; K. Ikeda; S. Funakoshi; K. Shinzato; T. Ikeda; H. Otsuka; S. Yoshi S. Fukuhara; T. Akizawa; S. Morita; S. Koshikawa; H. Ishida; N. Itami; S. Miyagata; S. Yumita; H. Kawaguchi; R. Aoyagi; A. Tsuchida; N. Matsui; T. Sato; Y. Kannou; Y. Ishida; K. Oguchi; Y. Komatsu; Y. Chida; K. Matsuzaki; F. Takeda; K. Takao; N. Takagi; S. Takeuchi; H. Ogura; N. Ishida; J. Takahashi; F. Nakayama; T. Mineno; Y. Kawade; H. Murai; H. Seno; Y. Sato; K. Horikawa; R. Miyazaki; S. Okuno; T. Yamakawa; S. Hayashida; N. Takasugi; K. Fujiwara; M. Fukushima; S. Obayashi; T. Mizuguchi; K. Yuasa; S. Miyake; A. Shiroozu; H. Higashi; H. Kumagai; K. Ikeda; S. Funakoshi; K. Shinzato; T. Ikeda; H. Otsuka; S. Yoshi S. Fukuhara; T. Akizawa; S. Morita; S. Koshikawa; H. Ishida; N. Itami; S. Miyagata; S. Yumita; H. Kawaguchi; R. Aoyagi; A. Tsuchida; N. Matsui; T. Sato; Y. Kannou; Y. Ishida; K. Oguchi; Y. Komatsu; Y. Chida; K. Matsuzaki; F. Takeda; K. Takao; N. Takagi; S. Takeuchi; H. Ogura; N. Ishida; J. Takahashi; F. Nakayama; T. Mineno; Y. Kawade; H. Murai; H. Seno; Y. Sato; K. Horikawa; R. Miyazaki; S. Okuno; T. Yamakawa; S. Hayashida; N. Takasugi; K. Fujiwara; M. Fukushima; S. Obayashi; T. Mizuguchi; K. Yuasa; S. Miyake; A. Shiroozu; H. Higashi; H. Kumagai; K. Ikeda; S. Funakoshi; K. Shinzato; T. Ikeda; H. Otsuka; S. Yoshi Quality of life improvements in dialysis patients receiving darbepoetin alfa Quality of life improvements in dialysis patients receiving darbepoetin alfa Quality of life improvements in dialysis patients receiving darbepoetin alfa Therapeutic Apheresis and Dialysis, 12, 1, 72-77 Therapeutic Apheresis and Dialysis, 12, 1, 72-77 Therapeutic Apheresis and Dialysis, 12, 1, 72-77 2008/02 英語 公開
K.-I. Takahashi; K. Chin; H. Nakamura; S. Morita; K. Sumi; T. Oga; H. Matsumoto; A. Niimi; S. Fukuhara; J. Yodoi; M. Mishima K.-I. Takahashi; K. Chin; H. Nakamura; S. Morita; K. Sumi; T. Oga; H. Matsumoto; A. Niimi; S. Fukuhara; J. Yodoi; M. Mishima K.-I. Takahashi; K. Chin; H. Nakamura; S. Morita; K. Sumi; T. Oga; H. Matsumoto; A. Niimi; S. Fukuhara; J. Yodoi; M. Mishima Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure Antioxidants and Redox Signaling, 10, 4, 715-726 Antioxidants and Redox Signaling, 10, 4, 715-726 Antioxidants and Redox Signaling, 10, 4, 715-726 2008 英語 公開
H. Cho; A. Tsuburaya; J. Sakamoto; S. Morita; K. Oba; T. Yoshikawa; N. Miyajima H. Cho; A. Tsuburaya; J. Sakamoto; S. Morita; K. Oba; T. Yoshikawa; N. Miyajima H. Cho; A. Tsuburaya; J. Sakamoto; S. Morita; K. Oba; T. Yoshikawa; N. Miyajima A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: Adjuvant exercise for general elective surgery (AEGES) study group A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: Adjuvant exercise for general elective surgery (AEGES) study group A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: Adjuvant exercise for general elective surgery (AEGES) study group Japanese Journal of Clinical Oncology, 38, 1, 71-73 Japanese Journal of Clinical Oncology, 38, 1, 71-73 Japanese Journal of Clinical Oncology, 38, 1, 71-73 2008 英語 公開
S. Saji; M. Toi; S. Morita; H. Iwata; Y. Ito; S. Ohno; T. Kobayashi; Y. Hozumi; J. Sakamoto S. Saji; M. Toi; S. Morita; H. Iwata; Y. Ito; S. Ohno; T. Kobayashi; Y. Hozumi; J. Sakamoto S. Saji; M. Toi; S. Morita; H. Iwata; Y. Ito; S. Ohno; T. Kobayashi; Y. Hozumi; J. Sakamoto Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer Dose-finding phase I and pharmacokinetic study of capecitabine (Xeloda) in combination with epirubicin and cyclophosphamide (CEX) in patients with inoperable or metastatic breast cancer Oncology, 72, 5-6, 330-337 Oncology, 72, 5-6, 330-337 Oncology, 72, 5-6, 330-337 2008 英語 公開
S. Izumoto; A. Tsuboi; Y. Oka; T. Suzuki; T. Hashiba; N. Kagawa; N. Hashimoto; M. Maruno; O.A. Elisseeva; T. Shirakata; M. Kawakami; Y. Oji; S. Nishida; S. Ohno; I. Kawase; J. Hatazawa; S.-I. Nakatsuka; K. Aozasa; S. Morita; J. Sakamoto; H. Sugiyama; T. Yoshimine S. Izumoto; A. Tsuboi; Y. Oka; T. Suzuki; T. Hashiba; N. Kagawa; N. Hashimoto; M. Maruno; O.A. Elisseeva; T. Shirakata; M. Kawakami; Y. Oji; S. Nishida; S. Ohno; I. Kawase; J. Hatazawa; S.-I. Nakatsuka; K. Aozasa; S. Morita; J. Sakamoto; H. Sugiyama; T. Yoshimine S. Izumoto; A. Tsuboi; Y. Oka; T. Suzuki; T. Hashiba; N. Kagawa; N. Hashimoto; M. Maruno; O.A. Elisseeva; T. Shirakata; M. Kawakami; Y. Oji; S. Nishida; S. Ohno; I. Kawase; J. Hatazawa; S.-I. Nakatsuka; K. Aozasa; S. Morita; J. Sakamoto; H. Sugiyama; T. Yoshimine Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme Journal of Neurosurgery, 108, 5, 963-971 Journal of Neurosurgery, 108, 5, 963-971 Journal of Neurosurgery, 108, 5, 963-971 2008 英語 公開
S. Morita; P.F. Thall; P. Müller S. Morita; P.F. Thall; P. Müller S. Morita; P.F. Thall; P. Müller Determining the effective sample size of a parametric prior Determining the effective sample size of a parametric prior Determining the effective sample size of a parametric prior Biometrics, 64, 2, 595-602 Biometrics, 64, 2, 595-602 Biometrics, 64, 2, 595-602 2008 英語 公開
S. Morita; A.A. Kaptein; K. Oba; J. Sakamoto S. Morita; A.A. Kaptein; K. Oba; J. Sakamoto S. Morita; A.A. Kaptein; K. Oba; J. Sakamoto The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data The domain structure of the EORTC QLQ-STO22 supported by Japanese validation data Psycho-Oncology, 17, 5, 474-479 Psycho-Oncology, 17, 5, 474-479 Psycho-Oncology, 17, 5, 474-479 2008 英語 公開
K. Kobayashi; S. Morita; M. Shimonagayoshi; M. Kobayashi; Y. Fujiki; Y. Uchida; K. Yamaguchi K. Kobayashi; S. Morita; M. Shimonagayoshi; M. Kobayashi; Y. Fujiki; Y. Uchida; K. Yamaguchi K. Kobayashi; S. Morita; M. Shimonagayoshi; M. Kobayashi; Y. Fujiki; Y. Uchida; K. Yamaguchi Effects of socioeconomic factors and cancer survivors\\' worries on their quality of life (QOL) in Japan Effects of socioeconomic factors and cancer survivors\\' worries on their quality of life (QOL) in Japan Effects of socioeconomic factors and cancer survivors\\' worries on their quality of life (QOL) in Japan Psycho-Oncology, 17, 6, 606-611 Psycho-Oncology, 17, 6, 606-611 Psycho-Oncology, 17, 6, 606-611 2008 英語 公開
T.L.H. Nguyen; T.H.T. Nguyen; S. Morita; J. Sakamoto T.L.H. Nguyen; T.H.T. Nguyen; S. Morita; J. Sakamoto T.L.H. Nguyen; T.H.T. Nguyen; S. Morita; J. Sakamoto Injury and pre-hospital trauma care in Hanoi, Vietnam Injury and pre-hospital trauma care in Hanoi, Vietnam Injury and pre-hospital trauma care in Hanoi, Vietnam Injury, 39, 9, 1026-1033 Injury, 39, 9, 1026-1033 Injury, 39, 9, 1026-1033 2008 英語 公開
K.-I. Takahashi; K. Chin; T. Akamizu; S. Morita; K. Sumi; T. Oga; H. Matsumoto; A. Niimi; T. Tsuboi; S. Fukuhara; K. Kangawa; M. Mishima K.-I. Takahashi; K. Chin; T. Akamizu; S. Morita; K. Sumi; T. Oga; H. Matsumoto; A. Niimi; T. Tsuboi; S. Fukuhara; K. Kangawa; M. Mishima K.-I. Takahashi; K. Chin; T. Akamizu; S. Morita; K. Sumi; T. Oga; H. Matsumoto; A. Niimi; T. Tsuboi; S. Fukuhara; K. Kangawa; M. Mishima Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment Acylated ghrelin level in patients with OSA before and after nasal CPAP treatment Respirology, 13, 6, 810-816 Respirology, 13, 6, 810-816 Respirology, 13, 6, 810-816 2008 英語 公開
A. Nakajo; S. Hokita; S. Ishigami; F. Miyazono; T. Etoh; M. Hamanoue; S. Maenohara; T. Iwashita; H. Komatsu; K. Satoh; K. Aridome; S. Morita; S. Natsugoe; H. Takiuchi; S. Nakano; Y. Maehara; J. Sakamoto; T. Aikou A. Nakajo; S. Hokita; S. Ishigami; F. Miyazono; T. Etoh; M. Hamanoue; S. Maenohara; T. Iwashita; H. Komatsu; K. Satoh; K. Aridome; S. Morita; S. Natsugoe; H. Takiuchi; S. Nakano; Y. Maehara; J. Sakamoto; T. Aikou A. Nakajo; S. Hokita; S. Ishigami; F. Miyazono; T. Etoh; M. Hamanoue; S. Maenohara; T. Iwashita; H. Komatsu; K. Satoh; K. Aridome; S. Morita; S. Natsugoe; H. Takiuchi; S. Nakano; Y. Maehara; J. Sakamoto; T. Aikou A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer Cancer Chemotherapy and Pharmacology, 62, 6, 1103-1109 Cancer Chemotherapy and Pharmacology, 62, 6, 1103-1109 Cancer Chemotherapy and Pharmacology, 62, 6, 1103-1109 2008 英語 公開
K. Kuroi; K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; S. Ohsumi; T. Watanabe; S. Bain; F.H. Hausheer K. Kuroi; K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; S. Ohsumi; T. Watanabe; S. Bain; F.H. Hausheer K. Kuroi; K. Shimozuma; Y. Ohashi; A. Takeuchi; T. Aranishi; S. Morita; S. Ohsumi; T. Watanabe; S. Bain; F.H. Hausheer A questionnaire survey of physicians\\' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer A questionnaire survey of physicians\\' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer A questionnaire survey of physicians\\' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer Japanese Journal of Clinical Oncology, 38, 11, 748-754 Japanese Journal of Clinical Oncology, 38, 11, 748-754 Japanese Journal of Clinical Oncology, 38, 11, 748-754 2008 英語 公開
Y. Asano; T. Akizawa; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; S. Morita; T. Wakita; Y. Onishi; K. Kurokawa Y. Asano; T. Akizawa; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; S. Morita; T. Wakita; Y. Onishi; K. Kurokawa Y. Asano; T. Akizawa; S. Fukuhara; F. Gejyo; S. Matsuo; N. Yorioka; S. Morita; T. Wakita; Y. Onishi; K. Kurokawa Summary of CAP-KD study from the 37th western/eastern regional meeting, JSN Summary of CAP-KD study from the 37th western/eastern regional meeting, JSN Summary of CAP-KD study from the 37th western/eastern regional meeting, JSN Japanese Journal of Nephrology, 50, 5, 528-531 Japanese Journal of Nephrology, 50, 5, 528-531 Japanese Journal of Nephrology, 50, 5, 528-531 2008 英語 公開
M. Kawakami; Y. Oka; A. Tsuboi; Y. Harada; O.A. Elisseeva; Y. Furukawa; M. Tsukaguchi; T. Shirakata; S. Nishida; H. Nakajima; S. Morita; J. Sakamoto; I. Kawase; Y. Oji; H. Sugiyama M. Kawakami; Y. Oka; A. Tsuboi; Y. Harada; O.A. Elisseeva; Y. Furukawa; M. Tsukaguchi; T. Shirakata; S. Nishida; H. Nakajima; S. Morita; J. Sakamoto; I. Kawase; Y. Oji; H. Sugiyama M. Kawakami; Y. Oka; A. Tsuboi; Y. Harada; O.A. Elisseeva; Y. Furukawa; M. Tsukaguchi; T. Shirakata; S. Nishida; H. Nakajima; S. Morita; J. Sakamoto; I. Kawase; Y. Oji; H. Sugiyama Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 μg/body) in a patient with chronic myelomonocytic leukemia Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 μg/body) in a patient with chronic myelomonocytic leukemia Clinical and immunologic responses to very low-dose vaccination with WT1 peptide (5 μg/body) in a patient with chronic myelomonocytic leukemia International Journal of Hematology, 85, 5, 426-429 International Journal of Hematology, 85, 5, 426-429 International Journal of Hematology, 85, 5, 426-429 2007 英語 公開
A. Tsuboi; Y. Oka; H. Nakajima; Y. Fukuda; O.A. Elisseeva; S. Yoshihara; N. Hosen; A. Ogata; K. Kito; F. Fujiki; S. Nishida; T. Shirakata; S. Ohno; M. Yasukawa; Y. Oji; M. Kawakami; S. Morita; J. Sakamoto; K. Udaka; I. Kawase; H. Sugiyama A. Tsuboi; Y. Oka; H. Nakajima; Y. Fukuda; O.A. Elisseeva; S. Yoshihara; N. Hosen; A. Ogata; K. Kito; F. Fujiki; S. Nishida; T. Shirakata; S. Ohno; M. Yasukawa; Y. Oji; M. Kawakami; S. Morita; J. Sakamoto; K. Udaka; I. Kawase; H. Sugiyama A. Tsuboi; Y. Oka; H. Nakajima; Y. Fukuda; O.A. Elisseeva; S. Yoshihara; N. Hosen; A. Ogata; K. Kito; F. Fujiki; S. Nishida; T. Shirakata; S. Ohno; M. Yasukawa; Y. Oji; M. Kawakami; S. Morita; J. Sakamoto; K. Udaka; I. Kawase; H. Sugiyama Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma Wilms tumor gene WT1 peptide-based immunotherapy induced a minimal response in a patient with advanced therapy-resistant multiple myeloma International Journal of Hematology, 86, 5, 414-417 International Journal of Hematology, 86, 5, 414-417 International Journal of Hematology, 86, 5, 414-417 2007 英語 公開
S. Morita; B. Nakata; A. Tsuji; Y. Mitachi; T. Shirasaka; S. Saji; Y. Ohashi; J. Sakamoto; K. Hirakawa S. Morita; B. Nakata; A. Tsuji; Y. Mitachi; T. Shirasaka; S. Saji; Y. Ohashi; J. Sakamoto; K. Hirakawa S. Morita; B. Nakata; A. Tsuji; Y. Mitachi; T. Shirasaka; S. Saji; Y. Ohashi; J. Sakamoto; K. Hirakawa A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method A phase I study of combination therapy of the oral fluorinated pyrimidine compound S-1 with low-dose cisplatin twice-a-week administration (JFMC27-9902 Step2) in patients with advanced gastric cancer using a continual reassessment method Japanese Journal of Clinical Oncology, 37, 12, 924-929 Japanese Journal of Clinical Oncology, 37, 12, 924-929 Japanese Journal of Clinical Oncology, 37, 12, 924-929 2007 英語 公開
J. Sakamoto; S. Morita J. Sakamoto; S. Morita J. Sakamoto; S. Morita From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside. From translational research to a large randomized clinical trial: a long and streanuous way from bench to bedside. Nagoya journal of medical science, 69, 1-2, 9-16 Nagoya journal of medical science, 69, 1-2, 9-16 Nagoya journal of medical science, 69, 1-2, 9-16 2007 英語 公開
M. Ninomiya; K. Kondo; K. Matsuo; N. Hirabayashi; H. Kojima; M. Kobayashi; S. Kawamura; T. Ando; N. Musha; H. Konno; N. Nagata; H. Usuki; Y. Miyashita; K. Oba; S. Morita; J. Sakamoto M. Ninomiya; K. Kondo; K. Matsuo; N. Hirabayashi; H. Kojima; M. Kobayashi; S. Kawamura; T. Ando; N. Musha; H. Konno; N. Nagata; H. Usuki; Y. Miyashita; K. Oba; S. Morita; J. Sakamoto M. Ninomiya; K. Kondo; K. Matsuo; N. Hirabayashi; H. Kojima; M. Kobayashi; S. Kawamura; T. Ando; N. Musha; H. Konno; N. Nagata; H. Usuki; Y. Miyashita; K. Oba; S. Morita; J. Sakamoto Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma Journal of Chemotherapy, 19, 4, 444-450 Journal of Chemotherapy, 19, 4, 444-450 Journal of Chemotherapy, 19, 4, 444-450 2007 英語 公開
S. Morita; M. Toi; S. Saji; H. Iwata; S. Ohno; Y. Ito; T. Kobayashi; Y. Hozumi; J. Sakamoto S. Morita; M. Toi; S. Saji; H. Iwata; S. Ohno; Y. Ito; T. Kobayashi; Y. Hozumi; J. Sakamoto S. Morita; M. Toi; S. Saji; H. Iwata; S. Ohno; Y. Ito; T. Kobayashi; Y. Hozumi; J. Sakamoto Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer Practical application of the continual reassessment method to a phase I dose-finding trial in advanced breast cancer Drug Information Journal, 41, 6, 691-700 Drug Information Journal, 41, 6, 691-700 Drug Information Journal, 41, 6, 691-700 2007 英語 公開
S. Enkhbold; S. Tugsdelger; S. Morita; J. Sakamoto; N. Hamajima S. Enkhbold; S. Tugsdelger; S. Morita; J. Sakamoto; N. Hamajima S. Enkhbold; S. Tugsdelger; S. Morita; J. Sakamoto; N. Hamajima HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. HIV/AIDS related knowledge and risk behaviors among female sex workers in two major cities of Mongolia. Nagoya journal of medical science, 69, 3-4, 157-165 Nagoya journal of medical science, 69, 3-4, 157-165 Nagoya journal of medical science, 69, 3-4, 157-165 2007 英語 公開
M. Kurita; K. Shimozuma; S. Morita; Y. Fujiki; K. Ishizawa; H. Eguchi; Y. Saito; N. Ushirozawa; I. Wasada; Y. Ohashi; K. Eguchi M. Kurita; K. Shimozuma; S. Morita; Y. Fujiki; K. Ishizawa; H. Eguchi; Y. Saito; N. Ushirozawa; I. Wasada; Y. Ohashi; K. Eguchi M. Kurita; K. Shimozuma; S. Morita; Y. Fujiki; K. Ishizawa; H. Eguchi; Y. Saito; N. Ushirozawa; I. Wasada; Y. Ohashi; K. Eguchi Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale Clinical validity of the Japanese version of the Functional Assessment of Cancer Therapy-Anemia Scale Supportive Care in Cancer, 15, 1, 1-6 Supportive Care in Cancer, 15, 1, 1-6 Supportive Care in Cancer, 15, 1, 1-6 2007 英語 公開
S. Yamada; S. Takeda; T. Fujii; S. Nomoto; N. Kanazumi; H. Sugimoto; H. Kasuya; Y. Kodera; T. Nagasaka; S. Morita; A. Nakao S. Yamada; S. Takeda; T. Fujii; S. Nomoto; N. Kanazumi; H. Sugimoto; H. Kasuya; Y. Kodera; T. Nagasaka; S. Morita; A. Nakao S. Yamada; S. Takeda; T. Fujii; S. Nomoto; N. Kanazumi; H. Sugimoto; H. Kasuya; Y. Kodera; T. Nagasaka; S. Morita; A. Nakao Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: Positive peritoneal cytology may not confer an adverse prognosis Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: Positive peritoneal cytology may not confer an adverse prognosis Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: Positive peritoneal cytology may not confer an adverse prognosis Annals of Surgery, 246, 2, 254-258 Annals of Surgery, 246, 2, 254-258 Annals of Surgery, 246, 2, 254-258 2007 英語 公開
S. Morita; H. Baba; A. Tsuburaya; H. Takiuchi; T. Matsui; Y. Maehara; J. Sakamoto S. Morita; H. Baba; A. Tsuburaya; H. Takiuchi; T. Matsui; Y. Maehara; J. Sakamoto S. Morita; H. Baba; A. Tsuburaya; H. Takiuchi; T. Matsui; Y. Maehara; J. Sakamoto A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC) A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC) A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for advanced stomach cancer (TASC) Japanese Journal of Clinical Oncology, 37, 6, 469-472 Japanese Journal of Clinical Oncology, 37, 6, 469-472 Japanese Journal of Clinical Oncology, 37, 6, 469-472 2007 英語 公開
J. Sakamoto; S. Morita; K. Oba; T. Matsui; M. Kobayashi; H. Nakazato; Y. Ohashi J. Sakamoto; S. Morita; K. Oba; T. Matsui; M. Kobayashi; H. Nakazato; Y. Ohashi J. Sakamoto; S. Morita; K. Oba; T. Matsui; M. Kobayashi; H. Nakazato; Y. Ohashi Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: A meta-analysis of centrally randomized controlled clinical trials Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: A meta-analysis of centrally randomized controlled clinical trials Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curatively resected colorectal cancer: A meta-analysis of centrally randomized controlled clinical trials Cancer Immunology, Immunotherapy, 55, 4, 404-411 Cancer Immunology, Immunotherapy, 55, 4, 404-411 Cancer Immunology, Immunotherapy, 55, 4, 404-411 2006 英語 公開
W. Noguchi; S. Morita; T. Ohno; O. Aihara; H. Tsujii; K. Shimozuma; E. Matsushima W. Noguchi; S. Morita; T. Ohno; O. Aihara; H. Tsujii; K. Shimozuma; E. Matsushima W. Noguchi; S. Morita; T. Ohno; O. Aihara; H. Tsujii; K. Shimozuma; E. Matsushima Spiritual needs in cancer patients and spiritual care based on logotherapy Spiritual needs in cancer patients and spiritual care based on logotherapy Spiritual needs in cancer patients and spiritual care based on logotherapy Supportive Care in Cancer, 14, 1, 65-70 Supportive Care in Cancer, 14, 1, 65-70 Supportive Care in Cancer, 14, 1, 65-70 2006 英語 公開
Y. Matsuyama; S. Morita Y. Matsuyama; S. Morita Y. Matsuyama; S. Morita Estimation of the average causal effect among subgroups defined by post-treatment variables Estimation of the average causal effect among subgroups defined by post-treatment variables Estimation of the average causal effect among subgroups defined by post-treatment variables Clinical Trials, 3, 1, 1-9 Clinical Trials, 3, 1, 1-9 Clinical Trials, 3, 1, 1-9 2006 英語 公開
S. Morita; S. Fukuhara; T. Akizawa; Y. Asano; S. Koshikawa; K. Koide; K. Kurokawa S. Morita; S. Fukuhara; T. Akizawa; Y. Asano; S. Koshikawa; K. Koide; K. Kurokawa S. Morita; S. Fukuhara; T. Akizawa; Y. Asano; S. Koshikawa; K. Koide; K. Kurokawa Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease Prognostic factors for a composite end-point of renal outcomes in patients with chronic kidney disease Therapeutic Apheresis and Dialysis, 10, 1, 72-77 Therapeutic Apheresis and Dialysis, 10, 1, 72-77 Therapeutic Apheresis and Dialysis, 10, 1, 72-77 2006 英語 公開
N. Takahashi; S. Kikuchi; S. Konno; S. Morita; Y. Suzukamo; J. Green; S. Fukuhara N. Takahashi; S. Kikuchi; S. Konno; S. Morita; Y. Suzukamo; J. Green; S. Fukuhara N. Takahashi; S. Kikuchi; S. Konno; S. Morita; Y. Suzukamo; J. Green; S. Fukuhara Discrepancy between disability and the severity of low back pain: Demographic, psychologic, and employment-related factors Discrepancy between disability and the severity of low back pain: Demographic, psychologic, and employment-related factors Discrepancy between disability and the severity of low back pain: Demographic, psychologic, and employment-related factors Spine, 31, 8, 931-939 Spine, 31, 8, 931-939 Spine, 31, 8, 931-939 2006 英語 公開
T. Fukui; M. Rahman; T. Shimbo; S. Morita; J. Sakamoto T. Fukui; M. Rahman; T. Shimbo; S. Morita; J. Sakamoto T. Fukui; M. Rahman; T. Shimbo; S. Morita; J. Sakamoto Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side Recruitment of patients for a clinical trial: Factors on the physician side and reasons on the patient side Internal Medicine, 45, 8, 511-514 Internal Medicine, 45, 8, 511-514 Internal Medicine, 45, 8, 511-514 2006 英語 公開
S. Morita; J. Sakamoto S. Morita; J. Sakamoto S. Morita; J. Sakamoto Application of an adaptive design to a randomized phase II selection trial in gastric cancer: A report of the study design Application of an adaptive design to a randomized phase II selection trial in gastric cancer: A report of the study design Application of an adaptive design to a randomized phase II selection trial in gastric cancer: A report of the study design Pharmaceutical Statistics, 5, 2, 109-118 Pharmaceutical Statistics, 5, 2, 109-118 Pharmaceutical Statistics, 5, 2, 109-118 2006 英語 公開
S. Morita; Y. Oka; A. Tsuboi; M. Kawakami; M. Maruno; S. Izumoto; T. Osaki; T. Taguchi; T. Ueda; A. Myoui; S. Nishida; T. Shirakata; S. Ohno; Y. Oji; K. Aozasa; J. Hatazawa; K. Udaka; H. Yoshikawa; T. Yoshimine; S. Noguchi; I. Kawase; S.-I. Nakatsuka; H. Sugiyama; J. Sakamoto S. Morita; Y. Oka; A. Tsuboi; M. Kawakami; M. Maruno; S. Izumoto; T. Osaki; T. Taguchi; T. Ueda; A. Myoui; S. Nishida; T. Shirakata; S. Ohno; Y. Oji; K. Aozasa; J. Hatazawa; K. Udaka; H. Yoshikawa; T. Yoshimine; S. Noguchi; I. Kawase; S.-I. Nakatsuka; H. Sugiyama; J. Sakamoto S. Morita; Y. Oka; A. Tsuboi; M. Kawakami; M. Maruno; S. Izumoto; T. Osaki; T. Taguchi; T. Ueda; A. Myoui; S. Nishida; T. Shirakata; S. Ohno; Y. Oji; K. Aozasa; J. Hatazawa; K. Udaka; H. Yoshikawa; T. Yoshimine; S. Noguchi; I. Kawase; S.-I. Nakatsuka; H. Sugiyama; J. Sakamoto A phase I/II trial of a WT1 (Wilms\\' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data A phase I/II trial of a WT1 (Wilms\\' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data A phase I/II trial of a WT1 (Wilms\\' tumor gene) peptide vaccine in patients with solid malignancy: Safety assessment based on the phase I data Japanese Journal of Clinical Oncology, 36, 4, 231-236 Japanese Journal of Clinical Oncology, 36, 4, 231-236 Japanese Journal of Clinical Oncology, 36, 4, 231-236 2006 英語 公開
K. Oba; S. Morita; A. Tsuburaya; Y. Kodera; M. Kobayashi; J. Sakamoto K. Oba; S. Morita; A. Tsuburaya; Y. Kodera; M. Kobayashi; J. Sakamoto K. Oba; S. Morita; A. Tsuburaya; Y. Kodera; M. Kobayashi; J. Sakamoto Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials in Japan Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials in Japan Efficacy of adjuvant chemotherapy using oral fluorinated pyrimidines for curatively resected gastric cancer: A meta-analysis of centrally randomized controlled clinical trials in Japan Journal of Chemotherapy, 18, 3, 311-318 Journal of Chemotherapy, 18, 3, 311-318 Journal of Chemotherapy, 18, 3, 311-318 2006 英語 公開
T. Fukui; M. Rahman; S. Morita; J. Sakamoto T. Fukui; M. Rahman; S. Morita; J. Sakamoto T. Fukui; M. Rahman; S. Morita; J. Sakamoto Informed consent in the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial: A survey of collaborating physicians Informed consent in the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial: A survey of collaborating physicians Informed consent in the candesartan antihypertensive survival evaluation in Japan (CASE-J) trial: A survey of collaborating physicians Hypertension Research, 29, 7, 471-474 Hypertension Research, 29, 7, 471-474 Hypertension Research, 29, 7, 471-474 2006 英語 公開
K. Oba; S. Morita; M. Rahman; J. Sakamoto K. Oba; S. Morita; M. Rahman; J. Sakamoto K. Oba; S. Morita; M. Rahman; J. Sakamoto Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial Factors associated with compliance and non-compliance by physicians in a large-scale randomized clinical trial Trials, 7 Trials, 7 Trials, 7 2006 英語 公開
K. Ando; S. Morita; T. Higashi; S. Fukuhara; S. Watanabe; J. Park; M. Kikuchi; K. Kawano; I. Wasada; T. Hotta K. Ando; S. Morita; T. Higashi; S. Fukuhara; S. Watanabe; J. Park; M. Kikuchi; K. Kawano; I. Wasada; T. Hotta K. Ando; S. Morita; T. Higashi; S. Fukuhara; S. Watanabe; J. Park; M. Kikuchi; K. Kawano; I. Wasada; T. Hotta Health-related quality of life among Japanese women with iron-deficiency anemia Health-related quality of life among Japanese women with iron-deficiency anemia Health-related quality of life among Japanese women with iron-deficiency anemia Quality of Life Research, 15, 10, 1559-1563 Quality of Life Research, 15, 10, 1559-1563 Quality of Life Research, 15, 10, 1559-1563 2006 英語 公開
S. Morita; A.A. Kaptein; A. Tsuburaya; Y. Kodera; T. Matsui; J. Sakamoto S. Morita; A.A. Kaptein; A. Tsuburaya; Y. Kodera; T. Matsui; J. Sakamoto S. Morita; A.A. Kaptein; A. Tsuburaya; Y. Kodera; T. Matsui; J. Sakamoto Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Assessment and data analysis of health-related quality of life in clinical trials for gastric cancer treatments Gastric Cancer, 9, 4, 254-261 Gastric Cancer, 9, 4, 254-261 Gastric Cancer, 9, 4, 254-261 2006 英語 公開
S. Morita; M. Kobayashi; K. Oba; T. Ichihara; A. Nakao; J. Sakamoto S. Morita; M. Kobayashi; K. Oba; T. Ichihara; A. Nakao; J. Sakamoto S. Morita; M. Kobayashi; K. Oba; T. Ichihara; A. Nakao; J. Sakamoto Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals, and private general practitioners in Japan Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals, and private general practitioners in Japan Truth-telling to patients with advanced cancer: A comparison between cancer center, university hospitals, general city hospitals, and private general practitioners in Japan Annals of Cancer Research and Therapy, 14, 1, 1-11 Annals of Cancer Research and Therapy, 14, 1, 1-11 Annals of Cancer Research and Therapy, 14, 1, 1-11 2006 英語 公開
T. Matsui; K. Omura; K. Kawakami; S. Morita; J. Sakamoto T. Matsui; K. Omura; K. Kawakami; S. Morita; J. Sakamoto T. Matsui; K. Omura; K. Kawakami; S. Morita; J. Sakamoto Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer Genotype of thymidylate synthase likely to affect efficacy of adjuvant 5-FU based chemotherapy in colon cancer Oncology Reports, 16, 5, 1111-1115 Oncology Reports, 16, 5, 1111-1115 Oncology Reports, 16, 5, 1111-1115 2006 英語 公開
M. Rahman; S. Morita; T. Fukui; J. Sakamoto M. Rahman; S. Morita; T. Fukui; J. Sakamoto M. Rahman; S. Morita; T. Fukui; J. Sakamoto Physicians\\' attitudes towards and reasons for participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial Physicians\\' attitudes towards and reasons for participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial Physicians\\' attitudes towards and reasons for participation in the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial Journal of Epidemiology, 15, 2, 38-40 Journal of Epidemiology, 15, 2, 38-40 Journal of Epidemiology, 15, 2, 38-40 2005 英語 公開
H. Matsumoto; A. Niimi; M. Takemura; T. Ueda; M. Minakuchi; R. Tabuena; K. Chin; T. Mio; Y. Ito; S. Muro; T. Hirai; S. Morita; S. Fukuhara; M. Mishima H. Matsumoto; A. Niimi; M. Takemura; T. Ueda; M. Minakuchi; R. Tabuena; K. Chin; T. Mio; Y. Ito; S. Muro; T. Hirai; S. Morita; S. Fukuhara; M. Mishima H. Matsumoto; A. Niimi; M. Takemura; T. Ueda; M. Minakuchi; R. Tabuena; K. Chin; T. Mio; Y. Ito; S. Muro; T. Hirai; S. Morita; S. Fukuhara; M. Mishima Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma Relationship of airway wall thickening to an imbalance between matrix metalloproteinase-9 and its inhibitor in asthma Thorax, 60, 4, 277-281 Thorax, 60, 4, 277-281 Thorax, 60, 4, 277-281 2005 英語 公開
S. Morita; K. Kobayashi; K. Eguchi; T. Matsumoto; M. Shibuya; Y. Yamaji; Y. Ohashi S. Morita; K. Kobayashi; K. Eguchi; T. Matsumoto; M. Shibuya; Y. Yamaji; Y. Ohashi S. Morita; K. Kobayashi; K. Eguchi; T. Matsumoto; M. Shibuya; Y. Yamaji; Y. Ohashi Analysis of incomplete quality of life data in advanced stage cancer: A practical application of multiple imputation Analysis of incomplete quality of life data in advanced stage cancer: A practical application of multiple imputation Analysis of incomplete quality of life data in advanced stage cancer: A practical application of multiple imputation Quality of Life Research, 14, 6, 1533-1544 Quality of Life Research, 14, 6, 1533-1544 Quality of Life Research, 14, 6, 1533-1544 2005 英語 公開
S. Morita; S. Fukuhara; T. Akizawa; Y. Asano; K. Kurokawa S. Morita; S. Fukuhara; T. Akizawa; Y. Asano; K. Kurokawa S. Morita; S. Fukuhara; T. Akizawa; Y. Asano; K. Kurokawa Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD) Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD) Study design and methods for a clinical trial of an oral carbonaceous adsorbent used to prevent the progression of chronic kidney disease (CAP-KD) Clinical and Experimental Nephrology, 9, 3, 219-227 Clinical and Experimental Nephrology, 9, 3, 219-227 Clinical and Experimental Nephrology, 9, 3, 219-227 2005 英語 公開
Y. Ueda; H. Yamagishi; D. Ichikawa; J. Morii; K. Koizumi; N. Kakihara; M. Shimotsuma; A. Takenaka; T. Yamashita; H. Kurioka; M. Nishiyama; S. Morita; K. Nakamura; J. Sakamoto Y. Ueda; H. Yamagishi; D. Ichikawa; J. Morii; K. Koizumi; N. Kakihara; M. Shimotsuma; A. Takenaka; T. Yamashita; H. Kurioka; M. Nishiyama; S. Morita; K. Nakamura; J. Sakamoto Y. Ueda; H. Yamagishi; D. Ichikawa; J. Morii; K. Koizumi; N. Kakihara; M. Shimotsuma; A. Takenaka; T. Yamashita; H. Kurioka; M. Nishiyama; S. Morita; K. Nakamura; J. Sakamoto Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer Phase I study of a combination of S-1 and weekly paclitaxel in patients with advanced or recurrent gastric cancer Oncology, 69, 3, 261-268 Oncology, 69, 3, 261-268 Oncology, 69, 3, 261-268 2005 英語 公開
A. Tsuburaya; J. Sakamoto; S. Morita; Y. Kodera; M. Kobayashi; Y. Miyashita; J.S. Macdonald A. Tsuburaya; J. Sakamoto; S. Morita; Y. Kodera; M. Kobayashi; Y. Miyashita; J.S. Macdonald A. Tsuburaya; J. Sakamoto; S. Morita; Y. Kodera; M. Kobayashi; Y. Miyashita; J.S. Macdonald A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: The stomach cancer adjuvant multi-institutional trial group (Samit) trial A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: The stomach cancer adjuvant multi-institutional trial group (Samit) trial A randomized phase III trial of post-operative adjuvant oral fluoropyrimidine versus sequential paclitaxel/oral fluoropyrimidine; and UFT versus S1 for T3/T4 gastric carcinoma: The stomach cancer adjuvant multi-institutional trial group (Samit) trial Japanese Journal of Clinical Oncology, 35, 11, 672-675 Japanese Journal of Clinical Oncology, 35, 11, 672-675 Japanese Journal of Clinical Oncology, 35, 11, 672-675 2005 英語 公開
A.A. Kaptein; S. Morita; J. Sakamoto A.A. Kaptein; S. Morita; J. Sakamoto A.A. Kaptein; S. Morita; J. Sakamoto Quality of life in gastric cancer Quality of life in gastric cancer Quality of life in gastric cancer World Journal of Gastroenterology, 11, 21, 3189-3196 World Journal of Gastroenterology, 11, 21, 3189-3196 World Journal of Gastroenterology, 11, 21, 3189-3196 2005 英語 公開
S. Morita; M. Toi; T. Kobayashi; Y. Ito; Y. Hozumi; S. Ohno; H. Iwata; J. Sakamoto S. Morita; M. Toi; T. Kobayashi; Y. Ito; Y. Hozumi; S. Ohno; H. Iwata; J. Sakamoto S. Morita; M. Toi; T. Kobayashi; Y. Ito; Y. Hozumi; S. Ohno; H. Iwata; J. Sakamoto Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer Application of a continual reassessment method to a phase I clinical trial of capecitabine in combination with cyclophosphamide and epirubicin (CEX) for inoperable or recurrent breast cancer Japanese Journal of Clinical Oncology, 34, 2, 104-106 Japanese Journal of Clinical Oncology, 34, 2, 104-106 Japanese Journal of Clinical Oncology, 34, 2, 104-106 2004 英語 公開
S. Morita; Y. Ohashi; K. Hirakawa; B. Nakata; S. Saji; J. Sakamoto S. Morita; Y. Ohashi; K. Hirakawa; B. Nakata; S. Saji; J. Sakamoto S. Morita; Y. Ohashi; K. Hirakawa; B. Nakata; S. Saji; J. Sakamoto Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: A novel study design to evaluate safety and efficacy Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: A novel study design to evaluate safety and efficacy Phase I/II study of combination therapy of oral fluorinated pyrimidine compound S-1 with low-dose cisplatin in patients with unresectable and/or recurrent advanced gastric cancer: A novel study design to evaluate safety and efficacy Japanese Journal of Clinical Oncology, 34, 3, 159-161 Japanese Journal of Clinical Oncology, 34, 3, 159-161 Japanese Journal of Clinical Oncology, 34, 3, 159-161 2004 英語 公開
W. Noguchi; T. Ohno; S. Morita; O. Aihara; H. Tsujii; K. Shimozuma; E. Matsushima W. Noguchi; T. Ohno; S. Morita; O. Aihara; H. Tsujii; K. Shimozuma; E. Matsushima W. Noguchi; T. Ohno; S. Morita; O. Aihara; H. Tsujii; K. Shimozuma; E. Matsushima Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer Reliability and validity of the Functional Assessment of Chronic Illness Therapy-Spiritual (FACIT-Sp) for Japanese patients with cancer Supportive Care in Cancer, 12, 4, 240-245 Supportive Care in Cancer, 12, 4, 240-245 Supportive Care in Cancer, 12, 4, 240-245 2004 英語 公開
M. Rahman; S. Morita; T. Fukui; J. Sakamoto M. Rahman; S. Morita; T. Fukui; J. Sakamoto M. Rahman; S. Morita; T. Fukui; J. Sakamoto Physician\\'s reasons for not entering their patients in a randomized controlled trial in Japan Physician\\'s reasons for not entering their patients in a randomized controlled trial in Japan Physician\\'s reasons for not entering their patients in a randomized controlled trial in Japan Tohoku Journal of Experimental Medicine, 203, 2, 105-109 Tohoku Journal of Experimental Medicine, 203, 2, 105-109 Tohoku Journal of Experimental Medicine, 203, 2, 105-109 2004 英語 公開
M. Rahman; S. Morita; T. Fukui; J. Sakamoto M. Rahman; S. Morita; T. Fukui; J. Sakamoto M. Rahman; S. Morita; T. Fukui; J. Sakamoto Physicians\\' choice in using Internet and fax for patient recruitment and follow-up in a randomized controlled trial Physicians\\' choice in using Internet and fax for patient recruitment and follow-up in a randomized controlled trial Physicians\\' choice in using Internet and fax for patient recruitment and follow-up in a randomized controlled trial Methods of Information in Medicine, 43, 3, 268-272 Methods of Information in Medicine, 43, 3, 268-272 Methods of Information in Medicine, 43, 3, 268-272 2004 英語 公開
J. Sakamoto; S. Morita; Y. Kodera; M. Rahman; A. Nakao J. Sakamoto; S. Morita; Y. Kodera; M. Rahman; A. Nakao J. Sakamoto; S. Morita; Y. Kodera; M. Rahman; A. Nakao Adjuvant chemotherapy for gastric cancer in Japan: Global and Japanese perspectives Adjuvant chemotherapy for gastric cancer in Japan: Global and Japanese perspectives Adjuvant chemotherapy for gastric cancer in Japan: Global and Japanese perspectives Cancer Chemotherapy and Pharmacology, 54, SUPPL. 1, S25-S31 Cancer Chemotherapy and Pharmacology, 54, SUPPL. 1, S25-S31 Cancer Chemotherapy and Pharmacology, 54, SUPPL. 1, S25-S31 2004 英語 公開
J. Sakamoto; S. Morita J. Sakamoto; S. Morita J. Sakamoto; S. Morita Planning, administration, and management of the clinical trial based on EBM - What are key points to generate valid evidence? Planning, administration, and management of the clinical trial based on EBM - What are key points to generate valid evidence? Planning, administration, and management of the clinical trial based on EBM - What are key points to generate valid evidence? Japanese Journal of Allergology, 53, 4, 413-416 Japanese Journal of Allergology, 53, 4, 413-416 Japanese Journal of Allergology, 53, 4, 413-416 2004 英語 公開
S. Morita; K. Shimozuma; A. Sato; M. Nakamachi; J. Blazeby; K. West; S. Fukuhara; J. Sakamoto S. Morita; K. Shimozuma; A. Sato; M. Nakamachi; J. Blazeby; K. West; S. Fukuhara; J. Sakamoto Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module Pilot-testing of the Japanese version of the EORTC QLQ-STO22 gastric cancer module Gan to kagaku ryoho. Cancer & chemotherapy, 31, 8, 1195-1199 Gan to kagaku ryoho. Cancer & chemotherapy, 31, 8, 1195-1199 , 31, 8, 1195-1199 2004 日本語 公開
S. Morita; K. Kobayashi; Y. Ohashi; K. Eguchi; M. Shibuya; T. Matsumoto; Y. Yamaji; K. Nagao; J. Sakamoto; H. Niitani S. Morita; K. Kobayashi; Y. Ohashi; K. Eguchi; M. Shibuya; T. Matsumoto; Y. Yamaji; K. Nagao; J. Sakamoto; H. Niitani S. Morita; K. Kobayashi; Y. Ohashi; K. Eguchi; M. Shibuya; T. Matsumoto; Y. Yamaji; K. Nagao; J. Sakamoto; H. Niitani Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial Weekly assessment of quality of life in patients with advanced non-small-cell lung cancer during chemotherapy in a randomized phase III trial Annals of Cancer Research and Therapy, 12, 1-2, 105-117 Annals of Cancer Research and Therapy, 12, 1-2, 105-117 Annals of Cancer Research and Therapy, 12, 1-2, 105-117 2004 英語 公開
S. Morita; Y. Ohashi; K. Kobayashi; T. Matsumoto; K. Eguchi; M. Shibuya; Y. Yamaji; M. Fukuoka; K. Nagao; H. Niitani S. Morita; Y. Ohashi; K. Kobayashi; T. Matsumoto; K. Eguchi; M. Shibuya; Y. Yamaji; M. Fukuoka; K. Nagao; H. Niitani S. Morita; Y. Ohashi; K. Kobayashi; T. Matsumoto; K. Eguchi; M. Shibuya; Y. Yamaji; M. Fukuoka; K. Nagao; H. Niitani Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer Individually different "weights" of quality of life assessment in patients with advanced nonsmall-cell lung cancer Journal of Clinical Epidemiology, 56, 8, 744-751 Journal of Clinical Epidemiology, 56, 8, 744-751 Journal of Clinical Epidemiology, 56, 8, 744-751 2003 英語 公開
J. Sakamoto; S. Morita; T. Yumiba; H. Narahara; K. Kinoshita; Y. Nakane; H. Imamoto; H. Shiozaki J. Sakamoto; S. Morita; T. Yumiba; H. Narahara; K. Kinoshita; Y. Nakane; H. Imamoto; H. Shiozaki J. Sakamoto; S. Morita; T. Yumiba; H. Narahara; K. Kinoshita; Y. Nakane; H. Imamoto; H. Shiozaki A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: A new concept of clinical benefit response for non-measurable type of gastric cancer A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: A new concept of clinical benefit response for non-measurable type of gastric cancer A phase II clinical trial to evaluate the effect of paclitaxel in patients with ascites caused by advanced or recurrent gastric carcinoma: A new concept of clinical benefit response for non-measurable type of gastric cancer Japanese Journal of Clinical Oncology, 33, 5, 238-240 Japanese Journal of Clinical Oncology, 33, 5, 238-240 Japanese Journal of Clinical Oncology, 33, 5, 238-240 2003 英語 公開
S. Morita; K. Kobayashi; K. Eguchi; T. Matsumoto; M. Shibuya; Y. Yamaji; J. Sakamoto; Y. Ohashi S. Morita; K. Kobayashi; K. Eguchi; T. Matsumoto; M. Shibuya; Y. Yamaji; J. Sakamoto; Y. Ohashi S. Morita; K. Kobayashi; K. Eguchi; T. Matsumoto; M. Shibuya; Y. Yamaji; J. Sakamoto; Y. Ohashi Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model Influence of clinical parameters on quality of life during chemotherapy in patients with advanced non-small cell lung cancer: Application of a general linear model Japanese Journal of Clinical Oncology, 33, 9, 470-476 Japanese Journal of Clinical Oncology, 33, 9, 470-476 Japanese Journal of Clinical Oncology, 33, 9, 470-476 2003 英語 公開
T. Fukui; M. Rhaman; K. Hayashi; K. Takeda; J. Higaki; T. Sato; M. Fukushima; J. Sakamoto; S. Morita; T. Ogihara; K. Fukiyama; M. Fujishima; T. Saruta T. Fukui; M. Rhaman; K. Hayashi; K. Takeda; J. Higaki; T. Sato; M. Fukushima; J. Sakamoto; S. Morita; T. Ogihara; K. Fukiyama; M. Fujishima; T. Saruta T. Fukui; M. Rhaman; K. Hayashi; K. Takeda; J. Higaki; T. Sato; M. Fukushima; J. Sakamoto; S. Morita; T. Ogihara; K. Fukiyama; M. Fujishima; T. Saruta Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial of cardiovascular events in high-risk hypertensive patients: Rationale, design, and methods Hypertension Research, 26, 12, 979-990 Hypertension Research, 26, 12, 979-990 Hypertension Research, 26, 12, 979-990 2003 英語 公開

  • <<
  • >>
  • 表示
タイトル言語:
講演・口頭発表等
タイトル タイトル(日本語) タイトル(英語) 会議名 会議名(日本語) 会議名(英語) 主催者 主催者(日本語) 主催者(英語) 開催年月日 記述言語 会議種別 公開
Bayesian Population Finding (BaPoFi) with Biomarkers in a Randomized Clinical Trial. Bayesian Population Finding (BaPoFi) with Biomarkers in a Randomized Clinical Trial. Bayesian Population Finding (BaPoFi) with Biomarkers in a Randomized Clinical Trial. CEN-ISBS Conference CEN-ISBS Conference CEN-ISBS Conference 2017/08 公開
Incorporating historical data in Bayesian phase I trial design: The Caucasian-to-Asian toxicity tolerability problem Incorporating historical data in Bayesian phase I trial design: The Caucasian-to-Asian toxicity tolerability problem Incorporating historical data in Bayesian phase I trial design: The Caucasian-to-Asian toxicity tolerability problem The Ninth ICSA International Conference The Ninth ICSA International Conference The Ninth ICSA International Conference 2013/12 英語 口頭発表(招待・特別) 公開
Bridging dose-finding for a multinational cancer phase I trial Bridging dose-finding for a multinational cancer phase I trial Bridging dose-finding for a multinational cancer phase I trial Society for Clinical Trials 34th Annual Meeting Society for Clinical Trials 34th Annual Meeting Society for Clinical Trials 34th Annual Meeting 2013/05 英語 口頭発表(招待・特別) 公開
Bayesian study designs for new drug development Bayesian study designs for new drug development Bayesian study designs for new drug development ISBA 2012 World Meeting ISBA 2012 World Meeting ISBA 2012 World Meeting 2012 英語 口頭発表(招待・特別) 公開
Bridging dose-finding studies from West to East. Bridging dose-finding studies from West to East. Bridging dose-finding studies from West to East. The 2nd CRM Workshop The 2nd CRM Workshop The 2nd CRM Workshop 2011 英語 口頭発表(招待・特別) 公開
Sequential dose-finding in phase I clinical trials in Japan: East meets West Sequential dose-finding in phase I clinical trials in Japan: East meets West Sequential dose-finding in phase I clinical trials in Japan: East meets West The 2011 Society for Clinical Trials Meeting The 2011 Society for Clinical Trials Meeting 2011 英語 口頭発表(招待・特別) 公開
Practical Application of the Continual Reassessment Method to a Phase I Dose-Finding Trial in Japan: East meets West Practical Application of the Continual Reassessment Method to a Phase I Dose-Finding Trial in Japan: East meets West Practical Application of the Continual Reassessment Method to a Phase I Dose-Finding Trial in Japan: East meets West The 1st CRM Workshop The 1st CRM Workshop The 1st CRM Workshop 2009/10 英語 口頭発表(招待・特別) 公開
タイトル言語:
書籍等出版物
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 出版社 出版社(日本語) 出版社(英語) 出版年月 記述言語 担当区分 公開
森田 智視 森田 智視 MORITA Satoshi Encyclopedia of Biopharmaceutical Statistics, 3rd Edition Encyclopedia of Biopharmaceutical Statistics, 3rd Edition Encyclopedia of Biopharmaceutical Statistics, 3rd Edition Informa Healthcare Informa Healthcare Informa Healthcare 2010 分担執筆 公開
森田 智視 森田 智視 消火器癌化学療法 消火器癌化学療法 南山堂 南山堂 2009 分担執筆 公開
森田 智視 森田 智視 MORITA Satoshi Handbook of Statistics in Clinical Oncology, Second Edition. Handbook of Statistics in Clinical Oncology, Second Edition. Handbook of Statistics in Clinical Oncology, Second Edition. CRC Press CRC Press CRC Press 2005 分担執筆 公開
森田 智視 森田 智視 腎臓病: 先端医療シリーズ 腎臓病: 先端医療シリーズ 先端医療技術研究所 先端医療技術研究所 2005 分担執筆 公開
森田 智視 森田 智視 癌治療の新たな試み 新編III 癌治療の新たな試み 新編III 医薬ジャーナル社 医薬ジャーナル社 2005 分担執筆 公開
森田 智視 森田 智視 QOL評価学‐測定, 解析, 解釈のすべて QOL評価学‐測定, 解析, 解釈のすべて 中山書店 中山書店 2005 共訳 公開
森田 智視 森田 智視 実践医学統計学 実践医学統計学 朝倉書店 朝倉書店 2004 共訳 公開
森田 智視 森田 智視 臨床のためのQOL評価ハンドブック 臨床のためのQOL評価ハンドブック 医学書院 医学書院 2001 分担執筆 公開
森田 智視 森田 智視 新QOL調査票と評価の手引き 新QOL調査票と評価の手引き メディカルレビュー社 メディカルレビュー社 2001 分担執筆 公開
森田 智視 森田 智視 医学統計のための線型混合効果モデル-SASによるアプローチ- 医学統計のための線型混合効果モデル-SASによるアプローチ- サイエンティスト社 サイエンティスト社 2001 共訳 公開
森田 智視 森田 智視 シナリオで学ぶ医療経済学入門 シナリオで学ぶ医療経済学入門 サイエンティスト社 サイエンティスト社 2000 共訳 公開

  • <<
  • >>
  • 表示
タイトル言語:
外部資金:競争的資金・科学研究費補助金
種別 代表/分担 テーマ(日本語) テーマ(英語) 期間
基盤研究(C) 代表 ベイズ流アプローチによる探索的がん臨床試験デザインの開発 Bayesian study designs for new drug development in early-stage cancer clinical trials 2012〜2014
免疫アレルギー疾患等予防・治療研究事業 分担 HLA不適合血縁者間移植の安全性および有効性向上のための包括的研究 2011〜2011
がん臨床研究事業 分担 バイオマーカーに基づいた肺癌個別化治療における分子標的治療薬の至適治療法を検証するランダム化第Ⅲ相試験 2011〜2011
肝炎等克服緊急対策研究事業 分担 ゲノムワイド関連解析を用いた革新的な肝移植後肝炎ウィルス再感染予防・治療法の確立 2011〜2011
医療技術実用化総合研究事業 分担 大腸癌におけるオキサリプラチンの抹消神経障害に対する漢方薬:牛車腎気丸の有用性に関する多施設共同二重妄検ランダム化比較検証試験(臨床第Ⅲ相試験) 2010〜2011
基盤研究(C) 代表 ベイズ流アプローチによる探索的がん臨床試験デザインの開発 (平成26年度分) 2014/04/01〜2015/03/31
がん対策推進総合研究事業 分担 (平成29年度分) 2017/04/01〜2018/03/31
がん対策推進総合研究事業 分担 (平成30年度分) 2018/04/01〜2019/03/31
担当科目
講義名(日本語) 講義名(英語) 開講期 学部/研究科 年度
保健医療統計学 Health Statistics 前期 医学研究科(人間健康科学系専攻) 2015/04〜2016/03
保健医療統計学 Health Statistics 前期 医学研究科(人間健康科学系専攻) 2016/04〜2017/03
保健医療統計学 Health Statistics 前期 医学研究科(人間健康科学系専攻) 2017/04〜2018/03
保健医療統計学 Health Statistics 前期 医学研究科(人間健康科学系専攻) 2018/04〜2019/03
臨床研究実地研修 I Clinical Research Training I 前期集中 医学研究科 2018/04〜2019/03
高度医療看護論 Transplantation and Regeneration Nursing 前期前半 医学部(人間健康科学科) 2018/04〜2019/03
保健医療統計学 Health Statistics 前期 医学研究科(人間健康科学系専攻) 2019/04〜2020/03
臨床研究実地研修 I Clinical Research Training I 通年集中 医学研究科 2019/04〜2020/03
臨床研究実地研修II Clinical Research Training II 通年集中 医学研究科 2019/04〜2020/03
高度医療看護論 Transplantation and Regeneration Nursing 前期前半 医学部(人間健康科学科) 2019/04〜2020/03
全学運営(役職等)
役職名 期間
オープンキャンパス委員会 委員 2014/01/01〜2014/12/31
部局運営(役職等)
役職名 期間
医学部附属病院 臨床研究総合センター データサイエンス部長 2013/06/02〜
病院協議会 委員 2013/06/02〜2020/03/31
iPS等臨床試験センター整備専門委員会 〜2018/03/31
特定臨床研究実施管理委員会 〜2020/03/31
臨床研究総合センター協議会 〜2019/03/31
臨床研究総合センター運営会議 〜2020/03/31
臨床研究総合センター推進委員会 〜2020/03/31
臨床研究総合センター医療開発委員会 〜2017/03/31
iPS等臨床試験センター設置準備委員会 2018/04/01〜2020/03/31
研究開発戦略推進委員会 2018/04/01〜2020/03/31
シーズ選定委員会 2018/04/01〜2020/03/31
管理体制委員会 2014/10/01〜2020/09/30
寄附講座運営委員会(臨床システム腫瘍学講座) 2017/04/01〜2020/03/31
臨床研究総合センター財務委員会 委員 2019/04/01〜2020/03/31
臨床研究総合センター人事委員会 委員 2019/04/01〜2020/03/31
iPS等臨床試験センター設置準備室ミーティング 委員 2019/04/01〜2020/03/31
シーズ評価委員会 委員 2019/04/01〜2020/03/31
臨床試験データ等の移転規程化に向けたワーキンググループ 委員 2019/04/01〜2020/03/31
特定臨床研究実施管理委員会事務局ワーキング 委員 2019/04/01〜2020/03/31
ゲノム医学センター運営委員会 2019/04/01〜
学術情報システム・情報セキュリティ委員会 2019/03/01〜2020/03/31

  • <<
  • >>
  • 表示